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Summary
Ryanodine receptors (RyR), expressed within the ER or plasma membrane (PM), may 
contribute to regulated insulin secretion from pancreatic β-cells. Amplification by RyR of 
the Ca
2+
 signals evoked by voltage-gated Ca
2+
 channels may contribute to the second phase 
of insulin release, but the role of RyR in the plasma membrane is unresolved. My aim was 
to define the roles of RyR in pancreatic β-cells. I used INS-1E insulinoma cells, which have 
been reported to secrete insulin in response to glucose, to characterise the contribution of 
RyR to Ca
2+ 
entry and release. KCl-evoked Ca2+ entry in INS-1E cells was mediated by L-
type Ca
2+
 channels. Both caffeine and carbachol evoked Ca2+ entry and release. Caffeine-
evoked Ca
2+
 entry was inhibited by ryanodine and nimodipine. This might be due to direct 
activation of RyR in the PM, or activation of other Ca2+-permeable channels in the PM 
secondary to Ca
2+
 release via RyR. However, glucose did not evoke insulin secretion from 
INS-1E cells, and the Ca
2+
 signals evoked by caffeine and carbachol became very variable 
with increasing passage number. It was therefore impossible with INS-1E cells to establish 
the role of RyR in glucose-evoked insulin release, and preliminary results with primary β-
cells suggested that the quantitative analyses required to identify modest contributions from 
RyR would be impracticable. 
Previous work established that in HEK cells expressing type 1 parathyroid hormone 
receptors (PTH1R), PTH(1-34) potentiated carbachol-evoked Ca
2+
 release via a mechanism 
that required local delivery of cAMP to IP3 receptors (IP3R) within signalling junctions. My 
aim was to establish whether the interaction between adenylyl cyclase (AC) and IP3R 
persists during sustained stimulation with PTH, which has been reported to cause 
internalization of a functional PTH1R signalling pathway. In HEK cells expressing type 1 
PTH1R, stimulation with PTH(1-34) for 1-60 min potentiated carbachol-evoked Ca
2+ 
signals. The potentiation was greater after acute (1 min) relative to sustained (60 min) 
stimulation. However, intracellular concentrations of cAMP were greater after sustained 
stimulation. Inhibition of protein kinase A (PKA) or exchange proteins activated by cAMP 
(EPAC) had no effect on the Ca
2+
 signals evoked by carbachol after acute or sustained 
stimulation with PTH(1-34). Similar results were obtained with acute and sustained 
iv 
stimulation with NKH477 to activate AC or with a membrane-permeant analogue of 
cAMP, 8-Br-cAMP. Paired combinations of the three stimuli – PTH(1-34), NKH477 and 
8-Br-cAMP – had the same maximal effect as each alone during acute and sustained
treatments. Neither acute nor sustained treatment with PTH(1-34) alone affected the Ca
2+
 
content of the intracellular stores. These results indicate that sustained increases in cAMP 
reduce the extent to which cAMP potentiates carbachol-evoked Ca
2+
 release. Analyses of 
responses to PTH analogues that differ in their abilities to evoke internalization of 
signalling pathways and/or activate phospholipase C versus AC confirmed that the effects 
of acute and sustained stimulation with PTH on Ca
2+
 signalling were mediated by cAMP 
and unlikely to require internalization of PTH1R. 
Inhibition of AC with SQ22536 and 2′,5′-dideoxyadenosine reduced the amounts of 
cAMP produced by acute and sustained stimulation with PTH(1-34) by ~80%, but they had 
no effect on potentiation of carbachol-evoked Ca
2+
signals. Inhibition of cyclic nucleotide 
phosphodiesterases with IBMX had no effect on the Ca
2+
 signals evoked by carbachol after 
acute stimulation with PTH(1-34). However, during sustained stimulation (60 min), when 
cAMP levels were increased ~15-fold by IBMX, carbachol-evoked Ca
2+
 signals were ~10-
fold more sensitive to PTH(1-34), although the maximal potentiation remained smaller 
than observed during acute stimulation. Using an IP3 biosensor to measure cytosolic IP3 
demonstrated that sustained stimulation with PTH(1-34) attenuated the carbachol-evoked 
increase in cytosolic IP3 concentration. I conclude that acute and sustained responses to 
PTH(1-34) are mediated by local delivery of saturating concentrations of cAMP to IP3R 
within signalling junctions. Sustained increases in cAMP, via mechanisms that do not 
involve internalization of PTH1R or activation of PKA, diminish the effectiveness with 
which this local delivery of cAMP potentiates carbachol-evoked Ca
2+
 release, probably by 
diminishing carbachol-evoked IP3 formation.  
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Chapter 1. Introduction 
Intracellular signalling is an intricate process. Cells continuously receive external 
stimuli, which often result in the formation of intracellular messengers. These 
messengers subsequently decode the external stimuli into a specific cellular response. 
The most important and extensively studied second messengers are Ca
2+
 and cyclic 
adenosine monophosphate (cAMP) (Sutherland, 1970; Zaccolo et al., 2002). Exploring 
how changes in second messenger levels regulate various intracellular signalling 
pathways is an ongoing process. It could involve frequency, controlled amplitude and 
spatio-temporal modes of regulation (Berridge et al., 2000). For example, periodic 
increases or decreases in the levels of second messengers can be observed when 
glucagon stimulates Ca
2+
 and cAMP oscillations in HEK-293 cells expressing type III 
adenylyl cyclase (Dyachok et al., 2006; Wayman et al., 1995). The cross-talk between 
Ca
2+
 and cAMP signalling pathways add a secondary level of complexity (Bruce et al., 
2003; Siso-Nadal et al., 2009), enabling Ca
2+
 to regulate cAMP level and vice versa.  





 is an intracellular messenger that performs a diverse range of physiological and 
biochemical functions. Ca
2+ 
signals are highly temporally and spatially organised 
(Berridge, 1997), and control a wide variety of complicated cellular process like 
embryonic pattern formation, exocytosis, fluid secretion, cell contraction, apoptosis and 





resting cells is ~10-100nM. Activation of cells by depolarisation, mechanical 
deformation or by binding of ligands to receptors (e.g. hormones, neurotransmitters, 
etc) leads to increases in [Ca
2+
]c up to ~1µM (Berridge et al., 2003). Inside the cell,
Ca
2+
 signals follow complex temporal and spatial arrangements. Prolonged increases in 
[Ca
2+
]c are toxic. Cells have evolved mechanisms that allows tight regulation of [Ca
2+
]c
(Clapham, 1995). Increases in [Ca
2+
]c occur either by Ca
2+
 entry across the plasma
membrane (PM) or by Ca
2+ 
release from intracellular stores. Both are mediated by 
opening of Ca
2+
-permeable channels. Sequestration of Ca
2+
 occurs by various pumps 
and exchangers which continuously extrude Ca
2+
 into the extracellular space or 
intracellular stores. These processes together allow cells to rapidly and reversibly  
generate  changes in [Ca
2+




The endoplasmic reticulum (ER), or the sarcoplasmic reticulum (SR) in muscle, 
is the most important intracellular Ca
2+
 storage organelle. The free [Ca
2+
] inside the 
ER/SR lumen is approximately  400µM (Miyawaki et al., 1997). The continuous 
accumulation of Ca
2+ 
from the cytosol into the ER is made possible by ER membrane-
resident Ca
2+ 
pumps and an ER resident Ca
2+
-binding protein known as calreticulin 
(Michalak et al., 1999). Other intracellular organelles that also contribute to the rise in 
[Ca
2+
]i are the nucleoplasmic reticulum, mitochondria, Golgi apparatus, lysosomes,
secretory vesicles and nuclear envelope. Each intracellular organelle has a specific 
signalling mechanism for the regulation of Ca
2+
 release through Ca
2+
 -permeable 






] is ~2mM, compared to ~100nM in the cytosol. This gives an 
~20,000-fold concentration gradient in [Ca
2+
] across the PM (Clapham, 1995). In 
addition, the negative resting membrane potential adds a huge electrochemical 
difference, which favours Ca
2+
 influx across the PM (Parekh et al., 2005). The Ca
2+
 
channels that allow Ca
2+
 entry across the PM can be conveniently classified on the 
basis of their activation mechanisms. Voltage-operated Ca
2+ 
channels (VOC) are 
activated by depolarisation of the PM. They are predominantly found in excitable cells, 
for example, pancreatic β-cells, muscle and neurons, and they typically contribute to 
large and rapid Ca
2+ 
entry signals. VOCs are classified according to their voltage-
sensitivity and pharmacological characteristics into three families: L-type (Cav1); P/Q, 
R and N-type (Cav2); and T-type (Cav3). Cav1 and Cav2 are activated by large 
membrane depolarisations, while Cav3 are low-voltage-activated channels (Braun et al., 
2008). Cav1 and Cav3 are expressed in pancreatic β-cells (Yang et al., 2006). 
Receptor-operated Ca
2+
 channels (ROC) are activated by binding of a ligand to an 
extracellular domain of the channel, which leads to conformational changes and 
opening of an intrinsic channel. ROCs are activated by a wide variety of agonists, for 
example ATP, 5-HT, glutamate and acetylcholine. ROCs include several structurally 
diverse families including Cys-loop receptors (e.g. nicotinic acetylcholine and 5-HT3 
receptors), glutamate receptors (e.g., AMPA and NMDA receptors) and P2X receptors 
(Heimes et al., 2009; Inagaki et al., 1995; Jacques-Silva et al., 2010; Ruiz de Azua et 
al., 2011)  




 Second messenger-operated Ca
2+ 
channels (SMOCs) are a diverse category of 
channels that are activated by second messengers like diacylglycerol (DAG) and 
arachidonic acid. For example DAG activates some transient receptor potential 
channels (TRP), notably TRPC3, TRPC6 and TRPC7 (Hofmann et al., 1999; Okada et 
al., 1999). Some TRPCs are expressed in pancreatic β-cells (Islam, 2010). Arachidonic 
acid has been reported to activate channels (ARC) that appear to be specific oligomeric 
assemblies of Orai proteins (Mignen et al., 2007).  
 Store-operated Ca
2+ 





channels (CRAC) (Parekh et al., 2005). It is activated when the [Ca
2+
] within the ER 
falls (Liou et al., 2005; Luik et al., 2006). SOCE requires both a stromal interaction 
molecule (STIM 1 or STIM 2), much of which is expressed in ER membranes, and Orai 





 dissociates from the luminal EF-hand of STIM causing its 
oligomerization and translocation towards ER near the PM to form STIM puncta. The 
C-terminal CRAC activation domain (CAD) of STIM 1 can then interact with the C and 
N-termini of Orai1 to cause its pore to open. One suggestion is that tetrameric STIM 
CAD domains cause dimers of Orai to assemble into functional tetramers which  then 
mediate Ca
2+ 
entry (Cahalan, 2009; Luik et al., 2006). STIM 2 can also stimulate 
SOCE, but STIM 2 responds to lesser reductions in luminal [Ca
2+
] and may be involved 
in regulating basal rates of Ca
2+
 entry to replenish the ER Ca
2+
 stores (Brandman et al., 
2007; Parvez et al., 2008). Recently the CAD domain of STIM was claimed to bind 
also to the C-terminal of the α-subunit of Cav1.2 to cause inhibition of the L-type Ca
2+
 
channel (Park et al, 2010). This reciprocal regulation by STIM of SOCE (via Orai) and 
voltage-gated Ca
2+
 entry (via L-type Ca
2+
 channels) may account for the apparent 
absence or much diminished activity of SOCE in electrically excitable cells (Park et al., 
2010; Wang et al., 2010). Whether reduced expression of STIM in pancreatic β-cells 
accounts for their active L-type Ca
2+
channels and weak SOCE is not yet known 




release channels  
Ca
2+
 release from intracellular stores mostly takes place via inositol trisphosphate 
receptors (IP3R) and ryanodine receptors (RyR) (Foskett et al., 2007; Lanner et al., 
2010). IP3Rs are ligand-gated Ca
2+ 
channels, mostly expressed in animal cells. IP3Rs 




are chiefly localised within the ER membrane, but they can also be present on other 
membranes, for example, the nuclear envelope (Rahman et al., 2010), Golgi apparatus 
and plasma membrane. These channels have poor cation selectivity and a large 
conductance for Ca
2+
 (Rahman et al., 2010). 
 There are three subtypes of IP3Rs (IP3R1, IP3R2, IP3R3  expressed in mammalian 
cells   lmost  7   of the amino acid sequences are similar in all the IP3R subtypes, but 
they have distinct tissue distributions (Ross et al., 1992; Taylor et al., 1999) and some 
disparity in their regulation and sensitivity to IP3 and its analogue adenophostin 
(Saleem et al., 2012; Saleem et al., 2013). Fully functional IP3R channels are formed by 
their splice variants and homo-or hetero-tetramers of these subtypes (Taylor et al., 
1999). Each subunit of the tetramer consists of an IP3-binding core (IBC), a large 
cytosolic regulatory domain, suppressor domain at its cytoplasmic N terminus, 6 
transmembrane domains and a short cytoplasmic C-terminal tail (Foskett et al., 2007). 
The last two transmembrane domains with the intervening luminal loop form the IP3R 
channel pore. 
 For activation, IP3R needs IP3 and Ca
2+ 
(Marchant et al., 1997); however, other 
proteins and small intracellular molecules, for example, PKA (Nakade et al., 1994), 
calmodulin (Taylor et al., 2002) and ATP (Thrower et al., 2000) can also modulate 
IP3R activity. Small increases in [Ca
2+
]c  potentiate responses to IP3, while larger 
increases (> 1µM) are inhibitory (Berridge et al., 1989; Horne et al., 1997; Marchant et 
al., 1997). The mechanisms are not resolved, but IP3 appears to control IP3R gating by 
controlling whether Ca
2+
 binds to stimulatory or inhibitory binding sites (Adkins et al., 







release (CICR) which is exhibited by both IP3R and 
RyR. It allows the Ca
2+ 
release from one IP3R to stimulate neighbouring RyR or other 
IP3Rs. CICR is important for generation of regenerative Ca
2+ 
signals, since it allows the 
translation of local Ca
2+ 
signals into a global increase in [Ca
2+
]c (Berridge et al., 2000). 
IP3, a diffusible second messenger, is generated at the PM upon activation of a PM-
localised GPCR that stimulates phospholipase C (PLC). Some of the links between 
GPCRs and ion channels are summarised in figure 1.1. Binding of IP3 to the IBC of 
IP3R evokes conformational changes (Seo et al., 2012), which then lead to the opening 
of the pore located at the C-terminus of the tetramer. However, both Ca
2+
 and IP3 are 
needed for the activation of IP3R, yet the actual mechanism of how rearrangement of 
the N-terminus causes binding of Ca
2+
 and opening of the pore is not fully known. 




 Inactivation of IP3 is regulated by its metabolism to inositol 1,3,4,5- 
tetrakisphosphate (IP4) and inositol 1,4-bisphosphate (IP2) by IP3-kinase and IP3 5-
phosphatase, respectively. Studies in mouse neuroblastoma cells show that IP3 has an 
estimated half-life of only  9 s (Wang et al., 1995). IP4 perhaps acts as a signalling 
molecule (Irvine, 2007). IP4 has been reported to activate IP3R in permeabilized cells, 
however, it is     -fold less potent then IP3 (Saleem et al., 2013). IP4 has also been 
proposed to regulate Ca
2+
 entry (Miller et al., 2007), but the physiological role of IP4 is 
not entirely clear.        
 
 
Figure 1.1. Summary of key steps linking agonist activation of GPCR to ion 
channels. GPCR catalyze, via exchange of GDP for GTP on the α-subunit of G 
proteins, activation of G proteins  Dissociated Gα-GTP and Gβγ subunits of the G-
protein can then activate adenylyl cyclase, phospholipase C and phospholipase A2, and 
directly regulate some ion channels. The enzymes catalyse formation of the second 
messengers, cAMP, IP3, DAG, AA and PIP2 which can directly activate ion channels. 
DAG and cAMP can also indirectly regulate ion channels via proteins kinases C and A, 
respectively. 
 
 RyR are another family of Ca
2+ 
release channels found mainly in the membranes 
of ER/SR. These channels also have large-conductance and poor selectivity for Ca
2+
 
(Fill et al., 2002). Similar to IP3R, RyR also follows a bell-shaped dependency for 
regulation by [Ca
2+
]c. These channels are activated by low [Ca
2+


















µM and inactivated at higher [Ca
2+
]c (1-10 mM) (Chen et al., 1997; Hayek et al., 2000; 
Meissner, 2004). According to Berridge et al (2000), RyR are also capable of 
propagating Ca
2+ 
signals as regenerative waves across the cell. Apart from Ca
2+
, 
ryanodine, a plant alkaloid, also activates RyR in a concentration-dependent manner. 
Stimulation with low ryanodine concentrations increases the open-probability of the 
channel (Buck et al., 1992), whereas it inhibits channels at higher concentrations 
(Zimanyi et al., 1992). A second messenger, cADPR, has been shown to activate RyR 
in numerous cell types (Lee, 1997; Ogunbayo et al., 2011). However, the effect of 
cADPR on the RyR of muscle cells is still unclear (Copello et al., 2001). Intracellular 
formation of cADPR occurs by the action of CD38 on nicotinamide adenine 
dinucleotide (NAD) (Howard et al., 1993). The conversion of NAD phosphate (NADP) 
to nicotinic acid adenine dinucleotide phosphate (NAADP) is also catalysed by CD38. 
NAADP can also evoke release of Ca
2+
 (see below). The activation of CD38 is 
regulated by various factors like cyclic nucleotides, and specific cell-surface receptors. 
Depending on the activation mechanism, either cADPR or NAADP is formed (Lee, 
2000).   
 Three subtypes of RyR are known viz. RyR1, RyR2 and RyR3; all the subtypes 
are expressed in mammalian cells. RyR1 is mostly expressed in skeletal muscle cells, 
RyR2 in cardiac cells and RyR3 in neurones and smooth muscle cells. However, the 
RyR3 expression level is generally much lower than that of RyR1 or RyR2. The most 
important role of RyR is in striated muscle cells. RyR mediates excitation-contraction 
coupling in these cells (Shoshan-Barmatz et al., 1998). Depolarization of the PM 
activates VOCs, which are coupled to activation of RyR, but the activation mechanisms 
are different for each RyR subtype. RyR1 is directly activated by L-type Ca
2+
 channels, 
by a protein-protein interaction (Marx et al., 1998). Whereas in cardiac myocytes, 
activation of L-type Ca
2+
 channels first mediates Ca
2+
 entry that consequently activates 
RyR2 by CICR. Activation of RyR, either indirectly by CICR or directly by coupling to 
L-type Ca
2+
 channels, triggers release of Ca
2+
 from the SR, which leads to contraction 
(Bers, 2002; Best et al., 2012). 
 NAADP generation has also been shown to increase [Ca
2+
]c upon stimulation 
with specific agonists (Guse et al., 2008). It stimulates the release of Ca
2+
 from acidic 
organelles (Churchill et al., 2002; Gambara et al., 2008). The increases in [Ca
2+
]c 
triggered by NAADP further stimulate release of Ca
2+
 form ER via IP3R and RyR by 
CICR (Cancela et al., 1999). Churchill et al. (2002) showed that NAADP stimulates a 




lysosome-like structure present in sea urchin eggs. Indeed, this evidence suggested that 
NAADP mobilises Ca
2+ 
from a lysosomal store. NAADP activates two pore channels 
(TPC) localised on the lysosomes, thereby releasing Ca
2+
 (Calcraft et al., 2009; Galione 
et al., 2010; Patel et al., 2011). Mammalian TPCs have been classified as 
endolysosomal Ca
2+
 release channels. However, in a recent study, TPCs are described 
as Na
+
-selective channels activated by PI(3,5)P2 (Wang et al., 2012). Hence, whether 
TPCs are Ca
2+
 release channels activated by NAADP or Na
+
-selective channels 
activated by PI(3,5)P2 is a matter of debate. 
 Sphingosine-1-phosphate and sphingosylphosphoryl choline can also induce 
release of Ca
2+
 within the cell. These are known to activate intracellular Ca
2+
 channels 
by acting on PM localised receptors, but they can also act directly to release Ca
2+ 
from 
the ER. A channel responsible for this effect was initially suggested, but the original 
claim has been discredited (Rizzuto et al., 2006; Schnurbus et al., 2002).  
 
1.1.3. Recovery from Ca
2+ 
signals 
Maintenance of the resting [Ca
2+
]c and rapid recovery from increases in [Ca
2+
]c are 
achieved by transport of Ca
2+
 out of the cytosol across the PM or membranes of 
intracellular organelles. Ca
2+ 
extrusion across the PM takes place a) via high-affinity, 
low capacity ATP-dependent Ca
2+ 
ATPases (PMCA) that hydrolyse ATP to transport 
Ca
2+










 in exchange for the influx of three Na
+ 




 uptake into SR/ER occurs through high-affinity, low capacity ATP-
dependent SR/ER Ca
2+
-ATPase pumps (SERCA) present on the SR/ER membrane 
(Strehler et al., 2004). Inhibition of SERCA can be achieved using a variety of 
compounds (Michelangeli et al., 2011), amongst which cyclopiazonic acid (CPA) and 
thapsigargin are the most frequently used. These compounds stabilize the Ca
2+
-free 
conformation of SERCA. Thapsigargin binds irreversibly, whereas CPA is a reversible 
inhibitor.  
 Mitochondria also sequester Ca
2+
 via the mitochondrial Ca
2+
 uniporter (MCU) 
located in the inner mitochondrial membrane, using its electrochemical gradient 
(Colegrove et al., 2000). The MCU is a Ca
2+
-selective transporter; it uses the 




mitochondrial membrane potential as the energy source for  uptake of Ca
2+
 instead of 
coupling to ATP hydrolysis (Babcock et al., 1997; Kirichok et al., 2004). The MCU has 
low affinity for Ca
2+
 (10-20 µM), suggesting that the role of mitochondria in the 
regulation of [Ca
2+
]c is marginal. Nevertheless, accumulation of Ca
2+
 by mitochondria 
during physiological cellular responses has been established (Glitsch et al., 2002; 
Hajnoczky et al., 1995; Olson et al., 2010). This contradiction was explained by the 
distribution of mitochondria close to Ca
2+
-permeable channels, where the local [Ca
2+
]c 
was significantly higher in comparison to the global increase in [Ca
2+
]c (Rizzuto et al., 
2009). The electrophysiological properties of the MCU and the importance of 
mitochondrial Ca
2+
 uptake were established long before the molecular identity of the 
MCU was known. A protein localised in the inner mitochondrial membrane, which 
forms multimeric complexes and is sensitive to ruthenium red (an inhibitor of 
mitochondrial Ca
2+ 
uptake) has been recognised as the MCU. These results were further 
confirmed, when silencing the expression of this protein led to decreased mitochondrial 
Ca
2+
 uptake, and over-expression significantly increased mitochondrial Ca
2+
 uptake. In 
summary, these results suggest that the protein is MCU (Baughman et al., 2011; De 
Stefani et al., 2015; De Stefani et al., 2011). Figure 1.2 illustrates the major routes for 
Ca
2+















Figure 1. 2. Ca
2+ 
signalling pathways. Routes for Ca
2+
 transport to and from the 
cytosol are shown. Ca
2+ 





entry channels (SOCE), voltage-operated Ca
2+ 
channels 
(VOCs), and second messenger-operated Ca
2+
 channels (SMOCs) activated by such 
intracellular signals as DAG and AA. Ca
2+
 release via ER Ca
2+ 
channels occurs 
primarily via IP3R and RyR activated by IP3 and cADPR, respectively. NAADP, via 
TPC, mediates release of Ca
2+
 from lysosomes. Ca
2+
 sequestration takes place by the 
SERCA in the ER membrane, by an unidentified uptake mechanism in the lysosomal 
membrane, and by MCU in mitochondria. Extrusion of Ca
2+
 across the PM occurs via 
NCX and PMCA. 
 
1.1.4. Spatio-temporal organization of Ca
2+
 signals 
Interplay between the various Ca
2+
-transporting proteins and the substantial buffering 
capacity of the cytosol allow spatially organised Ca
2+
 signals (Berridge, 1997), such 
that increases in [Ca
2+
]c may either be restricted to the immediate vicinity of a single 
open channel or  spread to include the entire cell. These local Ca
2+ 
microdomains are 
the basic units of Ca
2+ 
signalling. They allow each Ca
2+
 channel to direct Ca
2+
 
distinctively to its targets (Fagan et al., 1998; Jouaville et al., 1999; Luzio et al., 2007) 
or to a protein which removes Ca
2+
 from the cytosol. For both IP3R and RyR, their 
stimulation by cytosolic Ca
2+
 allows  CICR to propagate regenerative cytosolic Ca
2+
 
signals (Lopez-Lopez et al., 1995). Increasing concentrations of IP3 cause Ca
2+
 release 




events to grow from openings of individual IP3R (‘Ca
2+
 blips’  to ‘Ca
2+
 puffs’, which 
arise from the coordinated opening of several clustered IP3R, and eventually to Ca
2+
 
waves that spread throughout the cell (Marchant et al., 1999; Rahman et al., 2009; 
Smith et al., 2009). Such spatially organised Ca
2+
 signals have important physiological 
consequences. In smooth muscle, local Ca
2+
 release via RyR close to the PM causes 
relaxation by hyperpolarising the PM, while Ca
2+
 entry via depolarisation-evoked 
opening of L-type Ca
2+
 channels causes contraction (Nelson et al., 1995). There are 
many other examples where a local increase in [Ca
2+
]c is selectively directed to a 
specific target. These include the Ca
2+
 signals underlying exocytosis (Tse et al., 1993), 
regulation of gene expression (Dolmetsch et al., 1998), mitochondrial metabolism 
(Hajnoczky et al., 1995), embryonic pattern formation, fertilisation and cell movement 
(Whitaker et al., 2008), and apoptosis (Lordan et al., 2009). Control of cellular process 
by Ca
2+ 
microdomains therefore requires a close juxtaposition of different organelles 
associated with Ca
2+ 
signalling. It is well recognised that local communications 






 channels and effectors 
support the versatility of Ca
2+
 signalling.    
 Sustained high [Ca
2+
]c is cytotoxic for the cell, even so, Ca
2+ 
controls 
comparatively long-lasting cellular process, for instance, insulin secretion (Gilon et al., 
2002), gene expression (Di Capite et al., 2009) and fertilization (Miyazaki, 2007). This 
discrepancy between Ca
2+
-dependent regulation of long-lasting intracellular processes 
without the cytotoxic effects of Ca
2+





 oscillations have been observed in different cell types such as, pancreatic 
β-cells (Bertram et al., 2010; Liu et al., 1998), human embryonic kidney cells (Bird et 
al., 2005; Thurley et al., 2011), vascular endothelial cells (Zhu et al., 2008), airway 
smooth muscle cells (Perez et al., 2005) and hepatocytes (Rooney et al., 1990). In non-
excitable cells, Ca
2+
 oscillations are typically initiated by PLC-coupled receptors 
followed by cycles of reuptake and release from the ER. In these cases, Ca
2+
 entry is 
mediated by SOCE to sustain Ca
2+
 oscillations (Bird et al., 2005; Wedel et al., 2007). 
Whereas, in excitable cells, for example, pancreatic β-cells and cardiomyocytes, 
frequent increases in [Ca
2+
]c are caused by cyclic depolarizations of PM localised VOC 
(Bers, 2002; Liu et al., 1998).  
 PLC-evoked Ca
2+
 oscillations involve cyclical Ca
2+
 release and sequestration, to 
and from intracellular stores. The exact mechanism is not entirely understood, but two 
models have been proposed (Sneyd et al., 2006). In the first model, [Ca
2+
]c controls IP3 




formation by regulating PLC activity. Therefore, the Ca
2+
 oscillations are in synchrony 
to the changes in IP3 concentration. In the second model, [Ca
2+
]c controls its release 
from the ER by directly decreasing or increasing the IP3R open probability at higher 
and low [Ca
2+
]c, respectively. Hence, Ca
2+
 oscillates in the presence of a continuously 
elevated IP3 concentration. Furthermore, other studies have shown that Ca
2+
 oscillations 
occur both in the presence of oscillating and constant IP3 concentration (Nash et al., 
2001), which suggests that the mechanism is most likely either receptor-specific or cell 
type-dependent. 
 Regardless of the fundamental feed-back mechanism, the temporal complexity of 
Ca
2+ 
oscillations offers an encoding mechanism capable of controlling cellular 
processes, which not only depends on their  frequency, but also on the duration and 
amplitude of the Ca
2+
 signals (Dolmetsch et al., 1998; Thurley et al., 2014). The 
complex temporal profile of Ca
2+
 signals, in combination with their delicate spatial 
control, further supports the versatility and specificity of Ca
2+ 
as a second messenger. 
 
1.2. cAMP as a second messenger 
The 'second messenger' concept  originated with the discovery of cAMP (Sutherland, 
1970). Similar to Ca
2+
, cAMP also regulates many cellular functions which include cell 
division, cell differentiation, gene transcription, and ion channel activity (Willoughby et 
al., 2007). For cAMP, the mechanism of maintaining intracellular cAMP concentration 
is different from Ca
2+
, synthesis of cAMP occurs mainly at the PM and its degradation 
occurs throughout the cytoplasm (Zaccolo et al., 2002). Intracellular 
compartmentalization of cAMP is acquired by binding to different cAMP signalling 
components including phosphatases, protein kinase A (PKA), adenylyl cyclase (AC), 
phosphodiesterase (PDE) (Dessauer, 2009; Zaccolo, 2011).  
 So far there are ten AC isoforms are known, of which nine are membrane-bound 
and one is soluble. Each shows differential regulation and tissue distribution. All nine 
PM bound ACs have a similar structure, with two groups of six trans-membrane 
domains linked by a long cytosolic domain consisting of a highly conserved ATP-
binding domain important for full AC activity (Willoughby et al., 2007). Following 
activation of AC, cAMP is released locally and it is then recognised by various 
signalling pathways. The basal levels of cAMP are maintained by phosphodiesterases 
(PDE), which degrade cAMP to 5'-AMP.  




 There are three major cAMP signalling effectors (a) protein kinase A (PKA) 
(Walsh et al., 1968), (b) exchange protein activated by cAMP (Epac) (de Rooij et al., 
1998), and (c) cyclic nucleotide-gated channels (CNGCs) (Nakamura et al., 1987; 





PKA and Epac play a significant role in release of Ca
2+
 from intracellular stores. PKA 
is the most common intracellular target for cAMP (Beavo et al., 2002). Each PKA 
consists of two regulatory (R) subunits and two catalytic (C) subunits (Tasken et al., 
1997)  Four R isoforms: RIα, RIβ, RIIα, RIIβ (Clegg et al., 1988; Jahnsen et al., 1986; 
Lee et al., 1983; Scott et al., 1987), and three C isoforms are known: Cα, Cβ, Cγ 
(Beebe et al., 1990; Showers et al., 1986; Uhler et al., 1986). Each R subunit consists 
of two conserved cAMP-binding sites (Weber et al., 1987) and a pseudo-substrate 
domain which inhibits the associated C subunit (Hofmann et al., 1977; Poteet-Smith et 
al., 1997). Near the N-terminal region of the RIIα subunit, there is a 44-residues long 
AKAP-binding domain (Carr et al., 1991; Newlon et al., 1997).  
 AKAPs belong to a family of scaffolding proteins of more than 20 members. 
Mostly they bind to RII isoforms, hence they target both type I and II PKA to specific 
sub-cellular organelles (Huang et al., 1997). Binding of cAMP to PKA decreases the 
affinity of the R subunit for the C subunit. Consequently, the holoenzyme dissociates 
and the C subunits are released into the cytosol. AKAPs then regulate PKA-mediated 
phosphorylation of intracellular proteins and provide the way in which cAMP, via 
PKA, can regulate very specific cellular process.    
 Epac is also activated by increases in intracellular cAMP concentration (de Rooij 
et al., 1998; Kawasaki et al., 1998). Originally Epac was discovered while screening 
for cAMP-binding motifs and by homology to the Ras superfamily of guanine 
nucleotide exchange factors (GEFs) (de Rooij et al., 1998; Kawasaki et al., 1998). 
There are three types of Epac; Epac 1 (cAMP-GEFI) (de Rooij et al., 1998; Kawasaki 
et al., 1998), Epac 2 (cAMP-GEFII) (Kawasaki et al., 1998) and Epac/cAMP-GEFI/II 
or Repac (related to Epac or guanine nucleotide exchange factor for RapI; GFR) 
(Ichiba et al., 1999). Epac 1 comprises three domains; a cAMP domain (CBD), a 
guanine nucleotide-exchange domain and a dishevelled Eg1-10 pleckstrin (DEP) 
domain which supports Epac membrane localisation (de Rooij et al., 2000; Kawasaki et 
al., 1998; Rehmann et al., 2003). Epac 2 has an extra CBD (de Rooij et al., 2000; 
Ozaki et al., 2000; Rehmann et al., 2003), whereas, Repac does not have a CBD and is 
not therefore regulated by cAMP (Ichiba et al., 1999). Binding of cAMP triggers the 




guanine nucleotide exchange activity of the Epac, which subsequently activates Rap1 
or Rap2, which are small ras-like GTPases (de Rooij et al., 2000; de Rooij et al., 1998; 
Kawasaki et al., 1998; Mei et al., 2002). It is anticipated that, in the absence of cAMP, 
Epac is in a conformation in which the CBD is folded upon the GEF domain. This 
inhibits the guanine nucleotide-exchange activity of the protein. Binding of cAMP then 
causes Epac to unfold and expose the GEF domain (de Rooij et al., 2000; Rehmann et 
al., 2003). 
 Regulation of Ca
2+
 release via Epac is independent of PKA. In the insulinoma 
cell lines INS-1E and clonal MIN-6 cells, glucagon-like-peptide 1 (GLP1) increased 
release of Ca
2+
 caused by Epac 2 linked activation of type 3 RyR (Kang et al., 2001; 
Tsuboi et al., 2003). In addition, agonists which stimulate cAMP-coupled receptors, 
such as the β2-adrenoceptor, have also been shown to trigger release of Ca
2+
 (Schmidt 
et al., 2001). cAMP, via Epac1, can activate Rap2B by enhancing its GTP loading. 
PLCƐ, which is stimulated by Rap2B, then catalyses formation of IP3 and the 
subsequent release of Ca
2+ 
from intracellular stores (Schmidt et al., 2001)  
 CNGCs were first discovered in the PM of frog and toad rod outer segments. 
These channels are activated by both cGMP and cAMP with different potencies 
(Fesenko et al., 1985; Haynes et al., 1985; Nakamura et al., 1987). While these 




into the cell, the ability of Ca
2+
 to block the 
entry of Na
+
, indirectly supports the influx of divalent ions (Nakamura et al., 1987). 
These channels play important roles in retinal photoreceptors, olfactory neurons and in 
heart by causing cAMP-mediated increases in [Ca
2+
]c (Cukkemane et al., 2011).  
 





pathways are not independent of each other. These two signalling 
pathways interact with each other at different levels and in a dynamic fashion (Bruce et 
al., 2003; Siso-Nadal et al., 2009). For example, oscillations in one messenger can 
instigate oscillation in the other (Gorbunova et al., 2002; Willoughby et al., 2006). In 
Xenopus spinal neurons, using mathematical modelling, it has been shown that cells are 
capable of generating their own characteristic patterns of Ca
2+
 and cAMP interaction, 
perhaps this allows cells to regulate uniquely their set of effector molecules such as 
transcription factors and kinases.    




 There are three main points where Ca
2+
 contributes to the modulation of cAMP 
levels: AC, PDE and GPCR. Through PKC, Ca
2+
 regulates phosphorylation and then 
desensitization of Gαs-coupled β1/2-adrenoceptors (Guimond et al., 2005), Ca
2+
 can 
alter AC activity (Cooper et al., 1995) either by inhibiting (Dyer et al., 2005) or by 
enhancing it (Wayman et al., 1994). Ca
2+
 has also been reported to stimulate PDE 
activities (Sharma et al., 1994). The family of ACs has been classified on the basis of 
their sensitivity to Ca
2+ 




sensitive, and AC II, 
IV, VII are insensitive to Ca
2+
 (Willoughby et al., 2007). In addition, different Ca
2+
-
sensitive ACs do not show similar sensitivity, AC VIII (Fagan et al., 2000), AC I 
(Wayman et al., 1994) and perhaps AC III (Dyer et al., 2005) show increases in 
activity in the presence of Ca
2+
, whereas AC V and VI activity are inhibited upon the 
entry of Ca
2+
 (Chiono et al., 1995; Yu et al., 1993).  
 PKA is the predominant means by which cAMP controls Ca
2+
 levels. PKA can 
phosphorylate all three subtypes of IP3R (Nakade et al., 1994; Tang et al., 2003; 
Tertyshnikova et al., 1998). But most efficiently it phosphorylates IP3R1, while IP3R2 
and IP3R are weakly phosphorylated (Wojcikiewicz et al., 1998).  
However, PKA-mediated phosphorylation of IP3R1 is also debatable; PKA decreases 
the potency of IP3 to IP3R, hence affects IP3R1 mediated release of Ca
2+
 from 
cerebellar microsomes (Supattapone et al., 1988; Volpe et al., 1990), but enhances the 
sensitivity of immuno-purified and reconstituted cerebellar IP3R to IP3 (Nakade et al., 
1994). In permeabilised cells, PKA-mediated phosphorylation of native IP3R, increases 
the sensitivity to IP3 (Wojcikiewicz et al., 1998). The reason underlying these 
differences is not clear, but probably indicates the loss of an essential protein during 
isolation of IP3R that is required for the effect of PKA. Nevertheless, it is generally 
accepted that PKA phosphorylates and sensitises the IP3R.   
 PKA-mediated phosphorylation of IP3R2 most likely occurs at Ser
1687
 (Sudhof et 
al., 1991; Yamamoto-Hino et al., 1994). Hormones or sulfhydryl reagents potentiate 
cAMP levels, which then enhance the release of Ca
2+
 from IP3-sensitive intracellular 
stores (Bird et al., 1993; Burgess et al., 1991). In parotid acinar cells, stimulation of AC 
using forskolin showed phosphorylation of IP3R2 and potentiation of Ca
2+
 release by 
carbachol. These responses were attenuated by the inhibition of PKA or mimetic 
mutations (Bruce et al., 2002). Hence, it is confirmed that PKA phosphorylates IP3R2 
and thereby enhances its sensitivity to IP3.  











 (Blondel et al., 1993) of which, Ser
934
 and Ser 
1130
 are conserved within the 
human form of the IP3R3 (Yamamoto-Hino et al., 1994). However, the PKA effect on 
IP3R3 is less clear in comparison to IP3R1 and IP3R2. In RINm5F cells an increase in 
IP3R3 sensitivity to IP3
 
is evoked by PKA-mediated phosphorylation (Wojcikiewicz et 
al., 1998). Yet, others have indicated that PKA-mediated phosphorylation of the IP3R 
blocks Ca
2+
 release (Giovannucci et al., 2000; LeBeau et al., 1999) by diminishing the 
open probability of intrinsic ion channels and by slowing the rate of IP3-evoked Ca
2+
 
release (Straub et al., 2002).  
 PKA has also been shown to enhance the activity of RyR (Herrmann-Frank et al., 
1993). PKA-mediated phosphorylation and activation of RyR1 in skeletal and RyR2 in 
cardiac muscle is well established (Reiken et al., 2003; Xiao et al., 2006). In RyR1 
channels, it is possibly via the dissociation of a FKBP12, which might also result in 
RyR channels gating stochastically rather than as an ensemble (Marx et al., 1998). It is 
suggested that PKA and intracellular Ca
2+ 
release channels form a signalling complex 
in combination with phosphatases that dephosphorylate the channels. For example, both 
peripheral and neuronal IP3R1 and AKAP9 in combination are responsible for 
anchoring PKA to IP3R1 (Tu et al., 2004). The protein phosphatases, PP1 and PP2A, 
have been shown to from macro-molecular complexes with RyR1, RyR2 and IP3R1 
channels (DeSouza et al., 2002; Marx et al., 2001).   
 All three IP3R subtypes are also directly regulated by high cAMP concentrations. 
cAMP increases the sensitivity of IP3R to IP3. It is suggested that cAMP either binds to 
a low-affinity binding site on IP3R or to an IP3R-associated protein (Tovey et al., 2010; 
Tovey et al., 2008). It was proposed that in HEK cells expressing  
parathyroid hormone receptor type 1(PTH1R), adenylyl cyclase 6 (AC6) selectively 
communicated with IP3R2 within AC6-IP3R2 signalling junctions. These signalling 
junctions allow super-saturating concentrations of cAMP to directly sensitise IP3R 
(Tovey et al., 2008). These interactions are discussed further in chapter 3.  
 In some settings, cAMP affects release of Ca
2+ 
by modulating the activity of PLC. 
In cardiac myocytes, stimulation of β-adrenoceptors evokes an increase in cAMP 
levels; the enhanced cAMP, through Epac-mediated activation of Rap1, increases PLCƐ 
activity and Ca
2+
 mobilisation (Oestreich et al., 2007). In primary gastric smooth 
muscle cells, PKA by phosphorylating G-protein coupled receptor kinase-2 (GRK2) 
and RGS4 proteins enhances the capacity of these proteins to block Gαq resulting in 




attenuation of PLCβ  activity (Huang et al., 2007). PKA-mediated phosphorylation of 
mouse prostacyclin receptors uncouples these receptors from Gq and thereby prevents 
PLC activation (Lawler et al., 2001).  
 Increased cAMP levels indirectly regulate the activity of the Ca
2+
 pumps, SERCA 
and PMCA. The activity of SERCA proteins is inhibited by phospholamban in cardiac 
muscle cells. This inhibition is reversed by PKA-mediated phosphorylation of 
phospholamban (Brittsan et al., 2000). In contrast, stimulation with G protein Rap1b 
constitutively activates SERCA proteins in platelets and megakaryocytes, PKA-
mediated phosphorylation of Rap1b dissociates it and thereby decreases SERCA 
activity. PKA mediates phosphorylation of PMCA, thus enhancing its activity, by 
increasing its affinity for Ca
2+
-calmodulin (Dean et al., 1997; Gromadzinska et al., 
2001). In addition, increased cAMP concentrations also affect some Ca
2+
 entry 
channels. These channels are regulated by PKA-mediated phosphorylation. In cardiac 
myocytes, stimulation of β-adrenoceptors increases L-type Ca
2+
 channel activity and 
this is by AKAP79-tethered PKA-mediated phosphorylation (Gao et al., 1997).  
 Further specific details of Ca
2+
 signalling in pancreatic β-cells (Chapter 2) and of 
the interplay between PTH, cAMP and Ca
2+ 
signals (Chapters 3 and 4) are discussed in 




















1.3. Aims of the projects  
Previous findings in this lab reported that, in RINm5F cells, a small number of RyR are 
localised in the PM and contribute to Ca
2+
 entry. In addition, several lines of evidence 
suggest that RyR may contribute to regulated insulin secretion (Johnson et al., 2004; 
Takasawa et al., 2010). All these observations encouraged me to define the presence 
and role of RyR in pancreatic-β cells  Since, RINm5F cells do not secret insulin, I have 
used INS-1E cells; these cells are reported to secrete insulin (Merglen et al., 2004). 
Therefore, the primary aim of the work illustrated in Chapter 2, was to characterise 
Ca
2+
 entry and release pathways mediated by RyR in INS-1E cells.  
 Ca
2+ 
signalling from IP3R has been studied in HEK cells expressing PTH1R. 
Previously, work from this lab proved that acute pretreatment with  PTH stimulates AC 
via PTH1R and potentiates IP3-evoked Ca
2+
 signals, which were suggested  to be 
mediated by AC-IP3R signalling junctions (Tovey et al., 2008). In addition, in a recent 
study, binding of PTH to PTH1R at the plasma membrane was shown to stimulate 
internalisation of PTH1R-AC signalling complexes, which then continue cAMP 
formation via AC for sustained durations (Ferrandon et al., 2009). These results 








DM, also known as gestational diabetes, occurs when pregnant women with no past 
history of diabetes develop a consistent increase in blood glucose levels. Patients with 
type 3 DM recover after the birth of the baby.   
2.1.2. Biogenesis of insulin 
Insulin was the first protein to have its amino acid sequence determined by Fred Sanger 
in 1958 (Sanger, 1988)  It is produced and secreted into the  plasma from β-cells in 
pancreatic islets of Langerhans (Seino et al., 2010)  In addition to β-cells, the islets of 
Langerhans also contain α-cells that produce glucagon, δ-cells that produce 
somatostatin, and γ-cells producing pancreatic polypeptide (Elayat et al., 1995). 
Besides insulin secretion, β-cells also secrete C-peptides and amylin. The amount of C-
peptide secreted from β-cells is similar to insulin levels. The basic role of C-peptides is 
to connect insulin chain A with chain B (described in next paragraph) (Munro et al., 
1987). Amylin also called islet amyloid polypeptide primarily slowdowns the rate of 
glucose entry into the bloodstream (Nishi et al., 1990).  
 Insulin is composed of two polypeptide chains: chain A and chain B have 21 and 
30 amino acid residues, respectively, in humans. The chains are linked by two 
disulphide bridges between residues A7 to B7 and A20 to B19 (Sanger, 1959; Sanger, 
1950)  However, in pancreatic β-cells primarily insulin is synthesized as a single 
polypeptide chain known as preproinsulin. It consists of a 24 amino acid signal 
peptide which orients the nascent polypeptide chain to the ER. Subsequently, after 
translocating into the lumen of the ER, preproinsulin is cleaved and forms proinsulin. In 
the lumen of ER, proinsulin folds into 3D conformation by forming three disulfide 
bonds (Huang et al., 1995)   fter  5–10 min proinsulin assembles in the ER and moved 
to the trans-Golgi network (TGN) where immature insulin granules are formed  
Transport of proinsulin to the TGN takes   3  min  Maturation of proinsulin into active 
insulin occurs by the action of cellular endopeptidases called prohormone convertases 
and the exoprotease carboxypeptidase E (Fu et al., 2013; Steiner et al., 1967). The 
endopeptidases cleave proinsulin at 2 positions, one fragment is called C-peptide and 
another is active insulin consisting of chain A and B, linked by 2 disulfide bonds. 
Consequently, the mature insulin is enclosed inside mature granules waiting for 
metabolic signals to be exocytosed from the cell into plasma. Usually the increase in 
blood plasma glucose concentration stimulates insulin secretion. Once an insulin 




molecule binds to insulin receptor (IR) and triggers protein activation cascade, 
predominantly it is released back into the extracellular fluid or degraded by the cell. 
The primary sites for insulin degradation are liver and kidney cells (Adrogue, 1992; 
Duckworth et al., 1998; Mak et al., 1992).  
 In humans, insulin instigates cellular responses by binding to the insulin receptor 
(IR). These receptors are transmembrane, multi-subunit glycoproteins which contain 
insulin-stimulated tyrosine kinase activity (Kaplan, 1984; Robinson et al., 2000). The 
localisation of insulin receptors is variable, with the highest levels of expression in cells 
that are most responsive to insulin for glucose, lipid, and proteins especially adipose, 
skeletal muscle, and liver (Goren, 2005; Henquin et al., 2003; Kang et al., 2008). The 
insulin receptor was first identified over 25 years ago, its cDNA was cloned in 1985. 
The crystal structure of its extracellular domain and protein tyrosine were determined in 
2006 (Lou et al., 2006) and 1994 (Hubbard et al., 1994) respectively. In mammals, the 
functional IR exists in two isoforms insulin receptor-A (IR-A) and insulin receptor B 
(IR-B), which results from alternative splicing of the initial transcript. The most 
significant functional difference among these two IR isoforms is the high affinity of IR-
A for insulin like growth factor II (IGF-II). Largely IR-A is expressed during prenatal 
stages, it amplifies the effect of IGF-II during foetal development and embryogenesis. 
In addition to this, IR-A is also significantly expressed in adult tissue particularly in 
brain tissue. Conversely, IR-B is primarily expressed in adults, well-differentiated 
tissues, including liver, where it increases the metabolic effects of insulin (Belfiore et 
al., 2009). Alteration in IR isoform expression in insulin target cells is one of the 
primary reasons of developing insulin resistance in DM-2. In few studies it is reported 
that expression of IR-A is increased in insulin target tissues from DM-2 patients, 
therefore suggesting that alteration in expression levels of IR isoforms may contribute 
to insulin resistance (Sesti et al., 2001).   
2.1.3. How does insulin secretion take place in pancreatic β-cells? 
Glucose-stimulated insulin secretion (GSIS  from β-cells is biphasic. The first phase of 
insulin secretion peaks about 5-6 min after a rise in the plasma concentration of 
glucose. It is thought to be due to rapid release of a primed pool of readily releasable 
insulin-containing granules situated at the plasma membrane (Caumo et al., 2004). The 
local sub-plasma membrane increase in [Ca
2+
]c caused by opening of L-type Ca
2+
 




channels triggers exocytosis of these vesicles. The second phase of insulin release is 
slower and persists for as long as the plasma glucose concentration remains elevated. It 
requires refilling of insulin vesicles, translocation of granules from reserve pools to the 
PM, and Ca
2+
 signals to evoke exocytosis (Bratanova-Tochkova et al., 2002; Islam, 
2010; Schulla et al., 2003).   
 Glucose enters β-cells via the GLUT transporter (GLUT-2 in kidney and bone 
cells or GLUT-1 in brain cells) in humans (Bertram et al., 1998) and its oxidative 
metabolism increases the cytoplasmic ATP/ADP ratio (Spacek et al., 2008). This 
causes closure of ATP-gated K
+
 channels (KATP) in the PM, increasing membrane 
resistance and preventing K
+
 from leaving the cell (Braun et al., 2008). These changes, 
along with an unknown leak current, cause the PM to depolarise and activate Cav1.2 
and Cav1.3, which then mediate Ca
2+ 
influx. The rapid rise in [Ca
2+
]c beneath the PM 
stimulates exocytosis of the large dense-core vesicles that contain insulin. This 
‘triggering pathway’ is responsible for the first phase of insulin release (Islam, 2010; 
Schulla et al., 2003). Its importance is clear from the clinical utility of the 
sulphonylurea drugs used to treat type 2 DM. These bind to KATP channels causing 
them to close and so mimic the effects of glucose on insulin secretion (Ashcroft, 2007). 
Figure 2.1. illustrates the triggering and amplifying pathways for insulin secretion in 
pancreatic β-cells.  
Glucose can also stimulate insulin secretion independently of KATP channels. 
Glucose can, for example, stimulate some insulin release when subunits of the KATP 
channel are mutated or knocked out, or when they are locked open by diazoxide (with 
high-KCl to activate L-type channels) (Henquin, 2009; Reimann et al., 1999; Seghers et 
al., 2000; Tucker et al., 1997). These KATP channel-independent pathways contribute 
most to the second phase of insulin secretion (Aizawa et al., 1998; Henquin, 2009; 
Jacobson et al., 2007). The mechanisms underlying these pathways are not clearly 
resolved. Evidence has been presented to implicate a volume-regulated anion channel 
(VRAC) (Best et al., 2007), transient receptor potential channels (TRPM2) (Togashi et 
al., 2006) and a variety of intracellular signalling molecules. These include cyclic 
AMP, which increases after glucose stimulation, and may activate protein kinase A 
(PKA) or exchange protein activated by cAMP (epac-2) to increase insulin secretion 
(Holz, 2004; Landa et al., 2005; Leech et al., 2010; MacDonald et al., 2005; Straub et 
al., 2001; Szaszak et al., 2008). 




Many additional signals modulate the responses of β-cells to glucose. 
Somatostatin and galanin suppress exocytosis of insulin granules by re-polarising the 
PM and so reducing [Ca
2+
]c (Daunt et al., 2006; Dufer et al., 2004). Incretins, like 
glucagon-like peptide-1 (GLP-1) or gastric inhibitory polypeptide (GIP) potentiate the 
responses of β-cells to glucose via their ability to stimulate AC (Holst et al., 2009). 
Exenatide (a synthetic exendin-4) is a stable analogue of GLP-1 that is now used to 
treat type 2 DM (Drucker, 2006a). GLP-1 also activates CD38 to catalyse synthesis of 
nicotinic acid adenine dinucleotide phosphate (NAADP) and cyclic ADP ribose 
(cADPR), NAADP stimulates Ca
2+
 release from acidic stores, and cADPR along with 
[Ca
2+
]c acts as co-agonist to stimulate RyR to release Ca
2+
 . A global rise in [Ca
2+
]c due 
to NAADP and cADPR triggers insulin secretion (Drucker, 2006; Holst et al., 2008; 
Kim et al., 2008; Ohta et al., 2011). Ca
2+
 release from internal stores via RyR and IP3R 
also contributes to a rise in [Ca
2+
]c and stimulates insulin secretion from β-cells. (Islam, 









Figure 2.1. Triggering and amplifying pathways for insulin secretion 
During the triggering pathway, glucose enters pancreatic β-cells via a transporter 
protein (GLUT-1). Glucose metabolism increases the ATP/ADP ratio, which causes the 
closure of KATP channels and opening of unknown non-selective cation channels 
(NSCC). This results in plasma membrane depolarisation (ΔΨ), opening of voltage- 
operated Ca
2+
 channels (VOC) and Ca
2+
 influx, which triggers exocytosis of insulin 
granules. During the amplifying pathway, agonist-induced G-protein-coupled receptor 
(GPCR) activation of Gs and Gq activate adenylyl cyclase (AC) and phospholipase C 
(PLC), respectively. AC catalyses the formation of cAMP, PLC leads to formation of 
IP3 and DAG, which can stimulate release of Ca
2+
 from intracellular stores. CD38 
catalyses formation of cADPR and NAADP, which also stimulate Ca
2+ 
release from 
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2.1.4. The role of ryanodine receptors in pancreatic β-cells 
RyR are large proteins (four subunits of almost 5000 residues) that form Ca
2+
-
permeable non-selective cation channels (Giannini et al., 1995; Islam, 2002; Otsu et al., 
1990). There are three subtypes (RyR1-3) that share ~60-70 % sequence similarity. 
Most studies suggest that β-cells express predominantly RyR2 and very few RyR1. 
RyR are expressed on ER and work from this laboratory suggests that RyR2 is also 




expressed at the PM (Coronado et al., 1994; Johnson et al., 2004; Mitchell et al., 2003; 
Rosker et al., 2009)  β-cells also express IP3R (largely IP3R3) (Johnson et al., 2004), 
although the relative densities of IP3R and RyR may differ between species. Mouse 
islets, for example, have very few IP3R relative to RyR (Takasawa et al., 1998).  
Several lines of evidence suggest that RyR may contribute to regulated insulin 







 signals evoked by L-type Ca
2+
 channels may 
allow them to contribute to the second phase of insulin release (Johnson et al., 2004). 
RyR are regulated by many signals associated with glucose-and/or hormone stimulation 
of β-cells. Glucose increases both ATP and cADPR concentrations in β-cells, and both 
stimulate RyR (Kato et al., 1999; Okamoto, 1999). Glucose and incretins stimulate 
increases in c MP concentration in β-cells. Both PKA and Epac are implicated in the 
subsequent actions of cAMP (Kelley et al., 2009; Leech et al., 2010), and both regulate 
RyR (Holz, 2004; Holz et al., 1999). In human islets, type 2 DM is associated with 
diminished expression of RyR2 and reduced levels of cADPR, whereas activation of 
RyR can trigger insulin secretion (Johnson et al., 2004; Squires et al., 2004; Takasawa 
et al., 1998).  
Most analyses of RyR in β-cells have assumed that their contributions come from 
mediating Ca
2+
 release from intracellular Ca
2+
 stores, but recent work from this 
laboratory provided evidence that small numbers of functional RyR2 are also expressed 
in the PM of RINm5F insulinoma cells and perhaps also in primary β-cells (Rosker et 
al., 2009). The contribution of these RyR in the PM to insulin secretion or glucose-
evoked Ca
2+
 signals is unknown, but they may contribute to regulation of both 













2.1.4. Aims  
The aim of my project was to define the presence and role of RyR in pancreatic β-cells. 
The most convincing evidence for functional expression of RyR in the PM is provided 
by analyses of rat insulinoma cells (RINm5F cells) (Rosker et al., 2009), but these are a 
poor model for β-cells because they do not secrete insulin in response to glucose. 
 For my work, I have used INS-1E cells, which have been reported to show 
important characteristics of pancreatic β-cells, like glucose responsiveness and insulin 
secretion between passages 40-100 (Merglen et al., 2004). Originally, the parental cell 
line INS-1 was isolated from a rat insulinoma induced by X-ray irradiation (Asfari et 
al., 1992). During expansion however, it was noted that INS-1 cells lacked a stable β-
cell phenotype, owing to their non-clonal nature. Merglen and co-workers overcame 
these problems in 2004, by isolating a clonal INS-1E cell line, which showed stable and 
robust secretory responses to physiological changes in glucose concentrations (Merglen 
et al., 2004). Furthermore, INS-1E cells respond to GLP-1 resulting in an increase in 
cAMP (Henquin et al, 2003) and they can be reliably transfected and loaded with 
fluorescent Ca
2+ 
indicators (Woolcott et al, 2  6).  





 release pathways mediated by RyR in INS-1E cells. In addition to this, 
basic glucose-evoked Ca
2+
 oscillations were characterised in primary mouse pancreatic 
islets of Langerhans to determine their potential for use as a model to study RyR.  
 
2.2. Materials and Methods 
 
2.2.1 Materials  
Table 2. 1. Lists the sources of the materials used. Table 2. 2 shows the list of solvents 











Caffeine Sigma-Aldrich (Poole) 
Pluronic acid Sigma-Aldrich (Poole) 
DMSO Sigma-Aldrich (Poole) 
Carbachol Sigma-Aldrich (Poole) 
Nimodipine Sigma-Aldrich (Poole) 
Foetal bovine serum (FBS) Sigma-Aldrich (Poole) 
Poly-L-lysine Sigma-Aldrich (Poole) 
Penicillin (100 U/ml) & streptomycin 
(    μg/ml  solution 
Sigma-Aldrich (Poole) 
 
Amphotericin B Sigma-Aldrich (Poole) 
Ionomycin Merck Euro Lab Ltd (Dorset). 
Ryanodine Ascent Scientific (Bristol) 
Fura-2AM Invitrogen (Paisley) 
TryplExpress Invitrogen (Paisley) 
Advanced RPMI 1640 medium Invitrogen (Paisley) 
L-glutamine Invitrogen (Paisley) 
HEPES Invitrogen (Paisley) 
β mercaptoethanol Invitrogen (Paisley) 
Soybean trypsin inhibitor Invitrogen (Paisley) 
Collagenase P Roche Applied Science (Welwyn Garden 
City) 
DNase Roche Applied Science (Welwyn Garden 
City) 
RPM1 1640 medium Invitrogen Ltd (Renfrew, Renfrewshire) 
Collagen  Sigma-Aldrich (Poole) 
poly-D-lysine Sigma-Aldrich (Poole) 
Gelatin Sigma-Aldrich (Poole) 
Fibronectin Sigma-Aldrich (Poole) 
BD Cell Tak BD biosciences (Oxford) 
 
  




Table 2.1. Materials used 
 
Drugs Solvent Storage (°C) 
Caffeine Water (50 mM stock)  4 
Carbachol (CCh) Water  (100 mM stock) 4 
Ionomycin DMSO (5 mM stock) -20 
Pluronic acid Water (20 % stock) 20 
Nimodipine DMSO (10 mM stock) 4 
Nimodipine  Methanol (10 mM stock) 4 
Verapamil Water ( (10 mM stock) 4 
Ryanodine DMSO  (100 mM stock) -20 
 
Table 2.2 Solvents used to prepare drugs  
 
2.2.2. INS-1E cell culture 
The rat insulinoma INS-1E cell line (passage 53) was kindly provided by Professor 
Pierre Maechler (Geneva, Switzerland) (Merglen et al., 2004). INS-1E cells were 
maintained at 37 °C in humidified air containing 5% CO2  and cultured in advanced 
RPMI 1640 medium containing 11 mM D-glucose supplemented with heat-inactivated 
foetal bovine serum (5%), L-glutamine (2 mM), sodium pyruvate (1 mM) HEPES (10 
mM , and β-mercaptoethanol (5  μM   INS-1E cells were passaged at 80% confluence, 
and medium was replaced every third day. For single-cell analyses, cells were seeded (8 
x 10
5
 cells/well), and allowed to attach onto 22-mm round glass coverslips, each pre-
coated with 0.01% poly-L-lysine for 48 h before performing experiments. For 
population-based assays, cells were seeded (50 x 10
6
 cells/well) and allowed to grow 
for 48 h before experiments. 
 
2.2.3. Mouse pancreatic islet isolation and primary culture  
Pancreatic islets of Langerhans were isolated from male C57BL6 mice (12-weeks old) 
that were humanely sacrificed using Schedule 1 methods according to Home Office- 
approved procedures. Mice were killed by exposure to a rising concentration of CO2 
followed by dislocation of the neck. The pancreas and spleen were surgically removed 
en bloc and washed in ice-cold HEPES-buffered Krebs-Ringer phosphate buffer 




containing 0.4% bovine serum albumin (KRH 0.4% BSA) composed of (mM): 129 
NaCl, 5 NaHCO3, 4.8 KCl, 1.2 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 5.6 glucose, 10 
HEPES and 0.4% BSA (pH 7.4, NaOH). The spleen and any fat were excised from the 
pancreas, and the pancreas was further washed in fresh KRH 0.4% BSA. Each pancreas 
was partially digested by inflating it with 5 ml of ice-cold digest cocktail comprising 
KRH 0.4% BSA supplemented with collagenase P (0.85 mg/ml) and DNase I (0.1 
mg/ml), soybean trypsin inhibitor (2.5 mg/ml) using a syringe and 30-gauge needle. 
Both the inflated pancreas and remaining digest cocktail were transferred into a 50-ml 
centrifuge tube and incubated in a water bath at 37C for 14 min. This was followed by 
a vigorous shake for 1 min. The pancreas suspension was assessed by eye to ensure 
islets were disassociated from the exocrine tissue. If the tissue dissociation procedure 
was incomplete, the pancreas suspension was returned to the 37
o
C water bath for 
repeated cycles of 1 min in the water bath followed by a vigorous manual shake for 1 
min until the pancreas digestion was complete (cloudy suspension free of large pieces 
of pancreatic tissue). The pancreatic tissue was then washed 3 times in 50 ml ice-cold 
KRH with 0.4% BSA by centrifuging the pancreas suspension at 4C for 2 min at 150 x 
g. The supernatant was discarded between washes, and the remaining pellet (after 
completed wash steps) was re-suspended in 10 ml of ice-cold KRH with 0.4% BSA. 
Islets were easily distinguished as small dense oval structures, and separated manually 
from any exocrine tissue using a Leica MS5 stereomicroscope and a P200 Gilson 
pipette.  Isolated islets were allowed to recover overnight by culturing in RPMI 1640 
medium containing 11 mM D-glucose supplemented with heat-inactivated FBS (10%), 
penicillin (    U/ml , streptomycin (    μg/ml , and amphotericin B (  25 μg/ml  at 
37°C in a 5% CO2 humidified atmosphere in suspension culture dishes  For 
measurements of [Ca
2+
]c, islets were allowed to attach to the central part of poly-L-
lysine (0.01%)-coated 25-mm round glass coverslips for 24 h under the culture 
conditions mentioned above (Carter et al., 2009) 
 
2.2.4. Measurement of [Ca
2+
]c in single INS-1E cells 
Fura-2, a ratiometric Ca
2+





in INS-1E cells as described in Rosker et al. (2009). Almost confluent cultures 
of INS-1E on 22-mm round, poly-L-lysine-coated coverslips were loaded with fura-
2/AM (final concentration 2 µM, from a stock solution of 2 mM in DMSO, 45 min, 




20°C) by incubation in KRH supplemented with Pluronic F127 (0.02%), washed and 
incubated for a further 45 min in KRH to allow de-esterification of the indicator. All 
experiments were performed in Krebs-Ringer bicarbonate HEPES buffer KRH, or Ca
2+
-
free KRH. KRH had the following composition: 137 mM NaCl, 5.36 mM KCl, 0.81 
mM MgSO4, 0.34 mM Na2HPO4, 0.44 mM KH2PO4, 1.26 mM CaCl2, 4.17 mM 
NaHCO3, 10 mM HEPES, 3 mM  glucose, pH 7.4. CaCl2 was omitted from Ca
2+
-free 
KRH and 1 mM EGTA was added.  
 Single-cell measurements of [Ca
2+
]c were performed in KRH at 20°C using an 
Olympus IX71 inverted fluorescence microscope. The cells were alternately excited at 
5-s intervals with light (340 nm and 380 nm) provided by a Xe-arc lamp and 
monochromator, while collecting emitted light at 510 nm using a Luca EMCCD camera 
(Andor Technology, Belfast, UK). At the end of each experiment, the autofluorescence 
of cells was determined by quenching the fura-2 fluorescence by addition of ionomycin 
(1 µM) and MnCl2 (10 mM). These autofluorescence values were subtracted from each 
fluorescence measurement at 340 nm and 380 nm before computing fluorescence ratios 
(F340/F380). MetaFluor software was used for the collection and analysis of fluorescence 
data. Each cell within a field was defined by a circular region of interest (ROI). 
Fluorescence from each ROI was analysed separately. Fluorescence ratios were 
calibrated to [Ca
2+
]c using equation 2.1 (Grynkiewicz et al., 1985):  
 Ca
2 






    equation (2.1) 
Where KD is the equilibrium dissociation constant of fura-2 for Ca
2+
 (220 nM), R the 
F340/F380 determined in the cells, Rf is the F340/F380 ratio in Ca
2+
-free conditions; Rb is 
the ratio in saturating Ca
2+





-saturated indicator, respectively. Calibrated results are presented as 
either [Ca
2+
]c or ∆ Ca
2+
]c  (i.e. the difference between [Ca
2+
]c before and after 
stimulation). Results are expressed as means ± SEM. 
 
2.2.5. Three sequential stimulations protocol  
To determine the effects of one treatment (e.g., removal of extracellular Ca
2+
) on the 
response to another treatment (e.g., addition of caffeine), the same cells were 
sequentially treated three times with the same stimulus, which was combined with the 
additional treatment during the second stimulation. The protocol allowed the control 




response, the affect of the second treatment, and its reversibility to be conveniently 
measured.  
 Fura-2-loaded INS-1E cells were prepared for imaging (Section 2.2.4) and bathed 
in KRH (500 µl). The medium was removed and replaced with KRH containing the 
stimulus. After 5 min, the medium was removed, the cells were washed 3 times with 
KRH and incubated in the alternative medium (e.g., KRH, Ca
2+
-free KRH)  
for 10 min. This medium was then removed and replaced with the same modified 
medium, but with the stimulus present. After 5 min, this medium was removed, the 
cells were washed in KRH, and they were again treated in KRH containing the first 
stimulus (conditions that exactly match the first stimulation). The methods used to 
record and calibrate fluorescence signals are described in Section 2.2.4. Figure legends 
describe the exact treatments. 
 
2.2.6 Statistical analyses 
The statistical analyses was performed at two levels because each experiment result 
consists of data collected from 3 independent coverslips, in which each coverslip 
consisted of ≥ 3  cells  Subsequently, one-way ANOVA analysis was also applied at 
two stages firstly to compare data collected between individual cells on each day, then 
on individual coverslips. Further, a Tukey post hoc test was used to compare all 
possible pair of means i.e. difference between first, second and third stimulation 
responses. One-way ANOVA was used because it allows one to separate the 
contribution of within-treatment variability and between treatment variability to the 
overall variance, and so to resolve whether difference between-treatment account for 




2.3.1. Mechanism of Ca
2+ 
release in INS-1E cells 
In most cell types, Ca
2+ 
release from intracellular stores occurs via IP3R and RyR 
(Foskett et al., 2007; Lanner et al., 2010) (Section 1.1.2). Similarly, in INS-1E cells, 
Ca
2+
 release from intracellular stores has been shown to be mediated via both RyR and 
IP3R (Gamberucci et al., 1999; Woolcott et al., 2006). The aim for this study was to 
further validate previous findings, in addition to characterising whether these Ca
2+
 




release channels were functional in INS-1E cells. If so, this glucose-responsive 
insulinoma INS-1E cell line could then be used to investigate the roles of both RyR and 
IP3R in insulin secretion. Caffeine was used to stimulate Ca
2+ 
release through RyR as it 
has been reported that the ER of INS-1 cells expresses caffeine-sensitive RyR2 
(Gamberucci et al., 1999; Woolcott et al., 2006). Carbachol (CCh, an agonist of 
muscarinic acetylcholine receptors) was utilised to stimulate Ca
2+
 release via IP3R. CCh 
activates PLC, production of IP3 and hence Ca
2+ 
release from intracellular stores via 
IP3R (Blondel et al., 1993; Woolcott et al., 2006).   
 A stimulation protocol was designed where INS-1E cells were sequentially 
challenged 3 times for durations of 5 min each with either caffeine or CCh in medium 
containing a basal non-stimulatory glucose concentration (3 mM), allowing a recovery 
period of 10 min between each challenge (Section 2.2.5). Caffeine reproducibly evoked 
an increase in [Ca
2+
]c (Fig. 2.2A, D), in response to 3 successive challenges which were 




]c) evoked by caffeine was: 
150 ± 19 nM, 120 ± 27 nM and 136 ± 17 nM, for the first, second and third challenges, 
respectively. CCh evoked a rise in [Ca
2+
]c of  77 ± 3  nM,  47 ± 25 nM and  3  ±  4 
nM for challenges one, two and three, respectively (Fig  2 3 , C   These results 
suggested that both caffeine and CCh evoked robust increases in [Ca
2+
]c, thus making 
this three sequential stimulation protocol (Section 2.2.5) suitable for determining the 




 To examine the effects of extracellular Ca
2+
 on responses to caffeine or CCh, 
cells were first stimulated with caffeine or CCh, then normal  RH was exchanged for 
Ca
2 
-free  RH containing EGT  (Fig  2 2B, 2 3B  3 -s before the second challenge 
with CCh or caffeine in Ca
2+
-free conditions; the extracellular Ca
2+
 was then restored 
prior to the third challenge. The data suggest that removal of extracellular Ca
2+
 
reversibly attenuates the response to caffeine (Fig. 2.2B, E). The response to caffeine 
(Δ Ca
2+
]c) was 6  ±    nM in the absence of extracellular Ca
2 
, but in its presence the 
responses were  63 ±  9 nM (first challenge  and  39 ± 2  nM (third challenge   
Similarly, the response to CCh was 73 ± 22 nM in the absence of extracellular Ca
2 
, but 
in its presence the responses were  83 ± 7 nM (first challenge  and  23 ± 26 nM (third 
challenge  (Fig  2 3B, D   The two responses in the presence of extracellular Ca
2+
 were 
not statistically different. These results suggests that both caffeine and CCh can 




stimulate release of Ca
2+
 from intracellular stores, but a significant component of the 
response requires extracellular Ca
2+
.  
 When responses to caffeine in Ca
2+
-free medium containing EGTA were studied 
(Fig  2 2B, second peak , there was a sustained decrease in basal [Ca
2+
]c  Perhaps, the 
presence of EGT  in the Ca
2+
-free KRH caused excessive loss of Ca
2 
 from the cells 
during the relatively prolonged incubation  This was potentially masking the profile of 
caffeine-evoked responses in Ca
2+
-free conditions. Therefore, a further experiment was 
designed to overcome this potential problem  The experiment was repeated, but 2 min 
prior to the second challenge with caffeine, cells were bathed in Ca
2 
-free  RH without 
EGT  (Fig 2 2C, second peak   fter studying data from 89 cells, it was confirmed that 
the absence of EGT  in the Ca
2 
-free  RH abolished the sustained decrease in basal 
[Ca
2+
]c  during caffeine responses in Ca
2 
-free conditions (Fig  2 2C, F, second peak   
However a further complication was noted in that the third challenge to caffeine was 
now significantly lower than the first caffeine challenge  The problem with variability 
in the Ca
2 












Figure 2.2. Caffeine-evoked Ca
2+
 signals in INS-1E cells 
(A, B, C), Representative traces, from 37, 15 and 37 cells in 1 experiment respectively, 
show three successive stimulations with caffeine (10 mM, 5 min, with 10 min intervals 
between stimuli) in normal KRH (A) or in Ca
2+
-free KRH with EGTA for the second 
challenge (B), or in Ca
2+
-free KRH for the second challenge (C). (D, E, F) Summary 




]c) evoked by caffeine 
(first, second and third challenge) (D), caffeine in Ca
2+
-free KRH with EGTA (second 
challenge) (E) and caffeine in Ca
2+
-free KRH (second challenge) (F) for each of the 
three challenges in each set of experiments. Results in D, E and F include only cells 
that responded to the first addition of caffeine (71%, 78% and 60% in D, E and F, 
respectively), and show means ± SEM from 3 independent experiments, with ~85, ~108 
and ~60 cells analysed, respectively. 
*
P < 0.05 with one-way analysis of variance and 








































































































Figure 2.3. CCh-evoked Ca
2+
 signals in INS-1E cells. (A, B) Representative traces, 
from 10 and 21 cells from 1 experiment respectively, show three successive 
stimulations with CCh (100 µM, 5 min, with 10-min intervals between stimuli) in 
normal KRH (A) or in Ca
2+
-free KRH for the second CCh challenge. (C, D) Summary 
results  show the peak (after ~30-35s) increase in [Ca
2+
]c evoked (Δ Ca
2+
]c) by CCh 
(first, second and third challenge) (C), or CCh in Ca
2+
-free KRH (second challenge) 
(D), for each of the three challenges in each set of experiments. Results in C and D 
include only cells that responded to the first addition of CCh (70% and 69% in C and 
D, respectively), and show means ± SEM from 3 independent experiments, with ~79 
and ~72 cells analysed, respectively. 
*
P < 0.05 with one-way analysis of variance and 
Tukey multiple comparisons test.  
 
 Subsequent experiments assessed the Ca
2+
-dependence of the caffeine and CCh 
responses, and whether RyR had a role. In order to elucidate a role for RyR, the plant 
alkaloid, ryanodine, was used. Ryanodine inhibits RyR at micromolar concentrations in 
a use-dependent manner (Rousseau et al., 1987; Smith et al., 1988). The three 
sequential stimulus protocol was used with slight changes. Following the initial 









































































its solvent control, DMSO (Fig. 2.4C). The caffeine-evoked Ca
2+
 responses to the 
second and third challenges were therefore carried out in the presence of ryanodine to 
allow for its use-dependence  The response to caffeine added with ryanodine (∆ Ca
2+
]c) 
was 48 ± 20 nM (second challenge) and -12 ± 3 nM (third challenge). These responses 
were significantly lower than those to caffeine alone 161 ± 20 nM (first challenge). The 
two response in the presence (second challenge) and absence (first challenge) of 
ryanodine were significantly different (Fig. 2.4D), whereas, with DMSO there was no 
attenuation in the caffeine-evoked Ca
2+ 
response (Fig. 2.4C, B).  
 The effects of ryanodine were then tested on CCh-evoked Ca
2+ 
responses in INS-
1E cells (Fig. 2.5). Following the first stimulation with CCh, ryanodine was added in 
the presence of CCh for the second challenge, and removed before the third CCh 
challenge  The response to CCh with ryanodine (∆ Ca
2+
]c) was 82 ± 25 nM (second 
challenge), but CCh alone caused a rise in [Ca
2+
]c of   8 ±  6 nM (first challenge  and 
6  ± 33 nM (third challenge). Thus, the presence of ryanodine (Fig. 2.5A; second 
challenge) did not cause a significant change in the CCh-evoked Ca
2+ 
response (Fig. 
2.5A). However, a significant attenuation in the CCh-evoked Ca
2+
 response was noted 
in the third challenge with CCh alone (Fig. 2.5A). 
 These results show that ryanodine inhibits caffeine-evoked Ca
2+
 entry and release 
in a use-dependent manner. However, CCh-evoked Ca
2+ 
responses remain unchanged in 
the presence of ryanodine specifically during the second challenge.  





Figure 2.4. Effect of ryanodine on caffeine-evoked Ca
2+
 signals  
(A) Representative trace, from 31 cells in 1 experiment, show three successive 
stimulations with caffeine (10 mM, 5 min, with 10-min interval between stimuli, first 
challenge), caffeine in the presence of  ryanodine (100 µM) (second and third 
challenge) in normal KRH. (B) Inhibition of caffeine-evoked Ca
2+
 release using 





]c) evoked by caffeine (10 mM) (first challenge) or caffeine with ryanodine (D) 
or DMSO (C) (second and third challenge) for each of the three challenges in each set 
of experiments. Result in C and D include only cells that responded to the first addition 
of caffeine (90% and 91%, in C and D respectively), and show means ± SEM from 3 
independent experiments, with ~110 and ~113 cells analysed in C and D, respectively.  
*

































































Figure 2.5. Effect of ryanodine on CCh-evoked Ca
2+
 responses 
(A) Summary results show the peak (after ~30-35s) increase in [Ca
2+
]c evoked by CCh 
(    µM  with and without ryanodine (    µM  (Δ Ca
2+
]c) for each of the three 
challenges in each set of experiments. Results include only cells that responded to the 
first addition of CCh (83%), and show means ± SEM from 3 independent experiments, 
with ~125 cells analysed.  
 
2.3.2. Mechanism of Ca
2+ 
entry in INS-1E cells 
Ca
2+
 entry across the PM can be mediated by VOC in primary β-cells and INS-1E cells 
(Gustafsson et al., 2005; Islam, 2010). To study Ca
2+
 entry pathways in pancreatic β-
cells, a high-KCl concentration was used to trigger depolarisation of the PM, thereby 
activating VOC to allow Ca
2+ 
entry from the extracellular medium (Gustafsson et al., 
2005; Lemmens et al., 2001). To confirm previous findings, I characterised the KCl-
evoked Ca
2+
 signalling pathways in INS-1E cells, and whether they were mediated by 
VOC. 
 The effects of KCl on [Ca
2+
]c in INS-1E cells were assessed by the three 
sequential stimulus protocol as described in section 2.2.5. As expected, KCl caused 
robust increases in [Ca
2+
]c. The 3 successive challenges were not significantly different 




]c) were:   85 ±  33, 74  ±  38 and 
798 ± 3  nM, for the first, second and third challenges, respectively. These results 
confirm that KCl-evokes an increase in [Ca
2+
]c in INS-1E cells, as others have 
previously shown (Szollosi et al., 2010; Woolcott et al., 2006). To examine whether 
these KCl-evoked rises in [Ca
2+
]c were mediated by Ca
2+
 entry or release pathways, the 
experiments were repeated in the absence of extracellular Ca
2+
. Briefly, INS-1E cells 
were first stimulated with high-KCl in Ca
2+






















free  RH prior to a second challenge with high- Cl in Ca
2 
-free  RH, then Ca
2 
 was 




]c  were analysed 
for   8  cells in each of 3 independent experiments  The results revealed that removal of 
extracellular Ca
2+
 reversibly inhibited the KCl-induced rises in [Ca
2+
]c (Fig. 2.6B, D). 
The response to  Cl (Δ Ca
2+
]c) was 7 ±  2 nM in the absence of extracellular Ca
2 
, but 
in its presence the responses were 73  ±   3 nM (first challenge  and 662 ±     nM 
(third challenge   The two responses in the presence of extracellular Ca
2+
 were not 



















Figure 2.6. KCl-evoked Ca
2+
 signals in INS-1E cells. (A, B) Representative traces, 
from 39 and 35 cells in 1 experiment, respectively, show three successive stimulations 
with KCl (40 mM, 5 min, with 10-min intervals between stimuli) in normal KRH (A) 
or in Ca
2+





]c) evoked by KCl alone (first, second and third challenges) 
(C) and KCl-Ca
2+
 (second challenge) (D) for each of the three challenges in each set of 
experiments. Results in C and D include only cells that responded to the first addition 
of KCl (100% and 95% in C and D, respectively), and show means ± SEM from 3 
independent experiments, with ~124 and ~80 cells respectively analysed in each. 
*
P < 
0.05 with one-way analysis of variance and Tukey multiple comparisons test. 
 
An antagonist of L-type VOC, nimodipine, was used to examine whether the  Cl-
evoked Ca
2 
 entry in INS- E cells was mediated by L-type VOC  Since, nimodipine is 
insoluble in water, methanol was used as a solvent  Controls were carried out to 
confirm the absence of methanol effects on the Ca
2  
responses (Fig. 2.7A)  INS-1E cells 










































































added with KCl before the second challenge, and then removed prior to the third KCl 
challenge The % of methanol used to make final nimodipine concentration (10µM) in 5 
ml KRH was 0.2%. A significant decrease in the KCl-evoked Ca
2  
rises was observed 
in the presence of nimodipine. The increase in peak [Ca
2+
]c was 33  ± 59 nM (second 
challenge) in the presence of nimodipine compared to the initial KCl-evoked Ca
2+
 
response in the absence of nimodipine   95 ± 38 nM (first challenge  (Fig. 2.7B). 
When nimodipine was washed out before the third KCl challenge in the absence of 
nimodipine, there was no recovery in the KCl-evoked Ca




significantly lower (37  ± 6  nM, third challenge) compared to the first challenge 
(  95 ± 38 nM  (Fig. 2.7B). Unfortunately, it became apparent from the solvent 
control experiments, that methanol may have contributed to some of the inhibition of 
the KCl responses observed (Fig. 2.7A). Since, the second challenge to KCl in the 
presence of methanol (solvent control  was significantly lower (∆ Ca
2+
]c 627± 52 nM) 
than in its absence 1082 ± 49 nM (first challenge) (Fig. 2.7A). These results suggested 
that the inhibitory effect of methanol (solvent) could not be ruled out when interpreting 
the changes in KCl-evoked Ca
2+
 responses in the presence of the L-type VOC blocker 
nimodipine in these experiments.   
 
 
Figure 2.7. Effect of nimodipine on KCl-evoked Ca
2+
 entry in INS-1E cells. 
(A, B) Summary results show the peak (after ~30-35s) increase in [Ca
2+
]c evoked by 
 Cl (4  mM  (Δ Ca
2+
]c) for each of the three challenges in each set of experiment. 
Results include only cells that responded to the first addition of KCl (64% and 70% in 
A and B respectively), and show means ± SEM from 3 independent experiments, with 
~79 and ~77 cells analysed in A and B, respectively. 
*
P< 0.05 with one-way analysis of 










































The effects of nimodipine on KCl-evoked Ca
2+
 responses were next examined using 
DMSO as a solvent. The % of DMSO used to make final nimodipine concentration 
(10µM) in 5 ml KRH was 0.2%. Figure 2.8A shows that nimodipine significantly 
inhibited KCl-evoked Ca
2+
 entry in comparison to the matched control experiment. The 
peak increase in [Ca
2+
]c in the absence of nimodipine was 952 ± 101 nM (first 
challenge) and it was 347 ± 142 nM (second challenge) in its presence (Fig. 2.8A). 
However, recovery of the KCl-evoked response was not observed following removal of 
nimodipine: the peak increase in [Ca
2+
]c was 220 ± 117 nM for the third challenge (Fig. 
2.8A). The KCl-evoked increase in peak [Ca
2+
]c in the presence of DMSO was 984 ± 
27 nM (second peak), which was similar to the effect of KCl alone during the first 




 As nimodipine showed only 69% inhibition compared to the first peak response 
in INS- E (Fig  2 8   and β-cells (Woolcott et al., 2006). These results were confirmed 
using another L-type VOC inhibitor, verapamil (Fig. 2.8B) (Wollheim et al., 1984). 
Verapamil almost completely inhibited KCl-evoked Ca
2+ 
responses, the peak increase 
in [Ca
2+
]c was 29 ± 9 nM (second challenge) in the presence of verapamil in 
comparison to 890 ± 165 nM in its absence (first challenge) and 440 ± 170 nM (third 
challenge) (Fig. 2.8B). The first and third KCl-evoked Ca
2+
 responses were not 
significantly different (Fig. 2.10B).    
 






Figure 2.8. Effect of nimodipine and verapamil on KCl-evoked Ca
2+
 entry in INS-
1E cells. (A, B, C) Summary results show the peak (after ~30-35s) increase in [Ca
2+
]c 
evoked by KCl (4  mM  (Δ Ca
2+
]c) for each of the three challenges in each set of 
experiments. Results in A, B and C include only cells that responded to the first 
addition of KCl (94%, 96%, 95% respectively), and show means ± SEM from 3 
independent experiments, with ~104, ~135 and ~111cells analysed in A, B and C 
respectively. 
*
P < 0.05 with one-way analysis of variance and Tukey multiple 
comparisons test. (D) Inhibition of KCl-evoked Ca
2+ 
entry either using nimodipine or 
verapamil.  
 
The effect of ryanodine on KCl-evoked Ca
2+ 
responses was investigated by 
initially challenging INS-1E cells with KCl, then adding ryanodine with KCl for the 
second challenge, and subsequently removing ryanodine before the third KCl-
challenge  The response to  Cl with ryanodine (∆ Ca
2+
]c) was 894 ± 24 nM (second 
challenge), but the KCl alone response was  2 2 ± 86 (first challenge  and 8 7 ± 76 
nM (third challenge) (Fig. 2.9A). These results suggest that most likely ryanodine has 
no effect on KCl-evoked Ca
2+
































































Figure 2.9. Effect of ryanodine on KCl-evoked Ca
2+
 entry in INS-1E cells 
(A) Summary results show the peak (after ~30-35s) increase in [Ca
2+
]c evoked by KCl 
(4  mM  with and without ryanodine (    µM  (Δ Ca
2+
]c) for each of the three 
challenges in each set of experiments. Results include only cells that responded to the 
first addition of KCl (60%), and show means ± SEM from 3 independent experiments, 
with ~75 cells analysed in each. No significant differences were observed. 
 Nimodipine was used to examine whether VOC contribute to the caffeine-evoked 
Ca
2+ 
responses. While performing this experiment DMSO was used as solvent and the 
% of DMSO used to make final nimodipine concentration (10µM) in 5 ml KRH was 
0.2%. INS-1E cells were first stimulated with caffeine alone, nimodipine was then 
added with caffeine during the second challenge, and nimodipine was then removed 
before the third caffeine-challenge. The response to caffeine with nimodipine (∆ Ca
2+
]c) 
was 94 ± 9 nM (second challenge), but the response to caffeine alone was  96 ± 3  nM 
(first challenge  and 65 ± 2  nM (third challenge). The two responses to caffeine after 
exposure to nimodipine (second and third challenges) were significantly different from 
the response to the first stimulation with caffeine (Fig. 2.10). These results show that 
caffeine-evoked Ca
2+
























Figure 2.10. Effect of nimodipine on caffeine-evoked Ca
2+
 signals. Summary results 
show the peak (after ~30-35s) increase in [Ca
2+
]c evoked by caffeine (10 mM) with and 
without nimodipine (   µM  (Δ Ca
2+
]c) for each of the three challenges in each set of 
experiments. Results include only cells that responded to the first addition of caffeine 
(60%), and show means ± SEM from 3 independent experiments, with ~125 cells 
analysed in each. 
*
P < 0.05 with one-way analysis of variance and Tukey multiple 
comparisons test. 
 




INS-1E cells respond to caffeine, CCh and KCl with an increase in [Ca
2+
]c (Fig. 2.2, 
2.3, 2.8), but there was variability in the responses of INS-1E cells to caffeine (Fig. 
2.11), CCh (Fig. 2.12) and KCl (Fig.2.6C, D) between cell batches. The Ca
2+
 responses 
for caffeine-evoked signals were  2-fold higher from the initial set of experiments (Fig. 




release was  2-fold lower in later experiments, and the three 
successive challenges were different (Fig. 2.12B). For KCl-evoked responses, the Ca
2+
 
signals decreased by  0.3-fold (Fig. 2.6D) in comparison to the initial set of experiments 
(Fig. 2.6C). This variability was observed between successive passages making 























Figure 2.11. Variable caffeine-evoked Ca
2+
 signals from different passages of INS-
1E cells. (A, B) Summary results show the peak (after ~30-35s) increase in [Ca
2+
]c 
evoked by caffeine (   mM, 5 min  (Δ Ca
2+
]c) for each of the three challenges in each 
set of experiments. Results in A and B include only cells that responded to the first 
addition of caffeine (78% and 80% in A and B, respectively), and show means ± SEM 
from 3 independent experiments, with ~108 (passage 52) and ~112 cells (passages 57 
and 58) analysed in A and B respectively. 
 
 
Figure 2.12. Variability of CCh-evoked Ca
2+
 signals from different passages of INS-
1E cells. (A, B) Summary results show the peak (after ~30-35s) increase in [Ca
2+
]c 
evoked by CCh (    µM, 5 min  (Δ Ca
2+
]c) for each of the three challenges in each set 
of experiments. Results in A and B include only cells that responded to the first 
addition of CCh (68% and 70% in A and B, respectively), and show means ± SEM 
from 3 independent experiments, with ~ 99 (passage 52) and ~109 cells (passages 57 
and 58) analysed in A and B respectively. 
*
P < 0.05 with one-way analysis of variance 

































































 oscillations in mouse pancreatic islets of 
Langerhans  
Given the variability of the Ca
2+
 signals in INS-1E cells, mouse islets of Langerhans 
were considered as an alternative model for assessing the contributions of RyR to Ca
2+
 
signals in β-cells. Mouse islets of Langerhans showed robust Ca
2+
 oscillations in 
response to glucose (10 mM) for up to 60 min (Fig. 2.13). However, the success rate for 
completing experiments was very low because there were problems with adherence of 
islets (they often detached during sustained recordings) and the cell viability was often 
low.  
 For single-cell imaging experiments, islets were seeded onto poly-L-lysine 
(0.01%)-coated 22-mm round glass coverslips for 24 h under the culture conditions as 
described in section 2.2.3. However, most islets failed to adhere to the coverslips. 
Whilst troubleshooting the adherence problems, islets were plated onto different 
extracellular matrixes such as collagen (0.1%), poly-D-lysine (0.2%), gelatin (0.4%), 
fibronectin (5  μg/ml  and BD Cell Tak ( 2 5 μg/ml  and extracellular matrix (ECM , 
but none of these resolved the issue completely. These issues were addressed using 
different optimisation strategies a) performing experiments at 37°C, b) dye loading and 
de-esterification in serum-free RPMI 1640 medium rather than KRH, however the 
problems mainly persisted.  
 The biggest problem with islets after 24 h of culture was that because of their 
large size, the central core starts to appear necrotic. Probably, it was a consequence of 
inadequate oxygen supply (Kuhn et al., 1985). Hence, even if an islet was attached 
adequately to the coverslip, due to β-cell death at the core of these islets, they did not 
respond to glucose. This issue was addressed by seeding islets immediately after 
isolation onto poly-L-lysine-coated coverslips and performing experiments within 24 h. 
However, the success rate remained very low because of low throughput: a maximum 
of only 2 islets could be viewed per coverslip. Most of the islets did not adhere to the 
coverslips and the islets which adhered did not consistently show glucose-evoked Ca
2+
 
responses. In situations where responses were observed, islets often detached from the 
coverslip before completion of the experiment. Hence, calibration of [Ca
2+
]c signals 
was impossible. These issues made it impossible to obtain sufficient recordings from of 









Figure 2.13. Glucose-evoked Ca
2+ 
oscillation in pancreatic β-cells 
After culturing mouse islets for 2 days, cells were loaded with Fura-2 on the third day. 
A typical trace shows glucose (10mM)-evoked increase in [Ca
2+
]c in a single mouse 
islet. Slow waves showing regular rise and fall in [Ca
2+
]c were associated with fast 
oscillations superimposed upon the plateau when [Ca
2+
]c was elevated.  
 
2.4. Discussion 
Several studies propose that RyR might contribute to regulation of insulin secretion 
during the second phase of insulin release (Johnson et al., 2004; Takasawa et al., 2010). 
Also, in human islets, type 2 DM is associated with reduced expression of RyR2, 
whereas activation of RyR can trigger insulin secretion (Johnson et al., 2004; Squires et 
al., 2004; Takasawa et al., 1998) (see section 2.1.4). Considering these published 
reports, with the long term aims a) to define the presence of RyR in β cells and b  to 
understand the role of RyR in insulin secretion specifically in type 2 DM condition 
following study was designed. Firstly, basic Ca
2+ 
signalling pathways and insulin 
secretion assays were characterised in INS-1E cells. My results establish that in INS-1E 
cells, RyR and IP3R mediate Ca
2+ 
release from intracellular stores (Fig. 2.2B-F, 2.3B, 
D) and L-type VOCs have long been established as a Ca
2+ 
entry pathway (Fig. 2.6A, C) 
(Gustafsson et al., 2005). RyR- and IP3R-mediated Ca
2+ 
release has been shown in 
previous studies (Blondel et al.,  993; Gustafsson et al., 2  5; Woolcott et al., 2  6   
 lso in addition to KCl (Fig. 2.6A, C), RyR (Fig. 2.2A, B) may also be involved in 
Ca
2+
 entry in INS-1E cells.  
 RyR-mediated Ca
2+
 entry and release were further confirmed using ryanodine 
(Fig. 2.4, 2.4). The presence of RyR in pancreatic β-cells cells has also been confirmed 
by others previously (Chen et al.,  996; Gustafsson et al., 2  5; Lemmens et al., 2   ; 

















Mitchell et al., 2  3; Woolcott et al., 2  6   Ryanodine inhibits RyR in a use-
dependent manner. It inhibits open RyR channels, hence causing inhibition of Ca
2+ 
signals mediated by RyR. Partial inhibition of caffeine-evoked Ca
2+
 response in a 
second challenge (Fig. 2.4A, D) might be because of sub-population of open RyR 
channels, which were inhibited by ryanodine. Complete inhibition of the caffeine-
evoked Ca
2+
 response in the third challenge (Fig. 2.4A, D) is possibly because, by the 
third caffeine stimulation, all remaining RyR may be open to be inhibited by ryanodine. 
The use-dependent effect of ryanodine is well established (Chen et al,  996).  
 These results suggest that the caffeine-evoked Ca
2+
 entry and release are probably 
mediated via RyR located on PM (Moonga et al., 2002; Rosker et al., 2009) and in 
stores. RyR located on PM may cause Ca
2+
 entry via three mechanisms (Fig. 2.14). 
Firstly, indirectly by activation of Ca
2+
-sensitive non-selective cation channels like 
transient receptor potential (TRP) channels, specifically TRPM4 or TRPM5 (Cheng et 
al., 2007; Liman, 2010). These might cause further depolarization and so greater 
activation of  L-type VOC (Fig. 2.14). Secondly, by causing PM depolarization by 
itself. A small number of RyRs in the PM may be sufficient as both RyR and IP3R have 
large conductance, hence very few channels can mediate significant Ca
2+
 entry (Fig. 
2.14) (Dellis et al., 2006; Rosker et al., 2009). A third mechanism for Ca
2+
 entry across 
the plasma membrane involves activation of SOCE, stimulated by Ca
2+ 
release from 
intracellular stores RyR (Fig. 2.14) (Holz, 2  4; Holz et al.,  999 . Apart from these an 
additional effect of caffeine observed by Islam et al. (1995) was that caffeine by 
inhibiting PDE probably increases intracellular cAMP accumulation, which may further 
stimulate Ca
2+
 entry via PKA phosphorylation of VOC (Islam et al., 1995)  My results 
have not thus far discriminated between the three alternatives. The caffeine-evoked 
Ca
2+
 entry observed could be due to Ca
2+
entry via directly by RyR activation, increased 










Figure 2.14. Novel ryanodine receptor-mediated Ca
2+ 
entry pathway in pancreatic 
β-cell. (A) Ca
2+ 
entry mediated by VOC. (B) Ca
2+
 entry mediated by plasma membrane 
localised ryanodine receptor (RyR) directly or indirectly by depolarising VOCs. (C). 
Ca
2+




signals were not affected by inhibition of RyR (Fig  2.5    Data 
obtained from this work corroborate what others have previously shown (Graves et al., 
2003; MacMillan et al., 2005). This perhaps suggests that CCh-evoked Ca
2 
 release 
pathways are independent of caffeine-evoked Ca
2 
 release pathways  However, 
caffeine-evoked Ca
2+
 signals should be assessed in the presence of an IP3R inhibitor to 
prove this argument. The decrease observed in CCh-evoked Ca
2+
 responses in the third 
challenge (Fig. 2.5A), might be a consequence of ryanodine treatment in the second 
challenge (Fig. 2.5A). Perhaps high ryanodine concentrations inhibited other PM non-
selective ion channels like TRP channels or/and unknown receptors in internal stores or 
caused a change in membrane potential, which affect IP3-mediated Ca
2+
 release 
(MacMillan et al., 2005). In pancreatic β-cells (Renuka et al., 2  6; Tamarina et al., 
2  5 , glucose stimulates PLC, leading to the formation of IP3 and D G  In a few 
reports IP3R-mediated Ca
2 
 release is associated with weak SOCE in pancreatic β-cells 
(Dyachok et al., 2   ; Dyachok et al., 2  4   Perhaps in my results Ca
2  
release seen in 
Ca
2 
-free conditions (Fig. 2.4B), could be responsible for triggering weak SOCE in the 





 entry mediated by VOC is well characterized in pancreatic β-






















agreement with these previous studies. Using two approaches these results were further 
confirmed a) by performing experiments under Ca
2+
-free conditions (Fig. 2.6B, D) and 
b) by using L-type VOC blocker such as nimodipine (Szollosi et al., 2010) and 
verapamil (Fig. 2.8). 
 When compared, the Ca
2 
 response observed via  Cl-evoked Ca
2 
 entry (Fig  
2 8 , C  is considerably higher compared to Ca
2 
 signals evoked by caffeine (Fig  
2 2 , D  and CCh (Fig  2 3 , C   It might indicate that in pancreatic β-cells, a major 
contribution of Ca
2 
 entry is via VOC  Previously, it was shown that Ca
2 
entry via VOC 




 release (CICR  (Lemmens et al., 2      Possibly, 
in my data (Fig  2 6 , C  the initial rise in  Cl-evoked Ca
2 
 entry could be due to 
activation of VOC  The Ca
2 
-entry from the VOC could then stimulate CICR, and the 
subsequent depletion of the ER stores could activate SOCE, which may explain the 
sustained components of the  Cl-evoked Ca
2 
 responses (Dyachok et al., 2001; Liu et 
al., 1997). Inhibition of RyR did not affect KCl-evoked Ca
2+ 
signals (Fig. 2.9) (Graves 
et al., 2003; Gustafsson et al., 2005; Holz et al., 1999). Hence, KCl-evoked Ca
2+
 entry 
was found not to be associated with CICR. Alternatively, caffeine-evoked Ca
2+ 
signals 
were significantly affected by inhibition of L-type VOC (Fig. 2.10). These results land 
support to the hypothesis that PM RyR may mediate Ca
2+
 entry.  
 A residual KCl-evoked Ca
2+
entry in second challenge is observed after inhibition 
of L-type VOC (Fig. 2.8A) using nimodipine. It could be because a) due to activation 
of other VOC present in pancreatic β-cells like the P/Q type VOC and non-selective 
cation channels like TRP channels, which are found in pancreatic β-cells, b) due to 
lower sensitivity of β-cells to nimodipine. The latter has been previously reported, 
whereby human β-cells showed differential expression of L-type Ca
2+
 channel 
subtypes, containing more Cav 1.3 channels, which are less sensitive to nimodipine 
than Cav 1.2 channels (Pollo et al., 1993). Hence, by using verapamil (Fig. 2.8B) I 
further confirmed that Ca
2+
 entry is also mediated by L-type VOC. Others have also 
observed inhibition of KCl-evoked Ca
2+
 signals using verapamil (Findlay et al., 1985; 
Wollheim et al., 1984). 
 Despite characterising Ca
2+ 
entry and release pathway in INS-1E cells, these cells 
were found to be impracticable to examine the physiological role and location of RyR 
in pancreatic β-cells because INS-1E cells did not show reproducible Ca
2+
 signals when 
stimulated with caffeine, CCh and KCl, over different passages (Fig. 2.6C, D, 2.11, 
2.12). These cells were found not to be suitable to perform 96-well plate population-




based assays (Tovey et al., 2006) as that demands confluent, adherent cultures of cells 
in a monolayer and INS-1E cells do not grow in monolayers. Dr Nadia Shah from our 
research group has shown that the INS-1E cells used in this study failed to exhibit the 
characteristic GSIS. Work carried out by Dr Nadia Shah suggested the INS-1E cells 
had developed a hypersensitive response to sub-physiological glucose levels and 
additionally failed to show the characteristic dose-dependent GSIS. This is most likely 
due to following reasons  
 a) the de-differentiation of INS-1E cells back to an insulinoma type, which has 
been previously observed  in other β-cell lines (Efrat, 1999). This occurs due to an 
increase in hexokinase activity required to overcome the metabolic demands of rapidly 
dividing cells (Efrat, 1999).  
 b) One of the major causes for type 2 DM is persistently increased glucose 
concentration in plasma. It results in decreased sensitivity to glucose, and 
accompanying insulin resistance. Previously, it is published that culturing of INS-1 
cells at high glucose concentration (≥   mM  causes reduction in insulin gene 
transcription and decreases binding activity of β-cell specific transcription factors STF1 
and C activators (Olson et al., 1998). Although my experiments are unlikely to be prone 
to glucose-evoked insulin resistance (because that is a response at target tissue), but 
they may be prone to local accumulation of insulin in culture feeding back to affect 
GSIS. Yet, the possibilities  of  chronic exposure of INS-1E cells to the 
supraphysiological concentration of glucose (≥  mM  present in the growth medium 
affected the characteristic responses of INS-1E cell line reported by Merglen et al 
(2003) cannot be ruled out completely. 
 In addition to this it is also suggested that higher glucose concentrations (≥ 
11mM) in growth medium causes toxicity of β-cells. The toxic effect arising due to 
higher glucose concentrations can be reversed, if cells were grown at lower glucose 
concentration (≥ 2.5mM) within few weeks of higher glucose concentration exposure. 
However; it is irreversible if cells were cultured at higher glucose concentrations for 
months (Eizirik et al., 1992; Gleason et al., 2000). Perhaps this glucose toxic effect is 
could also be responsible for changes in caffeine, CCh and KCl-evoked Ca
2+
 responses 
with the increasing passage numbers.. In contrast to these reports, others have observed  
GSIS in INS-1E cells even after growing in culture medium supplemented with ≥11 
mM glucose (Gamberucci et al., 1999; Kang et al., 2003; Zuniga-Hertz et al., 2015), 
yet the possibility of developing diabetic β-cell characteristic in INS-1E cells cannot be 




ruled out. The only alternative is to grow INS-1E cells in culture medium supplemented 
with ≤2.5 mM glucose and then measure GSIS. It is shown that cells grown under these 
conditions show reproducible Ca
2+ 
signals and GSIS. To measure GSIS cells were 
bathed in glucose free medium for  2 hr before assessing insulin secretion (Maechler et 
al., 2000; Maechler et al., 2000). Presumably it enhances GSIS upon stimulation with 
different glucose concentrations. In addition to these improvements in culturing INS-1E 
cells, the best alternative to replace INS-1E was to use primary mouse pancreatic islets 
of Langerhans. Glucose-evoked Ca
2+ 
oscillations in mouse pancreatic islets of 
Langerhans have been observed previously (Fridlyand et al., 2010). However this 
alternative was also found unworkable. 
 My primary results conclude that in INS-1E cells RyR and IP3R mediates Ca
2+
 
release and VOC mediates Ca
2+
 entry. Additionally, Ca
2+
 entry is also found to be 
sensitive to caffeine and ryanodine. However, due to inconsistent response of INS-1E 
cells and primary mouse islets this project was impossible to carry on for this thesis. 
Hence, the direction of this thesis was changed to study Ca
2+
 signalling mediated via 
PTH receptors (Chapter 2 and 3). 
2.5. Conclusions  





 entry is largely mediated by L-type VOC. These observations are 
consistent with many published analysis of β-cells and INS-1E cells (Blondel et al., 
 993; Gustafsson et al., 2  5; Woolcott et al., 2  6 . Ca
2+
 entry may be mediated 
directly by plasma membrane ryanodine receptors (Rosker et al., 2009), it may result 
from release of Ca
2+
 via intracellular RyR causing activation of Ca
2+
-sensitive non- 
selective cation channels or it may mediated by store-operated Ca
2+ 
entry after release 
of Ca
2+
 via intracellular RyR. However, results also provided evidence for a Ca
2+
 entry 
pathway that is sensitive to caffeine and/or ryanodine. I consider these possible 








Chapter 3. Potentiation of carbachol-evoked Ca
2+
 signals by 
acute and sustained stimulation by PTH is mediated by 
cAMP  
3.1. Introduction  
 
3.1.1. Parathyroid hormone  
In the chief cells of the parathyroid glands, parathyroid hormone (PTH) is synthesised 
as a precursor protein, pre-pro PTH (115 residues) (Habener et al., 1975; Kemper et al., 
1974). The 'pre' sequence (25 residues ) directs the pre-proPTH mRNA-ribosome 
complex towards the ER, where the hydrophobic nature of the 'pre' sequence facilitates 
penetration of pre-pro PTH across the ER membrane (Habener et al., 1978). Cleavage 
of the 'pre' sequence from proPTH occurs within the ER inter-cisternal space, before its 
entry into the ER (Habener et al., 1979; Habener et al., 1979). The 'pro' sequence is a 
short peptide, similar to other secretory proteins for example proalbumin (Patterson et 
al., 1977) and targets PTH to the Golgi apparatus. Within the Golgi, the 'pro' sequence 
is cleaved from the N-terminal region of the pro-PTH and the mature 84-residue PTH 
peptide is then packaged into vesicles before regulated release (Habener et al., 1979) 
into the plasma.  
 Secretion of PTH from chief cells is controlled by the concentration of Ca
2+





]ECF inhibits secretion, whereas lower 
[Ca
2+
]ECF stimulates it (Care et al., 1966). Ca
2 +





and regulate secretion of PTH (Brown, 1993; Brown, 2013; Brown et al., 
2001; Racke et al., 1993). In addition to an increase in [Ca
2+
]ECF, secretion of PTH in 
vivo also depends on the rate at which [Ca
2+
]ECF changes. This contributes to a steep 
inverse sigmoidal relationship between [Ca
2+
]ECF and secreted PTH (Brown et al., 2001; 
Grant et al., 1990). These characteristics ensure that chief cells secrete higher amounts 
of PTH into the blood plasma soon after a rapid decrease in plasma [Ca
2+
]. PTH leads 
to an increase in the plasma [Ca
2+
] and a decrease in plasma phosphate levels (Brown et 
al., 2001). PTH either directly or indirectly affects the kidney (Gesek et al., 1992; Knox 
et al., 1975), bone (Hurwitz, 1996) and small intestine to regulate plasma [Ca
2+
] 
(Hurwitz, 1996; Nemere et al., 1986; Yoshimoto et al., 1986). In the kidney, PTH 




stimulates phosphate secretion (Grose et al., 1968; Mercado et al., 1975) and Ca
2+
 
reabsorption from the distal tubule (Houillier, 2013; Jeon, 2008). PTH also up regulates 
the activity of  α-hydroxylase, the enzyme responsible for biosynthesis of 1,25-
dihydroxy vitamin D3 (Fraser et al., 1973; Takeyama et al., 1997). PTH, by increasing 
the formation of 1,25-dihydroxyvitamin D3, increases the absorption of both Ca
2+
 and 
phosphate from the intestine. PTH also promotes release of Ca
2+
 and phosphate from 
the bone matrix (Boden et al., 1990; Christakos et al., 2014). The effects of PTH on the 
balance between the absorption of Ca
2+
 from the intestine, release of Ca
2+
 as from bone, 
and Ca
2+ 
reabsorption by the kidney restore the normal [Ca
2+




Figure 3.1. Regulation of [Ca
2+
]ECF  by the endocrine system. A decrease in [Ca
2+
]ECF  
stimulates release of PTH from the parathyroid gland. Increased PTH levels in 
extracellular fluid stimulate processes that restore normal [Ca
2+
]ECF. These include 
increased Ca
2+ 
resorption from bone, increased Ca
2+ 
reabsorption from kidney cells, and 
reduced Ca
2+
 loss from small intestine mediated by the effects of PTH on vitamin D 
























3.1.2. Parathyroid hormone receptors 
Three PTH receptor (PTHR) subtypes have been identified and cloned: parathyroid 
hormone receptor type 1 (PTH1R) (Abou-Samra et al., 1992; Juppner et al., 1991), 
parathyroid hormone receptor type 2 (PTH2R) (Usdin et al., 1995) and parathyroid 
hormone receptor type 3 PTH3R (Rubin et al., 1999; Rubin et al., 1999). Each PTHR 
type shows significant variation in its tissue distribution and ligand specificity. PTH1R, 
is primarily expressed in kidney and bone cells (Tian et al., 1993; Urena et al., 1993). 
PTH and PTH-related peptide (PTHrP), a different gene product with significant N-
terminal homology with PTH, show similar potency for activation of PTH1R (Abou-
Samra et al., 1992; Juppner et al., 1991). PTH2R, which shares 30-60% amino acid 
identity with PTH1R, is expressed mainly in brain and pancreatic tissues (Usdin et al., 
1995). In contrast with PTH1R, PTH2R is activated only by PTH, but not by PTHrP 
(Usdin et al., 1995). In addition to PTH, PTH2R can also be potently activated by an N-
terminal 39-residue tuberoinfundibular peptide (TIP39), an endogenous peptide found 
in the hypothalamus (Dobolyi et al., 2002; Usdin et al., 2002; Usdin et al., 1999). 
PTH3R was first identified and cloned from zebrafish. The identification was based on 
its similarity to zebrafish PTH2R (Rubin et al., 1999; Rubin et al., 1999). Zebrafish 
PTH3R was potently activated by PTH in comparison to PTHrP. No known mammalian 
homologue of zPTH3R has been identified (Hoare et al., 2000). 
 PTHRs belong to the GPCR class II family. Other receptors that belong to this 
family include the receptors for glucagon, calcitonin, secretin, and vasoactive intestinal 
peptide (Harmar, 2001; Mannstadt et al., 1999; Pellegrini et al., 1998). It is established 
that PTH1R and PTH2R couple to at least two intracellular signalling pathways: Gs 
which stimulates AC, and Gq  which stimulates PLC (Abou-Samra et al., 1992; Behar 
et al., 1996; Huang et al., 1996; Usdin et al., 1995) . This coupling to dual signalling 
pathways is a characteristic feature of class II GPCR (Abou-Samra et al., 1992; Behar 
et al., 1996; Iida-Klein et al., 1992; Jelinek et al., 1993). In comparison to PTH1R and 
PTH2R, less is known about the signalling pathways activated by zPTH3R. However, a 
few studies suggest that binding of PTH to these receptors stimulates cAMP formation 
(Rubin et al., 1999). 




3.1.3. The binding domain of PTH1R 
PTH is a polypeptide and consists of 84-residues (PTH(1-84)). However, it is well 
established that the first 34 residues at the N-terminal region are fully active and 
stimulate responses both in vivo and in vitro (Potts et al., 1971; Tregear et al., 1973). 
The C-terminal residues may protect the peptide from enzymatic degradation in vivo 
(O'Riordan et al., 1973; Potts et al., 1971; Tregear et al., 1973). 
 Comparison of PTH(1-34) sequences from ten different animal species has 
revealed that the first six N-terminal residues are highly conserved among all these 
species. Hence, this region is important for either binding or activation of the PTH1R. 




hPTH(1-34) NH2, it was shown that Val
2
 is 
crucial for activation, and Glu
4
 for binding of PTH(1-34) to PTH1R (Gardella et al., 
1991). The second important binding domain of PTH(1-34) peptide to PTH1R exists in 
the C-terminus and is highly conserved among all animal forms of PTH (Toribio et al., 
2002). Sequential truncation of C-terminal residues show that residues between 15-34 
of PTH(1-34) form a C-terminal domain that is involved in receptor binding (Caulfield 
et al., 1990; Gardella et al., 1993; Nussbaum et al., 1980). In comparison to the first 
and second binding domains of PTH(1-34), the third domain consists of only 1 residue 
i.e. Lys at position 13. Deletions or mutations in any of these receptor-binding regions 
cause a substantial loss in the binding to and activation of PTH1R by PTH (Adams et 
al., 1998; Zhou et al., 1997). 
 Similar to PTH(1-34), three important ligand-binding domains have been 
specified within the tertiary structure of PTH1R. The N-terminal domain, the juxta-
membrane region of the transmembrane domains, and the extracellular loops (Behar et 
al., 2000; Bergwitz et al., 1996; Hoare et al., 2001; Juppner et al., 1994). Almost all 
members of class II GPCR have six highly conserved extracellular cysteine residues 
within the N-terminal region (Lee et al., 1994). These residues form disulphide bonds 
(Grauschopf et al., 2000) that may allow the PTH1R to attain a conformation needed for 
binding of the 25-32-residue C-terminus of PTH (Pellegrini et al., 1998). Additionally, 
chimeric human/rat and rat/human PTH1R hybrids confirmed the interaction of the N-
terminus of PTH1R with the C-terminal domain of PTH(1-34) (Juppner et al., 1994). 
From other chimeric studies, it was confirmed that the fifth transmembrane domain of 
PTH1R interacts with the N-terminal domain of PTH(1-34) (Gardella et al., 1994). The 
PTH1R second ligand-binding domain (the juxtamembrane region of PTH1R) binds to 






 (a highly conserved lysine) and 19
th
 residues of PTH(1-34) (Adams et al., 
1998; Pellegrini et al., 1998; Shimizu et al., 2002). The PTH1R first extracellular loop 
is important for binding with the mid-region of PTH(1-34) (Greenberg et al., 2000; 
Piserchio et al., 2000) and the third extracellular loop binds exclusively with N-
terminal residues (residues 1 and 2) of PTH(1-34) (Hoare et al., 2001).  
 
3.1.4. Coupling of PTH1R to Gs 
Stimulation with PTH activates cAMP formation in cells expressing endogenous 
(Chase et al., 1967; Mine et al., 1989; Smith et al., 1975) or recombinant PTH1R 
(Abou-Samra et al., 1992; Pines et al., 1994; Takasu et al., 1999; Tovey et al., 2008). 
These studies also confirmed that PTH activates cAMP formation at very low 
concentrations in comparison to those required for Ca
2+
 responses. 
 The plasma membrane-localised AC converts ATP to cAMP, after the activation 
of Gs-coupled receptors (Simonds, 1999). These results suggest that stimulation with 
PTH activates cAMP formation, via coupling of PTH1R with Gs and thereby activation 
of AC. This hypothesis was proved in a study where in HEK-PR1 cells PTH(1-34) via 
PTH1R enhanced the photo-labelling of Gs by a photoreactive GTP analogue 
(Schwindinger et al., 1998).  
 Higaki et al. (1992) suggested that insertion of Zn
2+
 bridges between two 
histidine residues can block the mobilization of  two regions of a protein relative to 
each other (Higaki et al., 1992). A related investigation was done on PTH1R receptors 
and revealed that formation of Zn
2+ 
bridges between transmembrane domains 3 and 6 of 
PTH1R inhibits the activation of Gs (Sheikh et al., 1999). Binding of PTH might 
change the conformation of transmembrane domains 3 and 6, thereby allowing Gs to 
gain access to PTH1R (Sheikh et al., 1999). Further, studies performed using chimeras 
of the secretin receptor and PTH1R also supported the contribution of transmembrane 
domains 3 and 6 in the activation of Gs (Vilardaga et al., 2001). In a chimera consisting 
of cytoplasmic and transmembrane domains of the secretin receptor and the 
extracellular domains of PTH1R, substitution of transmembrane domains 3 and 6 with 
that of PTH1R showed an increase in cAMP levels when stimulated with PTH 
(Vilardaga et al., 2001)  In addition to this, in common with β-adrenoceptors, mutations 
in the N-terminal regions of the third intracellular loop of PTH1R significantly affect Gs 
coupling (Huang et al., 1996; Ostrowski et al., 1992). In COS-7 cells substitution of 






 with Ala within the N-terminal loop of the third transmembrane domain of 





 are critical for showing the similar effect. Hence, possibly 
Gαs-GDP binds to the third intracellular loop of PTH1R and with PTH binding, 
transmembrane domains 3 and 6 separate and GDP is replaced with GTP on Gαs  
 Besides, cAMP formation, coupling of PTH1R with Gi causes inhibition of cAMP 
formation which has been proved in photoaffinity labelling (Schwindinger et al., 1998) 
and functional studies (Iida-Klein et al., 1995; Pines et al., 1994). Pertussis toxin, 
which inhibits coupling of Gi to associated GPCR enhanced PTH-stimulated cAMP 
formation in COS-7 cells (Iida-Klein et al., 1995; Pines et al., 1994). Deletion of the C-
terminal tail of PTH1R also increased PTH-stimulated cAMP formation and 
interestingly it was unaffected by pre-treatment with pertussis toxin. This shows that 
the PTH1R C-terminal tail couples with Gi (Iida-Klein et al., 1995). These observations 
show that a single receptor can either activate or inhibit  C  Other receptors like β2-
adrenoceptors also share similar properties (Xiao et al., 1999; Xiao et al., 1995). The 
change of β2-adrenoceptor coupling from Gs to Gi is regulated by the PKA-mediated 
phosphorylation of the receptor (Daaka et al., 1997). The importance for the present 
work is that binding of different PTH analogues to PTH1R stimulates AC and thereby 
cAMP formation. Subsequently, the cAMP produced potentiates release of Ca
2+
 from 
intracellular stores (Fig. 3.2) (Tovey et al., 2008). 
 
3.1.5. Regulation of [Ca
2+
]c by PTH 
PTH stimulates both several Ca
2+
 entry pathways and release of Ca
2+
 from intracellular 
stores. In, for example, hepatocytes (Klin et al., 1994), smooth muscle cells (Picotto et 
al., 1997) and cardiac myocytes, (Rampe et al., 1991), stimulation with PTH causes 
Ca
2+
 entry across the PM. Whole-cell recording confirms that stimulation with PTH 
increases  the probability of Ca
2+ 
channel opening and use of selective L-type Ca
2+ 
blockers such as nimodipine and verapamil confirms that PTH modulates Ca
2+
 entry by 
L-type Ca
2+
 channels (Klin et al., 1994; Picotto et al., 1997; Rampe et al., 1991). The 
PTH-potentiated Ca
2+ 
entry is dependent on cAMP and PKA, and mimicked by cell-
permeable cAMP analogues (Fritsch et al., 1988; Klin et al., 1994; Picotto et al., 1997; 
Smogorzewski et al., 1993) and agonists of AC like forskolin (Picotto et al., 1997; 
Smogorzewski et al., 1993). Inhibition of PKA, using H89, blocked PTH-mediated 






 entry consistent with PKA stimulating L-type Ca
2+
 channels (Klin et al., 1994; 
Picotto et al., 1997). 
 PTH hyperpolarises the plasma membrane of osteoblasts (Ferrier et al., 1988; 
Fritsch et al., 1988) and distal convoluted tubule cells (Barry et al., 1998), perhaps due 
to Ca
2+
-mediated activation of K
+
 channels (Ferrier et al., 1988). The exact identity of 
the Ca
2+ 
channels responsible is unclear, but their pharmacology is consistent with them 
being VOC (Barry et al., 1998; Friedman et al., 1994; Gesek et al., 1992; Matsunaga et 
al., 1994). 
 In osteoblasts (Dunlay et al., 1990; Kaplan et al., 1995; Wiltink et al., 1993) and 
kidney cells (Dunlay et al., 1990; Schwindinger et al., 1998), PTH potentiates release 
of Ca
2+ 
from intracellular stores. In these cells expressing either recombinant (Abou-
Samra et al., 1992; Bringhurst et al., 1993; Pines et al., 1996; Takasu et al., 1999) or 
endogenous (Dunlay et al., 1990; Kaplan et al., 1995; Wiltink et al., 1993) PTH1R, 
stimulation with PTH causes formation of IP3. This suggests that PTH1R might 
stimulate PLC via Gq proteins. This hypothesis was proved by Schwindinger et al. in 
1998, using a photo-affinity label linking with GTP which showed that PTH1R can 





ATPase by PTH in renal proximal tubules, which is mediated by AA, was inhibited by 
anti-Gq/11 antibodies (Derrickson et al., 1997). 
 Binding of PTH within the N-terminal tail region of PTH1R stimulates coupling 
of PTH1R similarly for both Gq and Gs proteins. The binding site for Gq proteins 
within the N-terminal tail region (third intracellular loop) of the PTH1R is adjacent to 
the Gs-binding site (Huang et al., 1996). The ability of PTH1R to couple with Gq and 
Gs is dependent on the number of expressed PTH1R (Guo et al., 1995; Schwindinger et 
al., 1998). In cells expressing PTH1R ( 4       receptors/cell , receptors couple to both 
Gq and Gs, whereas, with fewer receptors (  72     receptors/cell), PTH1R 
preferentially couples to only Gs (Guo et al., 1995; Schwindinger et al., 1998). In 
kidney and bone cells, the characteristics of PTH to stimulate dual signalling pathways 
might be due to higher numbers of expressed PTH1R receptors (Takasu et al., 1999; 
Takasu et al., 1999). There are a few other settings where stimulation with PTH 
potentiated release of Ca
2+
 from intracellular stores, which was not mediated via the 
Gq/PLC signalling pathway. In rat osteosarcoma cells, no IP3 formation was observed 
when stimulated with PTH (Babich et al., 1991; Seuwen et al., 1995), also inhibition of 
IP3R using heparin in HEK-293 cells also did not affect PTH-potentiated release of 






 (Seuwen et al., 1995; Tong et al., 1996). If IP3 did not mediate the potentiation of 
Ca
2+
 release by PTH, then it was obvious to consider contributions from NAADP and 
cADPR. However, experimental data reported by Tong et al. (1996) indicates that 
neither NAADP nor cADPR were associated with PTH-evoked Ca
2+
 release. In 
addition, inhibition of RyR did not affect PTH-potentiated Ca
2+
 release (Seuwen et al., 
1995). The significance for the present work is that binding of different PTH analogues 
to PTH1R stimulates either Gq or Gs, or both signalling pathways and thereby leads to 
the formation of IP3 or cAMP respectively. These second messengers, either 
independently or in combination (Tovey et al., 2008), regulate release of Ca
2+
 from 
intracellular stores (Fig. 3.2). 
 
3.1.6. Selective activation of signalling pathways using PTH analogues 
PTH analogues have been designed and used to show different signalling pathways 
triggered upon binding of PTH to PTH1R (Table 3.1). Modifications in the PTH1R 
expression density on the cell surface can also favour selective coupling to AC or PLC 
(Guo et al., 2010; Mahon, 2012; Taylor et al., 2012). Association of the C-terminal tail 




 exchange regulatory factors-1/2 (NHERF-
1/2), both of which are expressed in HEK cells (Wang et al., 2010), favours coupling 
via Gq and/or Gi/o to PLCβ (Mahon, 2012; Wang et al., 2007). cAMP can also 
indirectly stimulate IP3 formation. As binding of cAMP to Epac1 has been reported to 
allow it to activate the small G protein, Rap 2B, and it then stimulates PLCε (Schmidt 
et al., 2001). In the present work different PTH analogues have been used to scrutinize 























Cell types References 
PTH(1-34) 












(Bisello et al., 
2002; Castro et 
al., 2002; Cupp 
et al., 2013; van 














(Bisello et al., 
2002; Cupp et 
al., 2013; Dean 
et al., 2008) 








(Cupp et al., 
2013) 
PTH(1-31) 










(Cupp et al., 












(Cupp et al., 
2013; van der 












(Cupp et al., 
2013) 
 
Table 3.1. Examples of PTH analogues that allow selective coupling of PTH1R to 
Gs and Gq 
 
 




3.1.7. Sustained signalling from type 1 PTH receptor 
Binding of PTH and PTHrP to PTH1R follows a two-step process. The first step 
involves an interaction between the C-terminal residue, the binding domain of the 
ligand, and the large extracellular N-terminal domain of the PTH1R. Second, a slow 
interaction between the N-terminal signalling domain of the ligand with the 
juxtamembrane (J) region of the PTH1R, which consists of the extracellular loops and 
seven transmembrane helices. The resulting high-affinity complex between the ligand 
and PTH1R acquires a conformation capable of interacting selectively with a G protein 
or other signalling proteins (Dean et al., 2006; Ferrandon et al., 2009). 
 PTH1R has the capacity to form two pharmacologically distinct, high-affinity, 
conformational states. One conformation called 'RG', is sensitive to GTPγS and is 
therefore most probably associated with heterotrimeric G proteins. A second 
conformation, termed R
0
, is insensitive to GTPγS and is therefore functionally 
uncoupled from G proteins (Dean et al., 2008; Okazaki et al., 2008). PTH or PTHrP 
residues that interact with the J-domain of the receptor are important in determining the 
signalling proteins with which active PTH1R interacts (Cupp et al., 2013; Ferrandon et 
al., 2009; Pioszak et al., 2009). Different analogues of PTH(1-34) favour PTH1R 
coupling to G protein or to the other signalling protein, according to their specific mode 
of activation (Table 3.1). 
 The signalling pathways activated by different analogues of PTH(1-34) are GPCR 
kinases (GR   and β-arrestin (Gesty-Palmer et al., 2011). PTH1R binding to β-arrestin 
triggers PTH1R desensitization by uncoupling receptors from G-proteins (Feinstein et 
al., 2011)  However, β-arrestin can also recruit additional signalling pathways, like 
extracellular signal-regulated kinases (ERK 1/2) (Gesty-Palmer et al., 2006). In 
addition to these interactions, recently it has been shown that binding of PTH(1-34) to 
PTH1R initiates internalization of active PTH1R/Gs/AC signalling complexes 
(Ferrandon et al., 2009). 
 Modification in the N-terminus of PTH(1-34) showed even more selectivity than 
PTH(1-34) itself for the R
0
 conformation (Okazaki et al., 2008). In whole cells, acute 
incubation with analogues that bind most selectively to R
0
, form longer-lasting 
complexes with PTH1R, more sustained activation of PTH1R and Gs, and more 
sustained stimulation of AC (Dean et al., 2008; Ferrandon et al., 2009; Okazaki et al., 
2008). Thus, AC activity measured 60 min after brief (10 min) exposure to PTH(1-34) 




is greater than for PTHrP(1-36), even though the initial response to each is similar 
(Bisello et al., 2002; Vilardaga et al., 2002). Nevertheless, long-lasting active G-
protein-coupled signalling via N-terminally modified PTHrP(1-36) has also been 
observed (Bisello et al., 2002). 
 Most likely two factors are accountable for the sustained activation of AC by 
PTH(1-34). Firstly, the high-affinity R
0
-PTH complex may provide a pool of PTH(1-
34)-bound PTH1R that can isomerize to the RG conformation, and so sustain activation 
of Gs at the plasma membrane after removal of free PTH(1-34). Secondly, and possibly 
more importantly, brief stimulation with PTH(1-34) causes fast internalization of 
functional PTH∙PTH1R∙Gs/β-arrestin∙ C signalling complexes via a β-arrestin- and 
dynamin-dependent endocytic pathway (van der Lee et al., 2013). These complexes, in 
which β-arrestin facilitates rather than blocks Gs activation (Wehbi et al., 2013), 
continue to generate cAMP from early endosomal compartments (Feinstein et al., 2011; 
Ferrandon et al., 2009). 
 Termination of signalling takes place when the retromer protein complex directs 
the signalling proteins towards the Golgi apparatus (Feinstein et al., 2011). PTHrP(1-
36) does not evoke this internalization (Ferrandon et al., 2009). Similar agonist-evoked 
internalization of functional signalling pathways has been reported for other GPCRs 
(Calebiro et al., 2009; Calebiro et al., 2010; Irannejad et al., 2013). The significance for 
the present work is that internalized PTH1R signalling complexes and those at the 
plasma membrane may deliver cAMP to different intracellular compartments. 
 
3.1.8. PTH triggers crosstalk between cAMP and Ca
2+ 
PTH potentiates the Ca
2+
 release evoked by IP3-linked agonists (Buckley et al., 2001; 
Short et al., 2000; Tovey et al., 2003). Low PTH concentrations did not stimulate IP3 
formation or Ca
2+
 release on their own, but they significantly potentiated the Ca
2+
 
release evoked by CCh (Buckley et al., 2001; Short et al., 2000; Tovey et al., 2003). 
Surprisingly, PTH potentiated the amount of Ca
2+
 release even by maximal CCh 
concentrations (Short et al., 2000; Tovey et al., 2003). Similar to PTH(1-34), forskolin 
(FK), which stimulates AC directly, 8-Br-cAMP, a membrane-permeant cAMP 
analogue and other agonists which activate AC through endogenous receptors (Tovey et 
al., 2008), potentiated CCh-evoked Ca
2+
 responses. Although higher cAMP levels are 




required to mimic PTH(1-34) effects as the level of cAMP formation using FK and 
prostaglandin E1 was less in comparison to PTH.  
 Potentiation of CCh-evoked Ca
2+
 release by PTH(1-34), FK or 8-Br-cAMP was 
not mediated by PKA or Epac1/2 (Tovey et al., 2010; Tovey et al., 2008) since 
inhibition of PKA did not affect the CCh-evoked Ca
2+ 
signal. By contrast PKA 
inhibition prevented FK-, PTH-, and 8-Br-cAMP-stimulated phosphorylation of various 
proteins in HEK-PR1 cells. Similarly, stimulation of HEK-PR1 cells with 8-Br-2′-O-
methyladenosine-3′,5′-cAMP which  selectively activates Epacs (Christensen et al., 
2003)  had no effect on CCh-evoked Ca
2+
 signals, whereas 8-Br-cAMP potentiated 
them. Although, these results suggested that PKA and Epac1/2 are not involved but the 
possibility cannot be ruled out as the role of Epac1/2 should have been confirmed by 
using specific and non toxic inhibitor, which have  not been available until now.   
 Increasing intracellular cAMP levels by inhibiting PDE using IBMX did not 
potentiate the CCh response. Furthermore reducing the cAMP formation (by almost   
80%) by inhibiting AC with SQ22536/2',5'-dideoxyadenosine (SQ/DDA) did not affect 
the ability of PTH(1-34) to potentiate responses to CCh (Tovey et al., 2008). The 
calculated global intracellular cAMP was ~1000-fold too low to affect all the 
intracellular IP3R. Therefore, it was entirely clear that the effects of IBMX are 
insufficient to allow cAMP to globally regulate IP3Rs. These results can be explained if 
cAMP signalling occurs locally within a hyperactive signalling complex i.e. 'cAMP 
junctions', where IP3R and AC are associated. Tovey et al. (2008) proposed that within 
this complex super-saturating cAMP concentrations pass directly from AC to IP3R, and 
are inaccessible to PDE. Upon stimulation, AC generates more cAMP than needed to 
maximally sensitize IP3R. Thus, it operates with a large safety margin which enables 
IP3R sensitization even when cAMP production is substantially reduced by inhibiting 
AC. This hypothesis was further supported  by complete inhibition of cAMP formation 
in a few c MP junctions, achieved by inhibition of expression of Gαs by means of 
siRNA, which affected PTH potentiation more strongly than partial inhibition of all AC 
(Tovey et al., 2008).  
 It was suggested that possibly the low affinity of IP3R for cAMP ensures 
junctions are isolated from surrounding AC-IP3R complexes, because the super-
saturating cAMP concentration needed to effectively sensitize IP3R is not achieved by 
diffusing cAMP. In this setting, the concentration-dependent effect of PTH or FK is 




attained via recruitment of more hyper-active cAMP junctions instead of the graded 
global increase in cAMP concentration (Tovey et al., 2008). 
 In permeabilized DT40 cells expressing single subtypes of each IP3R, cAMP 
sensitized IP3-evoked Ca
2+
 release from all three subtypes of IP3R (Tovey et al., 2010). 
Based on immunoprecipitation and siRNA studies, the specific subtypes of IP3R and 
AC involved in the hyperactive cAMP junctions were identified. IP3R type 2 (IP3R2) 
and AC type 6 (AC6) were found to be specifically associated (Tovey et al., 2008). 
These hyperactive cAMP junctions suggest a new interaction between Ca
2+
 and cAMP, 
and a novel signalling model based on recruitment of hyperactive IP3R2-AC6 
complexes in response to agonist stimulation. The significance for the present work is 
that when  PTH1R-AC signalling complexes are internalised (Ferrandon et al., 2009) 





 signalling mediated via AC-IP3R junctions. In HEK-PR1 cells, 
binding of PTH to PTH1R activates Gs and binding of CCh to muscarinic acetylcholine 
receptors (M3R) activates Gq. Gs activates AC, and Gq stimulates PLC. These enzymes 
catalyze formation of the second messengers, cAMP and IP3. IP3 activates IP3R to 
release Ca
2+
 from ER. cAMP activates PKA and can also directly sensitise IP3R to IP3 
leading to enhanced Ca
2+
 release. AC-IP3R junctions are defined as a hyperactive 
signalling complex, where supersaturating cAMP concentration directly sensitise IP3R 
























3.1.9. Aims  
In this chapter two questions associated with the effects of sustained stimulation with 
PTH(1-34) are addressed:      
a. Does sustained stimulation with PTH(1-34) cause sustained potentiation of CCh-
evoked Ca
2+
 signals?  





3.2. Materials and Methods  
 
3.2.1. Materials 
Table 3.2 lists the sources of materials used. Table 3.3 shows the PTH analogues used. 
All analogues were the human forms and were either supplied by Bachem (Bubendorf, 
Switzerland) or, for PTHrP(1-36), custom-synthesized by Selleckchem (Boston, MA). 





















H89 dihydrochloride R&D Systems (Minneapolis, MN) 
8-Br-cAMP R&D Systems (Minneapolis, MN) 
2',5'-dideoxyadenosine (DDA) Merck Biosciences (Middlesex, UK) 
NKH477 Merck Biosciences (Middlesex, UK) 
SQ22536 Merck Biosciences (Middlesex, UK) 
[2, 8-
3
H]-adenine Perkin Elmer (Waltham, MA) 
1, 2-bis(o-aminophenoxy)ethane- 
N, N, N, N'-tetraacetic acid 
(BAPTA) 
Molekula (Gillingham, UK) 
Carbamoylcholine chloride (CCh) Sigma-Aldrich (Gillingham, UK) 
3-isobutyl-1-methylxanthine 
(IBMX) 
Sigma-Aldrich (Gillingham, UK) 
Ionomycin Scientific (Stockport, UK) 
Cell culture media, G-418 Life Technologies (Paisley, UK) 
Fluo 4AM, fura 2AM Life Technologies (Paisley, UK) 
ESI-09 Biolog Life Science Institute (Bremen, 
Germany) 
 











Table 3.3. Sequences of the human PTH and PTHrP analogues used 
 





Drug Solvent Storage (
o
C) 
H89 Water (25 mM stock) -20 
8-Br-cAMP Water  (10 mM stock) -20 
DDA HBS (200 µM, final concentration) 4 
NKH477  Water (10 mM stock) 4 
SQ22536  HBS (1 mM, final concentration) 4 
BAPTA HBS (2.5 mM, final concentration) -20 
IBMX Water (100 mM stock) -20 
ESI-09 DMSO (50 mM stock) -20 
PTH analogs Water (100 µM stock) -20 
 
Table 3.4. List of solvents used to prepare drugs  
 
3.2.2. Culture of HEK-PR1 cells 
Human embryonic kidney 293 (HEK293) cells stably-expressing human parathyroid 
hormone receptor type 1 (HEK-PR1cells) (Short et al., 2000) were cultured in 
Dulbecco’s modified Eagle’s/Ham’s F-12 medium supplemented with foetal calf serum 
(10 %) and G-418 (800 µg/ml), at 37° C in 5 % CO2 and 95 % air. Cells were grown in 
175-cm
2
 flasks and used or passaged when confluent. The HEK-PR1 cells were 
established in this laboratory using methods fully described in (Short et al., 2000).  
  
3.2.3. Measurement of [Ca
2+
]c in HEK-PR1 cell populations 
Measurements of [Ca
2+
]c in cell populations were performed as previously described 
(Tovey et al., 2008). Fluo4-AM was dissolved in DMSO to produce a 2 mM stock 
concentration and then diluted in HBS to a final concentration of 2 µM. The non-ionic 
detergent Pluronic F127 (0.02 %) was added to avoid micelle formation. Confluent 
cultures of HEK-PR1 cells in 96-well plates were loaded with indicator for 1 h at 20 




°C. Complete cytosolic de-esterification of the indicator was achieved by subsequent 
incubation in HBS with Pluronic F127 (0.02%) for 45 min (20 °C). 
 [Ca
2+
]c was monitored using a fluorescence plate-reader (FlexStation III, MDS 
Analytical Devices) equipped to allow a maximum of 3 automated fluid additions 
(Tovey et al., 2006). Simultaneous readings of 8 wells were recorded, with excitation at 
485 nm and emission collected at >525 nm (the peak emission wavelength of Ca
2+
-
bound Fluo-4). Each well was monitored at intervals of 1.44s for a total of 120 s, unless 
otherwise stated. 
 Fluorescence values were analyzed with SoftMaxPro software, converted to 
[Ca
2+
]c using equation 3.1, and fitted to the Hill equation using GraphPad Prism to 
obtain concentration-effect relationships  Results, Δ Ca
2+
]c, are expressed as means ± 
SEM. 
           
        
        
  equation (3.1) 
where Kd is the dissociation constant of Fluo 4 for Ca
2+
 (345 nM) and F is the 
fluorescence value obtained. Calibration was done in situ in parallel wells. Values for 
Fmin (fluorescence in the absence of Ca
2+
) and Fmax (fluorescence with saturating Ca
2+
) 
were obtained by addition of BAPTA (10 mM) with 0.2 % Triton X-100 (Fmin), or 
CaCl2 (10 mM) with 0.2 % Triton X-100 (Fmax), respectively. 
 
3.2.4. Measurements of [Ca
2+
]c in single HEK-PR1 cells 
The protocol for measuring [Ca
2+
]c in single fura2-loaded HEK-PR1 cells is similar to 
that described in Section 2.2.4. However, for HEK-PR1cells, HBS buffer was used. 
HBS had the following composition (mM): NaCl 135, KCl 5.9, MgCl2 1.2, CaCl2 1.5, 




3.2.5. cAMP measurements using column chromatography 
cAMP measurements were performed under conditions that replicate those used for 
measurements of [Ca
2+
]c. HEK-PR1 cells were grown in 24-well plates until ~90% 
confluent, [
3
H]-adenine (2 µCi/well) was then added to the culture medium (DMEM-
F12 containing 10% FBS). After 2 h at 37
o
C in 5% CO2, the medium was removed. 




Cells were then washed with HBS, and used for experiments in HBS at 20
o
C. Because 
many cells extrude cAMP into the extracellular medium (Copsel et al., 2011), reactions 
were terminated by first removing the medium and then adding ice-cold trichloroacetic 
acid (5%, 1 ml). After 30 min on ice, the cell lysate (1 ml) was transferred to a Dowex 
column at 20
o
C (1 ml, Dowex 50 WX4-400 equilibrated with 1 M HCl). The eluate 
contains [
3
H] ATP and [
3
H] ADP, but [
3
H] cAMP is retained on the Dowex column. 
Each Dowex column was washed with H2O (2 ml) and the eluate pooled with the initial 
run-through fraction. [
3
H]cAMP was then eluted from the Dowex column using H2O (8 
ml) and loaded onto a alumina column (0.5 g/column, alumina equilibrated with 10 ml 
1M imidazole-HCl pH 7.5, then 8 ml of 0.1 M imidazole-HCl pH 7.5), from which 
[
3
H]cAMP was then eluted with 0.1 M imidazole pH 7.5 (4 ml) (Pantazaka et al., 2013; 
Salomon et al., 1974). Ultra-gold scintillant (5 ml) was added to each scintillation vial 
containing eluate from the Dowex or alumina columns. The activity of the eluates was 
determined by liquid scintillation counting. Amounts of 
3
H-cAMP were expressed as 







ATP fractions.  
3.2.4 Analysis 
Concentration-effect relationships were fitted to Hill equations with a variable Hill 
slope (h) using Prism version 5 (GraphPad, San Diego, CA, USA): 
   
         
                      
      equation (3.2) 
where, R is the response (e.g., [Ca
2+
]c) detected with the drug concentration, C (in M). 
RMax and RMin are the responses predicted by extrapolation of the fitted curve to an 
infinite concentration of C (RMax) and no C (RMin). EC50 is the concentration of C that 
evokes the half-maximal response, from which the pEC50 value was determined 
(pEC50 = -logEC50). For most analyses, the curves were fitted without restraining RMax, 
RMin or h. Concentration-effect relationships were fitted to the results from individual 
experiments before pooling parameters (Rmax, h, pEC50, etc) for statistical analyses.  
Results are shown as means ± SEM. Statistical comparison of sensitivities used pEC50 
values. Because the experiments were performed over a period of 2 years, there was 
some variability in CCh-evoked Ca
2+
 signals. Therefore, each experiment was 
performed with its control experiments and the statistical significance test has also been 




performed between each experiment and its corresponding control. For multiple 
comparisons one-way analysis of variance and Tukey multiple comparison test and for 
comparing two samples, paired t-test was used.  
3.3. Results  
3.3.1. PTH(1-34) potentiates CCh-evoked Ca
2+ 
responses 
In populations of HEK-PR1 cells expressing M3R, CCh, an agonist of muscarinic 
acetylcholine receptors (M3R), was used to activate PLC, formation of IP3 and release 
of Ca
2+
 from intracellular stores via IP3R. 1,2-bis(o-aminophenoxy) ethane-N,N,N',N'-
tetraacetic acid (BAPTA, 10 mM ), a Ca
2+
-chelating agent, was added before 
stimulation with a maximal CCh concentration (1 mM) to ensure that the increases in 
[Ca
2+
]c were due to the Ca
2+
 release from intracellular stores. The increase in [Ca
2+
]c 
evoked by CCh returned to the basal levels within   6 s   fter the increased [Ca
2+
]c  had 
returned to the resting level, the addition of PTH(1-34) (100 nM) in the continuous 
presence of CCh, showed a further release of Ca
2+
 (Fig. 3.3A). These results are in 
agreement with previous studies (Tovey et al., 2008; Tovey et al., 2003). A similar 
protocol was used to examine the PTH(1-34) concentration-dependence. The results 
show that the maximal potentiation of CCh-evoked Ca
2+
 release with PTH(1-34) 
occurred with a half-maximally effective concentration (pEC50) of  7.0 ± 0.01 (Fig. 
3.3B). Similar results have been published (Tovey et al., 2008; Tovey et al., 2003). 
 In the presence of BAPTA (10 mM), stimulation of HEK-PR1 cells with PTH(1-
34) (100 nM) showed no increase in [Ca
2+
]c. However, subsequent addition of a 
maximal concentration of CCh evoked an increase in [Ca
2+
]c  (Fig. 3.3C). Figure 3.3D 
shows the CCh dose-response curve obtained with or without PTH(1-34) (100nM) pre-
treatment. PTH(1-34) increased both the maximal amplitude and the sensitivity of the 
response to CCh. The pEC50 for CCh was increased from 4.4 ± 0.1 to 5.1 ± 0.1, and the 
maximal amplitude of the increase in [Ca
2+
]c increased from 131 ± 26 to 405 ± 83 nM 
in the presence of PTH(1-34) (Fig. 3.3D). In subsequent experiments 20 µM CCh was 
routinely used to obtain submaximal levels of Ca
2+
 release. These results are consistent 
with earlier studies (Short & Taylor 2000).   
 
 





Figure 3.3. PTH(1-34) potentiates CCh-stimulated Ca
2+
 signals. (A) In a population 
of HEK-PR1 cells, the typical trace shows transient release of Ca
2+
 from intracellular 
stores upon stimulation with a maximal CCh (1 mM) concentration (black,  the increase 
in [Ca
2+
]i  at 250 sec is an CCh addition artefact). In the continued presence of CCh (1 
mM), PTH(1-34) (100 nM) stimulated a further Ca
2+
 release (red). (B) The 





in the continuous presence of CCh (1 mM). (C) Typical trace shows HEK PR1 cells 
stimulated with PTH(1-34) (100 nM) (red) or HBS alone for 1 min before addition of 





]c) evoked in the presence or absence of PTH (100 nM). In each 
experiment BAPTA (10 mM) was added 30 s before the first addition of CCh or 
PTH(1-34). Results (A, C) are means ± SEM for 3 wells from one experiment, typical 





















































































3.3.2. Sustained stimulation with PTH(1-34) increases the sensitivity to 
PTH,  but reduces the amplitude potentiation of CCh-evoked Ca
2+ 
responses  
In HEK-PR1 cells, (Tovey et al., 2008) showed that PTH stimulates cAMP formation, 
and it was suggested that the cyclic nucleotide was directly delivered to IP3R within 
hyperactive AC-IP3R junctions (Section. 3.1.8). This, along with the evidence that 
binding of PTH(1-34) to PTH1R at the plasma membrane stimulates internalisation of 
PTH1R-AC signalling complexes, which then continues cAMP formation via AC for 
sustained durations (Ferrandon et al., 2009), persuaded me to examine the effect of 
prolonged PTH(1-34) stimulation on CCh-evoked Ca
2+
 responses. 
 In a population of HEK-PR1 cells, acute (1 min) or sustained (60 min) 
stimulation with PTH(1-34) potentiated the Ca
2+
 signals evoked by submaximal (20 
µM) (Fig. 3.4A) and maximal (1 mM) (Fig. 3.4B) concentrations of CCh in Ca
2+
-free 
medium. Figure 3.4C, D shows the PTH(1-34) concentration-effect curve obtained after 
varying the duration of pre-treatment with PTH(1-34) before the addition of maximal or 
sub-maximal CCh concentrations in the presence of BAPTA. These results show that 
PTH(1-34) potentiated CCh-evoked Ca
2+ 
responses after acute as well as sustained 
stimulation. However, in comparison with the acute effect, sustained exposure to 
PTH(1-34) reduced the maximal amplitude of the CCh-evoked Ca
2+
 signals by ~50%, 
whereas it increased the sensitivity to PTH(1-34) by almost 10-fold (Fig. 3.4C, D, 
Table 3.5).  
 The reduction in CCh-evoked Ca
2+
 signals after sustained stimulation with 
PTH(1-34) was evident after 15 min, and remained reduced after extending the 
incubation with PTH(1-34  to 6  min  The ~5   decrease in the maximal Δ Ca
2+
]c 
release after sustained stimulation with PTH(1-34) was observed, whether maximal 
(1 mM) or submaximal (20 µM) concentrations of CCh were used to evoke Ca
2+
 release 
(Table 3.5). In most subsequent experiments, submaximal concentrations of CCh were 
used for the stimulation of Ca
2+ 
release. It was found that 2.5 mM BAPTA was 
sufficient to chelate extracellular Ca
2+ 
without affecting the initial peak Ca
2+ 
signals, 
whereas 10 mM BAPTA reduced their amplitude (not shown). In most subsequent 
experiments 2.5 mM BAPTA was used. Acute stimulation with PTH(1-34) potentiates 
the Ca
2+
 signals evoked by CCh (Tovey et al., 2008), but the Ca
2+
 responses obtained 




after sustained PTH(1-34) stimulation have not previously been reported. Subsequent 




Figure 3.4. Sustained PTH(1-34) stimulation reduces potentiation of CCh-evoked 
Ca
2+
 signals. (A, B) Typical changes in [Ca
2+
]c signals from a population of HEK-PR1 
cells stimulated with a submaximal (20 µM, A) or maximal concentration (1 mM, B) of 
CCh alone, or with PTH(1-34) (100 nM, added 1 min before CCh). Results are means ± 
SEM for 3 wells from a single experiment. (C, D) Concentration-dependent effects of 
PTH(1-34), given for the indicated times, on the Ca
2+
 signals (peak [Ca
2+
]c) evoked by 
submaximal (20 µM, C) or maximal (1 mM, D) CCh concentrations. In each 
experiment, BAPTA (2.5 mM) was added 30 s before addition of CCh to chelate 
extracellular Ca
2+
. The codes apply to both panels. Results (C, D) are means ± SEM 
from 4 independent experiments. Significant differences are given in Table 3.5. 
 




































































































1 min 234 ± 29 7 8 ±     23  ±    7 5 ±   2 
5 min 228 ± 9 7 6 ±      79 ± 37 7   ±     
15 min  2  ± 7
*
 8 7 ±    
*
 94 ± 7
*
 7 9 ±    
*
 
30 min   5 ± 3 
*
 8 8 ±    
*
  42 ± 38
*
 8 8 ±    
*
 
60 min     ±  6
*
 8 2 ±   2
*
   8 ±  7
*




Table 3.5. Acute or sustained stimulation with PTH(1-34) potentiates CCh-evoked 
Ca
2+
 signals. Effect of stimulation with PTH(1-34) for different time durations, on the 
maximal Δ Ca
2+
]c signals evoked by submaximal (20µM) or maximal (1mM) CCh 
concentrations, and on the sensitivity to PTH(1-34   Maximal Δ Ca
2+
]c describes the 
difference between the peak Ca
2+
 signal evoked by CCh alone and that evoked by CCh 
in the presence of a maximally effective concentration of PTH(1-34). Results are means 
± SEM from ≥ 3 independent experiments. 
*
P < 0.05 with one-way analysis of variance 
and Tukey multiple comparisons test.  
 
3.3.3. Sustained or acute PTH(1-34) stimulation potentiates CCh-evoked 
Ca
2+
 responses in single HEK-PR1 cells. 
The results from cell populations (Fig. 3.4, Table 3.5) are further validated by analyses 
of single HEK-PR1 cells. The increase in the peak [Ca
2+
]c signal evoked by a maximal 
concentration of CCh (1 mM)  was 176 ± 12 nM (Fig. 3.5D). These responses were 
further potentiated when measured after acute (1 min) or sustained (60 min) stimulation 
with PTH(1-34) (Fig. 3.5A, B). The peak increase in [Ca
2+
]c signals evoked by 
maximal CCh (1 mM) after acute PTH(1-34) (100 nM) stimulation (372 ± 9 nM) (Fig. 
3.5D) was significantly higher than the response after sustained stimulation with 
PTH(1-34) (243 ± 11 nM) (Fig. 3.5D).  




 The percentage of cells that responded after acute or sustained PTH(1-34) 
stimulation is 100% and 99% respectively of the cells that responded to the first 





















Figure 3.5. PTH(1-34) potentiates CCh-evoked Ca
2+
 signals in single HEK-PR1 
cells. (A, B) Typical change in [Ca
2+
]c from a single HEK-PR1 cell stimulated with 
CCh (1 mM, first challenge) alone or with PTH (100 nM, added 1 min (A) or 60 min 
(B) before CCh (1 mM, second challenge). In these experiments normal HBS was 
replaced with nominally Ca
2+
-free HBS 5 min before addition of CCh. Results are from 
a single HEK-PR  cell, typical of  ≥  95 cells analysed in 3 independent experiments  
(C) Percentage of the cells in which the first stimulation with CCh (1 mM) evoked a 
detectable increase [Ca
2+
]c (control) and percentage of cells that responded to addition 
of CCh with PTH(1-34) after a 1-min (red) or 60-min (blue) pre-incubation with 
PTH(1-34).  (D) Summary results show the effects of 1-min or 60-min stimulation with 
PTH(1-34) (100 nM) on the peak increase in [Ca
2+
]c evoked by CCh (  mM  for each 
individual cell  Results (C, D  are means ± SEM from 3 coverslips, with   65 cells 
analysed on each. Results (D) are means ± SEM from 3 independent experiments. 
*
P < 



































































































3.3.4. Potentiation of CCh-evoked Ca
2+
 responses by PTH(1-34) is 
mediated by cAMP 
At the highest concentrations used (≥ 3   nM , PTH( -34) evoked small (< 40 nM) 
increases in [Ca
2+
]c in populations of HEK-PR1 cells (Fig. 3.6A) (Jobert et al., 1997). 
These Ca
2+
 signals were also observed after inhibition of AC by SQ/DDA, PDE by 
IBMX, PKA by H89 or Epac 1/2 by ESI-09 (Fig. 3.6B-E). PTH(1-34), alone or with 
SQ/DDA, IBMX, H89 and ESI-09, gave similar increases in peak [Ca
2+
]c. Previously 
published data suggests that stimulation with PTH(1-34) evokes Ca
2+
 signals, which 
might be due to activation of Gs, Gq or both signalling pathways (Cupp et al., 2013). 
This suggested that the results in figure 3.6, could be due to activation of either of these 
signalling pathways. 
 To investigate whether PTH(1-34) stimulates Ca
2+
 signals by activating Gq or Gs 
pathways, the effects of different PTH analogues were assessed. The selection of 
analogues was based on their specific mode of signalling after binding to PTH1R. 
Tyr
1
PTH(1-34) and PTH(2-38) are full agonists for activation of AC (Table 3.1). 
PTH(1-34) and PTHrP(1-34) are full agonists for activation of both AC and PLC (Pines 
et al., 1996; Tsukazaki et al., 1996). PTH(1-31) is a full agonist for activation of AC 
and a strong partial agonist for activation of PLC (Sneddon et al., 2004; Whitfield et 
al., 1995), though a recent study in CHO cells expressing PTH1R suggests that PTH(1-
31) was similar to PTH(1-34) in its ability to stimulate both AC and PLC (Cupp et al., 
2013; Takasu et al., 1999) (Table 3.1). 
 Results shown in Figure 3.6A indicate that high concentrations of PTH(1-31), 
PTHrP(1-34) and PTH(1-34), which are reported to activate PLC, evoked small 
increases in [Ca
2+
]c. By contrast, PTH(1-34) potentiates CCh-evoked Ca
2+
 responses at 
much lower concentrations (Fig. 3.4C, D, 3.7A). The analogues which stimulate only 
AC, PTH(2-38) and Tyr
1
PTH(1-34), alone did not evoke increases in [Ca
2+
]c at any 
concentration (Fig. 3.7A). Acute stimulation with Tyr
1
PTH(1-34) or PTH(2-38) 
potentiated the maximal Δ Ca
2+
]c evoked by CCh (20 µM) to the same extent as 
PTH(1-34) (Fig. 3.7A, Table 3.6   The levels of maximal Δc MP produced by the 
three analogues were also comparable (Fig. 3.7B, Table 3.6). Furthermore, the 
relationship between the change in intracellular cAMP concentration and the 
potentiated Ca
2+
 signals were similar for the three analogues (Fig. 3.7C).  





Figure 3.6. Direct effects of PTH analogues on Ca
2+
 signals (A) HEK-PR1 cells were 
stimulated with PTH analogues for 1 min. Results show concentration-dependent 
effects of PTH analogues alone on the peak increase in [Ca
2+
]c. (B-D) HEK-PR1 cells 
were incubated with SQ22536 (  mM  and DD  (2   μM  (B, SQ/DDA, 20 min) to 
inhibit AC, H89 (C,    μM, 2  min  to inhibit P  , or IBMX  (D, 1 mM, 5 min) to 
inhibit cyclic nucleotide phosphodiesterases before addition of the indicated 
concentrations of PTH(1-34). Results show the peak increase [Ca
2+
]c evoked by 
addition of PTH(1-34). (E) Cells were incubated with ESI- 9 (   μM, 5 min  to inhibit 
Epac. Results show the peak increase [Ca
2+
]c evoked by 3 μM PTH( -34) alone or with 



















































































































Figure 3.7. cAMP mediates potentiation of CCh-evoked Ca
2+
 signals by PTH(1-34).  
(A) Populations of HEK-PR1 cells were stimulated with PTH analogues for 1 min 
before CCh (20 µM) addition in the presence of BAPTA (2.5 mM). Results show 
concentration- dependent effects of PTH analogues on the peak increase in [Ca
2+
]c 
evoked by CCh (20 µM). (B) Effects of PTH analogues on intracellular cAMP 
measured after 1 min under conditions identical to those used for measurements of peak 
[Ca
2+
]c signals. Results show 
3







cAMP. (C) Results from (A) and (B) were used to establish the non linear regression 
relationship between cAMP and the potentiated CCh-evoked increases in [Ca
2+
]c for 
cells stimulated with the indicated PTH analogues for 1 min, therefore each line 
















































































PTH (1-34) 6 7 ±    3 233 ±    6   ±   2    3 ±   2 
PTH (1-34) 7 7 ±      2 5 ±  3 7   ±          ±     
PTH (2-38) 6 9 ±      2 6 ± 2  6 5 ±    4   7 ±     
 
Table 3.6. Acute stimulation with PTH analogues stimulates cAMP formation and 
potentiates Ca
2+ 
signals. Effect of stimulation with PTH analogues (1 min) on the 
maximal Δ[Ca
2+
]c and ΔcAMP signals evoked by CCh (20 µM) and their sensitivities 
to PTH analogues. Maximal Δc MP describes the difference between the basal level of 
cAMP and that detected after maximal stimulation (as % of ATP). Results show means 
± SEM from ≥ 3 experiments    
 
3.3.5. Sustained stimulation with NKH477 and 8-Br-cAMP reduce the 
potentiation of CCh-evoked Ca
2+ 
responses  
  decrease in the maximal Δ Ca
2+
]c evoked by CCh after prolonged PTH(1-34) 
stimulation (Fig. 3.4, Table 3.5) could be a consequence of a change in signalling from 
internalized PTH1R (Ferrandon et al., 2009) or a consequence of a sustained increase in 
intracellular cAMP concentration. These possibilities were explored using two 
approaches. Firstly, by directly stimulating AC with NKH477. Secondly, by delivering 
cAMP directly into the cell, in the form of 8-Br-cAMP, a membrane-permeable cAMP 
analogue.  
 Forskolin is often used to activate AC (Hosono et al., 1992), but it is relatively 
insoluble in water. Hence NKH477 was used as it is cell-permeable, more water-
soluble than forskolin (Hosono et al., 1992), and more potent than forskolin in 
stimulating AC (Toya et al., 1998).  
 An unavoidable limitation in performing these experiments is that PTH(1-34) 
quickly stimulates AC via PTH1R, whereas NKH477 or 8-Br-cAMP activate AC more 




slowly because they must first diffuse across the plasma membrane. Two-minute 
stimulations with 8-Br-cAMP did not show potentiation of CCh-evoked Ca
2+
 responses 
(not shown), presumably because this provides insufficient time for 8-Br-cAMP to 
reach intracellular targets. For NKH477 and 8-Br-cAMP, 2 or 5 min respectively were 
identified as the shortest stimulation times after which there was potentiation of CCh-
evoked Ca
2+
 responses (Fig. 3.8A, 3.9C, Table 3.7, 3.8). 
 In populations of HEK-PR1 cells, acute or sustained stimulation with NKH477, 
8-Br-cAMP or PTH(1-34) potentiated the increase in the peak [Ca
2+
]c signals evoked 
by CCh (Fig. 3.9). Sustained stimulation with NKH477 or PTH(1-34) showed a 
significant decrease (  5    in the maximal Δ Ca
2+
]c signals and a     -fold increase in 
sensitivity to NKH477 or PTH(1-34) compared to acute stimulation (Fig. 3.9A, B, 
Table 3.8). However, after prolonged stimulation with 8-Br-cAMP, the sensitivity to 8-
Br-cAMP was unchanged but there was a significant decrease (  5    in the maximal 
Δ Ca
2+
]c signals relative to acute stimulation (Fig. 3.9C, Table 3.8). With NKH477, 
levels of cAMP produced after acute or sustained stimulation were also measured under 
identical conditions to those used to measure Ca
2+
 signals  However, maximal Δc MP 
and pEC50 values could not be calculated because even 1 mM NKH477 failed to 
achieve a maximal response (Fig. 3.8B). Furthermore, the relationship between the 
change in intracellular cAMP concentration and the potentiated Ca
2+
 signals was 
established (Fig. 3.8C). This analysis was designed to assess whether the underlying 
relationship between cAMP and how enhanced Ca2
+ 
signals differed when different 
stimuli and/or timings were used to evoke cAMP formation.. From these results, it is 
clear that whether AC is activated directly by NKH477 or via PTH1R, sustained 
activation produces more cAMP than brief stimulation, but lesser potentiation of CCh-
evoked Ca
2+
 signals (Fig. 3.8A, Table 3.7).  
   
 





Figure 3.8. Sustained stimulation with NKH477 reduces potentiated CCh-evoked 
Ca
2+
 signals. (A) Populations of HEK-PR1 cells were stimulated with NKH477 for the 
indicated time before analysing CCh (20 µM)-evoked Ca
2+ 
signals in the presence of 
BAPTA (2.5 mM). Results show concentration-dependent effects of NKH477 on the 
increase in peak [Ca
2+
]c signals evoked by CCh. (B) Effects of NKH477 on intracellular 
cAMP measured after 5 or 15 min under conditions identical to those used for 
measurements of [Ca
2+
]c. Results show 
3







H-cAMP. Results (A, B) are means ± SEM from 3 independent experiments. (C) 
Results from (A) and (B) were used to establish the non linear regression relationship 
between cAMP and the potentiated CCh-evoked increases in [Ca
2+
]c for cells stimulated 





































































2 min 5.0 ± 0.3 257 ± 3 
5 min 5.0 ± 0.1 225 ± 9 
15 min 5   ±      55 ±   
*
 
30 min 6.0 ± 0.1
*




Table 3.7. Acute or sustained stimulation with NKH477 potentiates Ca
2+
 signals. 
Effect of stimulation with N H477 for different times on the maximal Δ Ca
2+
]c signals 
evoked by CCh (20 µM) and the sensitivity to NKH477. Results are means ± SEM 
from ≥ 3 independent experiments  
*
P < 0.05 with one-way analysis of variance and 












Figure 3.9. Diminished potentiation of CCh-evoked Ca
2+
 signals after acute or 
sustained stimulation with NKH477, 8-Br-cAMP or PTH(1-34). (A-C) Populations 
of HEK-PR1 cell were stimulated with PTH(1-34) for 1 or 30 min (A), NKH477 for 2 
or 30 min (B) or 8-Br-cAMP for 5 or 30 min (C), before analysing CCh (20 µM)-
evoked Ca
2+ 
signals in the presence of BAPTA (2.5 mM). Results show peak increases 
in [Ca
2+
]c evoked by the each of these stimulants after subtracting the response evoked 



















































































1 min 251 ± 2 7.6  ± 0.1 ND ND ND ND 
2 min ND ND 221 ± 10 5.1 ± 0.3 ND ND 
5 min ND ND ND ND 211 ± 5 3.5 ± 0.1 
30 min 132 ± 12 8.7 ± 0.1 121 ± 26 5.9 ± 0.1 113 ± 7 3.7 ± 0.1 
 
Table 3.8. Responses to CCh after acute and sustained stimulation of production of 
intracellular cAMP. Peak increases in [Ca
2+
]c evoked by CCh (20 µM) were recorded 
after parallel incubations for the periods indicated with PTH(1-34), NKH477 or 8-Br-
c MP  Results show the maximal Δ Ca
2+
]c after subtracting the responses evoked by 
CCh (20µM) alone and the sensitivity for each stimulus. Results are means ± SEM, 
from 3 independent experiments. 
 
3.3.6. Sustained stimulation with PTH(1-34), NKH477 and 8-Br-cAMP 
in combination produce non-additive effects  
Acute or sustained stimulation with PTH(1-34), NKH477 and 8-Br-cAMP caused 
similar potentiation of CCh-evoked Ca
2+
 signals (Fig. 3.9, Table 3.8). Additionally, in a 
previous study, acute stimulation with PTH(1-34) and 8-Br-cAMP in combination 
showed non-additive effects (Tovey et al., 2008). These observations prompted me to 
assess whether acute or sustained stimulation of HEK-PR1 cells with these agents, in 
combination, would affect the peak increase in [Ca
2+
]c signals and thus overcome the 
decrease in maximal Ca
2+
 signals observed after prolonged stimulation with PTH(1-34) 
(Fig. 3.9A) 
 In populations of HEK-PR1 cells, acute stimulation with PTH(1-34), NKH477 
and 8-Br-cAMP in combination showed similar potentiation of CCh-evoked Ca
2+
 
responses (Fig. 3.10, Table 3.9). The peak increases in Ca
2+
 signals evoked by CCh 
were similar after acute stimulations with combinations of these agonists. Similarly, 
sustained stimulation with PTH(1-34), NKH477 and 8-Br-cAMP in combination 































showed similar potentiation of CCh-evoked Ca
2+ 
signals. However, these responses 
were significantly lower than the Ca
2+
 responses observed after acute stimulations with 












Figure 3.10. Acute or sustained stimulation with PTH(1-34), NKH477 and 8-Br-
cAMP alone or in combination, have similar non additive effects on CCh-evoked 
Ca
2+ 
signals. Populations of HEK-PR1 cells were stimulated with the indicated 
combinations of PTH(1-34) (1 µM, 1 or 30 min), NKH477 (200 µM, 2 min or 30 min)  
and 8-Br-cAMP (10 mM, 5 or 30 min), before measuring potentiation of CCh (20 µM)-
evoked Ca
2+
 signals in the presence of BAPTA (2.5 mM). Results show the peak 
[Ca
2+
]c signals evoked by CCh (20 µM). Results are means ± SEM from 3 independent 
experiments. The statistical analysis was between the acute stimulation (1, 2 or 5 min 
and sustained stimulation (30 min) for each combination stimuli. 
*
P < 0.05 with paired 























Table 3.9. CCh-evoked Ca
2+
 signals after stimulation with PTH(1-34), NKH477 
and 8-Br-cAMP, alone or in combination. Effect of PTH(1-34) (1 or 30 min), 
NKH477 (2 or 30 min) and 8-Br-cAMP (5 or 30 min) alone or in combination as 
indicated on the maximal Δ Ca
2+
]c signals evoked by CCh (20µM), measured from 
populations of HEK-PR1 cells. Results are means ± SEM from 3 independent 
experiments. 
*
P < 0.05 relative to paired comparisons at 1, 2, or 5 min as appropriate. 
Paired Student's t-test was used for the analysis.  
 





In populations of HEK-PR1cells H89, an inhibitor of PKA (Lochner et al., 2006), was 
used to assess whether PKA inhibition affects acute or sustained stimulation with 
PTH(1-34). The results show that inhibition of PKA with H89 did not affect the CCh-
evoked Ca
2+
 signals after acute or sustained stimulation with PTH(1-34). Furthermore, 
H89 did not change the increase in sensitivity and decrease in maximal responses 
observed after sustained stimulation with PTH(1-34). (Fig. 3.11A, B, D, Table 3.10). 
Likewise, PKA inhibition did not affect levels of cAMP produced after acute or 




 1, 2, or 5 min 30 min 
Control 122 ± 6 113 ± 9 
NKH477 331 ± 20 256 ± 12
*
 
PTH(1-34) 385 ± 26 268 ± 10
*
 
8-Br-cAMP 386 ± 21 222 ± 24
*
 
8-Br-cAMP + NKH477 355 ± 27 257 ± 22
*
 
NKH477 + PTH(1-34) 356 ± 12 295 ± 25
*
 
PTH(1-34) + 8-Br-cAMP 360 ± 28 208 ± 08
*
 




after stimulation with PTH(1-34) and H89 for 1 or 60 min was 95 ± 0.1 and 98 ± 0.2%, 
respectively, of the levels detected in matched control cells (n = 3) (Fig. 3.11C). 
That inhibition of PKA using H89 does not affect levels of intracellular cAMP 
formation has been observed previously (Chijiwa et al., 1990).  
 These results agree with previous studies of HEK-PR1 cells where inhibition of 
PKA using H89 reduced PTH(1-34)-, FK- and 8-Br-cAMP- induced protein 
phosphorylation without affecting potentiation of CCh-evoked Ca
2+
 signals (Tovey et 
al., 2008). It seems reasonable to suppose, because I used identical treatments with 
H89, that PKA was also effectively inhibited in the experiments described here, 
















Figure 3.11. PKA is not involved in CCh-evoked Ca
2+
 signals and cAMP 
production potentiated by PTH(1-34). (A, B) Populations of HEK-PR1 cells were 
incubated with H89 (10 µM, 20 min) before stimulation with PTH(1-34) for 1 or 60 
min. The CCh (20 µM)-evoked Ca
2+
 responses were then assessed in the presence of 
BAPTA (2.5 mM). Results show concentration-dependent effects of acute (A) or 
sustained (B) stimulation with PTH(1-34) and H89 treatment on peak increases in 
[Ca
2+
]c evoked by CCh (20 µM) in the continuous presence of BAPTA (2.5 mM). (C) 
Effects of PTH(1-34) (3 µM) with or without incubation with H89 (10 µM, 20 min), on 
intracellular cAMP measured after 1 min or 60 min stimulation. These cAMP 
measurements were done under conditions identical to those used for the measurements 
of [Ca
2+
]c. Results show 
3







The statistical analysis was done in between the acute stimulation (1 min) and sustained 
stimulation (60 min) for each combination stimuli. 
*
P < 0.05 with paired Student's t-test 
(comparing matched stimuli for acute and sustained stimulation). (D) PTH(1-34)-
potentiated CCh-evoked Ca
2+ 
release is not affected by PKA inhibition using H89. 

























































































Control 7.4 ± 0.20 364 ± 29 8.5 ± 0.20
*
 153 ± 14
*
 
H89 7.4 ± 0.40 322 ± 40 8.3 ± 0.20
*




Table 3.10. PKA inhibition does not affect the potentiation by PTH(1-34) of CCh-
evoked Ca
2+
 signals Effect of PTH(1-34), for 1 or 60 min, with H89 (10 µM, 20 min) 
pre-treatment on the maximal Δ Ca
2+
]c signals evoked by CCh (20 µM) and on the 
sensitivity to PTH(1-34). Results are means ± SEM from 3 independent experiments. 
*
P < 0.05 relative to paired comparisons at 1 min. Paired Student's t-test was used for 
the analysis.  
 




Results shown in figure 3.9 and the table 3.8 show that acute or sustained stimulation 
with PTH(1-34), NKH477 or 8-Br-cAMP similarly potentiate CCh-evoked Ca
2+ 
signals. Furthermore, PKA is not involved in mediating the effects of acute or sustained 
stimulation with PTH(1-34) on the Ca
2+
 signals evoked by CCh (Fig. 3.11A, B, Table 
3.10). Incubation of HEK-PR1 cells with H89 before brief or sustained stimulation with 
NKH477 or 8-Br-c MP did not affect the increase in peak Δ Ca
2+
]c signals evoked by 
CCh (Fig. 3.12, Table 3.11). These results suggest that PKA is not involved in 
NKH477- or 8-Br-cAMP- potentiated Ca
2+ 
responses. No effect of PKA inhibition on 
acute stimulation with forskolin and 8-Br-cAMP potentiated Ca
2+
 signals has been 
observed previously (Tovey et al., 2008). As described previously (Section 3.3.7), the 
treatment with H89 has been shown to effectively inhibit PKA (Lochner et al., 2006), 
but my conclusion would be stronger if supported by additional inhibitors of PKA and a 
direct demonstration of their effective inhibition of PKA. 
 
   






Figure 3.12. PKA is unlikely to be involved in potentiation of CCh-evoked Ca
2+
 
signals by NKH477 or 8-Br-cAMP. (A, B) Populations of HEK-PR1 cells were 
incubated with H89 (10 µM, 20 min) before stimulation with NKH477 (5 or 15 min) or 
8-Br-cAMP (10 mM, 5 or 40 min). The CCh (20 µM)-evoked Ca
2+ 
signals were then 
assessed in the presence of BAPTA (2.5 mM). Results show the concentration-





signals evoked by CCh. Results are means ± SEM from 3 
independent experiments. The statistical analysis was done in between the acute 
stimulation (5 min) and sustained stimulation (40 min) for each combination stimuli. 
*
P 





















































































Control 5   ±     225 ± 9 5   ±      55 ±   
*
 




Table 3.11. PKA inhibition does not affect the potentiation of CCh-evoked Ca
2+
 
signals by NKH477. Effect of stimulation with NKH477 (5 or 15 min) alone or with 
H89 (10 µM, 20 min) pre-treatment on the maximal Δ Ca
2+
]c signals evoked by CCh 
(20 µM) and on the sensitivity to NKH477, measured from populations of HEK-PR1 
cells. Results are means ± SEM from 3 independent experiments. 
*
P < 0.05 relative to 
paired comparisons at 5 min. Paired Student's t-test was used for the analysis.  
 




by PTH(1-34) is 
independent of Epac. 
ESI-09 is a new membrane-permeant antagonist of Epac 1/2 (Chen et al., 2013). Thus, 
it was necessary to optimise the concentration and incubation times to avoid directly 
affecting CCh-evoked Ca
2+
 signals. Populations of HEK-PR1 cells were incubated with 
different concentrations of ESI-09 before measuring the peak increase in [Ca
2+
]c evoked 
by CCh. Pre-treatment with ESI-09 (10-50 µM) for 15 min inhibited CCh-evoked Ca
2+
 
signals (Fig. 3.13A). A brief (5 min) treatment with ESI-09 (10 µM) had no significant 
effect on the Δ Ca
2+
]c signals evoked by PTH(1-34) (3 µM) alone (Fig. 3.13B) or CCh 
compared to matched controls (Fig. 3.13B, Table 3.12).  
  These results confirm that use of high concentrations of ESI-09 (> 10µM) or 
prolonged treatment (> 5 min) is not practical because they directly inhibit CCh-evoked 
Ca
2+
 release (Fig. 3.13A). Others have also recently reported non-specific effects of 
ESI-09 (Rehmann, 2013). Subsequently, ESI-09 (10 µM, 5 min) was used to confirm 
whether inhibition of Epac 1/2 affects the acute potentiation by PTH(1-34) of the CCh-
evoked increase in [Ca
2+
]c (Fig. 3.13C, Table 3.12). Since ES1-09 inhibits Ca
2+ 
signals 




evoked by CCh beyond 5 min incubation, sustained PTH(1-34) stimulation experiments 
could not be performed. 
 Inhibition of Epac 1/2 had no effect on the potentiation of CCh-evoked Ca
2+
 
signals by acute stimulation with 8-Br-cAMP. ESI-09 did not affect the increase in 
peak [Ca
2+
]c evoked by CCh (Fig. 3.13D, Table3.12). These results suggest that Epacs 
1/2 are not involved in the potentiation of CCh-evoked Ca
2+
 signals by PTH(1-34) or 8-
Br-cAMP (Tovey et al., 2008). The conclusion is weakened by the limited opportunity 
to explore higher concentrations of ESI-09 or more prolonged incubations, but it is 
consistent with evidence that an effective and selective agonist of Epac does not mimic 
the effects of 8-Br-cAMP on CCh-evoked Ca
2+
 signals (Tovey et al., 2008) Both 


















Figure 3.13. Epac is probably not involved in potentiation of CCh-evoked Ca
2+
 
signals by PTH(1-34) and 8-Br-cAMP. (A) Populations of HEK-PR1 cells were 
incubated with the Epac 1/2 antagonist ESI- 9 (  , 25, 5  μM,  5 min  before addition 
of the indicated concentrations of CCh in Ca
2+
-free HBS. Results show the increase in 
[Ca
2+
]c evoked by CCh. Results are means ± SD from 2 independent experiments. (B) 
Cells were incubated with ESI-09 (10 µM, 5 min) before addition of increasing CCh 
concentrations. Results show the increases in [Ca
2+
]c evoked by CCh in the presence of 
BAPTA (2.5 mM). (C, D) Cells were incubated with ESI- 9 (   μM, 5 min  before 
stimulation with PTH(1-34) (1 min) (C) and 8-Br-cAMP (5 min) (D). Results show 
peak [Ca
2+
]c evoked by CCh (20 µM) in the presence of BAPTA (2.5 mM). Results (B-
D) are means ± SEM from 3 independent experiments.  
 
 





































































































Table 3.12. An inhibitor of Epac 1/2 does not affect potentiation by PTH(1-34) or 
8-Br-cAMP of CCh-evoked Ca
2+ 
signals. Effect of stimulation with CCh, PTH(1-34) 
(1 min) and 8-Br-cAMP (5 min) alone or with ESI-09 (10 µM, 5 min) pretreatment on 
the maximal Δ Ca
2+
]c signals evoked by either different CCh concentrations or CCh (20 
µM) when stimulated with PTH(1-34) or 8-Br-cAMP. The table shows the sensitivity 
to CCh, PTH(1-34) or 8-Br-cAMP under the different conditions. Results are means ± 










 pEC50  Maximal  Δ Ca
2 
 c (nM  
CCh   
Control 4 5 ±     283 ± 82 
+ ESI-09 4 5 ±     257 ± 38 
PTH(1-34) (1 min)   
Control 7.9 ± 0.1 161 ± 14 
+ ESI-09 7.8 ± 0.1 150 ± 18 
8-Br-cAMP (5 min)   
Control 2.7 ± 0.1 190 ± 06 
+ ESI-09 2.6 ± 0.1 198 ± 16 





Acute or sustained stimulation with PTH(1-34) potentiated Ca
2+
 responses evoked by 
CCh (Fig. 3.4, Table 3.5). However, the maximal Ca
2+ 
signal was reduced by   5  , 
and the sensitivity to PTH( -34  was increased by     -fold after sustained stimulation. 
From experiments performed in single HEK-PR1 cells, it was confirmed that the 
decrease in maximal Ca
2+ 
response after prolonged incubation with PTH(1-34) was not 
due to fewer cells responding in populations of HEK-PR1 cells. Instead, it was because 
of a reduction in Ca
2+
 signals within individual cells (Fig. 3.5).  
 Results in figures 3.6 and 3.7 and table 3.6 provide persuasive evidence that 
cAMP mediates the ability of acute or sustained stimulation with PTH(1-34) to 
potentiate Ca
2+
 signals evoked by CCh. PTH(1-34) and analogues (PTH(2-38) and 
Tyr
1
PTH(1-34)) that only stimulate AC (Table 3.1) (Cupp et al., 2013) showed 
potentiation of CCh-evoked Ca
2+ 
signals at lower concentrations of PTH (higher pEC50) 
(Fig. 3.7A, Table 3.6) than were required to stimulate cAMP accumulation (Fig. 3.7B). 
Previously, PTH(3-34), which was thought to allow selective activation of Gq 
(Fujimori et al., 1991; but see Takasu et al., 1999), was used to suggest that PTH(1-34) 
evokes its effects on Ca
2+
 signalling via the AC signalling pathway (Tovey et al., 
2008). However, a recent study challenges the utility of PTH(3-34). In CHO cells 
stably expressing PTH1R, PTH(3-34) stimulated AC (though with very low potency), 
but not PLC (Cupp et al., 2013). In the same study, PTH(2-38) and Trp
1
PTH(1-34) 
were as effective as PTH(1-34) in stimulating AC, but they failed to activate PLC 
(Cupp et al., 2013). Selective activation of AC by PTH(2-38) and Trp
1
PTH(1-34) is 
consistent with evidence that N-terminal modifications to PTH attenuate coupling to 
PLC (Cupp et al., 2013; Takasu et al., 1999). Collectively, these and published results 




 Even so, the Ca
2+
 signals evoked by high concentrations of PTH(1-34) (Fig. 
3.6A) are likely to result from direct stimulation of PLC (Section 3.1.4-6). The inability 
to detect IP3 formation under these conditions (Short et al., 2000; Tovey et al., 2008; 
Tovey et al., 2013) is unsurprising when the Ca
2+ 
signals are so small (Fig. 3.6A) and 
they are detected under conditions where there is also maximal potentiation of IP3-
evoked Ca
2+
 release by cAMP. 




 In addition, data obtained using NKH477 (Fig. 3.8, Table 3.7) and 8-Br-cAMP 
(Fig. 3.9, Table 3.8), mimicked the responses evoked by PTH(1-34) and the maximal 
effects of acute or sustained exposure to PTH(1-34). NKH477 and 8-Br-cAMP in 
combination were non-additive (Fig. 3.10, Table 3.9). This further supports the 
conclusion that cAMP is the only signal linking PTH1R to sensitization of IP3R. 
Previously, it has been shown that G protein βγ subunits stimulate IP3R directly and 
thus cause release of Ca
2+
 (Zeng et al., 2003). However, PTH(1-34) cannot work via 
this pathway because PTH(1-34) alone does not cause release of Ca
2+
 specifically at 
lower concentrations (Fig. 3.6A) 
 There is no evidence to suggest that PKA (Fig. 3.11, 3.12, Table 3.10, 3.11) or 
Epacs (Fig. 3.13, Table 3.12) are required for PTH(1-34), NKH477 or 8-Br-cAMP to 
potentiate the Ca
2+
 signals evoked by CCh. Under conditions when H89 has previously 
been shown to inhibit PKA-evoked protein phosphorylation, it had no effect on the 
potentiation of CCh-evoked Ca
2+ 
signals evoked by PTH(1-34) (Tovey et al., 2008). 
H89 is not a specific inhibitor of PKA (Davies et al., 2000) but its off-target effects are 
less problematic when the conclusion rests on a lack of effect on the cellular response 
(potentiation of CCh-evoked Ca
2+
 signals). Nevertheless, the conclusion that cAMP 
affects IP3R without requiring activation of PKA is important, and it would be stronger 
for additional evidence (Tovey et al., 2008). There are other inhibitors of PKA (e.g. 
KT5720 and PKI) (Davies et al., 2000) and there are peptides that disrupt association of 
PKA with its anchoring proteins (AKAPs). While each of these tools has its limitations 
and/or practical difficulties, they could be use to reinforce the evidence excluding a role 
for PKA providing their effectiveness is verified. 
 Only Epac1 has been detected in HEK-PR1 cells (Qiao et al., 2002; Tovey et al., 
2008). Previously, stimulation of HEK-PR1 cells with 8-Br-2'- O- methyleadenosine-
3',5- cAMP, which selectively activates Epac1/2 (Christensen et al., 2003), had no 
effect on CCh-evoked Ca
2+
 signals, whereas 8-Br-cAMP potentiated them (Tovey et 
al., 2008). These results were supported by using a competitive antagonist of Epac1/2, 
ESI-09 (Fig. 3.13, Table 3.12) (Almahariq et al., 2013). ESI-09 may be ineffective if 
high concentrations of cAMP are locally delivered to IP3R from AC (Section 3.1.8) 
(Tovey et al., 2008). However, 8-Br-cAMP (which is uniformly dispersed in the 
cytosol) potentiated the Ca
2+
 signals evoked by CCh, and this response was also 
unaffected by ESI-09 (Fig. 3.13D, Table 3.12). I have not, however, directly 
demonstrated that Epac-1 was effectively inhibited by this treatment with ESI-09. 




These results indicate that PKA and Epac are unlikely to be required in the potentiation 
by acute or sustained stimulation with PTH(1-34) of Ca
2+
 signals evoked by CCh. Nor 
are these two conventional targets of cAMP likely to mediate the Ca
2+
 signals evoked 
directly by higher concentrations of PTH(1-34) (Fig. 3.6C, E). Evidence that PTH 
analogues that stimulate only AC do not directly evoke Ca
2+
 signals (Fig. 3.6A, 3.7A, 
Table 3.6) strongly suggests that cAMP/Epac-mediated activation of PLCƐ (Schmidt et 
al., 2001) does not contribute to PTH(1-34)-evoked Ca
2+
 signals. In addition to PKA 
and Epacs there are few other kinases for example phosphatidylinositol-3-kinase and 
Akt which could also be activated by sustained stimulation of PTH1R by PTH(1-34) 
(Yamamoto et al., 2007). However, it is very unlikely that Akt and 
phosphatidylinositol-3-kinase can contribute in sustained stimulation with PTH(1-34) 
potentiated CCh-evoked Ca
2+ 
signals. As acute or sustained stimulation with 8-Br-
cAMP (Fig. 3.9) and direct activation of AC using NKH477 (Fig. 3.8) were also similar 
to the responses evoked by PTH(1-34) and the maximal effect of sustained exposure to 
each stimulus were non-additive (Fig. 3.10 )   
 In summary, I conclude that in HEK-PR1 cells, both acute and sustained 
stimulation with PTH(1-34) potentiates CCh-evoked Ca
2+
 release However, the 
maximal Ca
2+
 release after sustained stimulation with PTH(1-34) is almost half that 
observed after acute stimulation. I also conclude that potentiation of CCh-evoked Ca
2+
 
signals by acute or sustained stimulation with PTH(1-34) is entirely mediated by 
cAMP, which sensitizes IP3R to IP3 without need for activation of PKA or Epacs. The 
mechanisms underlying the decrease in the maximal Ca
2+
 release after sustained 
stimulation with PTH(1-34) are explored in chapter 4.     




Chapter 4. AC-IP3R junctions mediate sustained potentiation 
of Ca
2+ 
signals by PTH  
 
4.1. Introduction 
In Chapter 3, I demonstrated that acute or sustained stimulation with PTH(1-34) 
potentiates CCh-evoked Ca
2+ 
signals, but the maximal Ca
2+ 
release is almost 50% less 
and the sensitivity to PTH is   10-fold higher after sustained stimulation. Both the acute 
and sustained effects of PTH(1-34) on CCh-evoked Ca
2+
 signals are mediated by 
cAMP, but they are independent of PKA and Epac. 
 Earlier work suggested that the potentiation of IP3-evoked Ca
2+ 
release was 
probably due to cAMP binding directly to IP3R, or to proteins associated with IP3R, to 
increase their sensitivity to IP3. The mechanisms underlying the long-term response to 
PTH(1-34) has not previously been addressed; it is the topic of this chapter I anticipated 
three potential mechanism underlying the decrease in maximal Ca
2+
 responses after 
sustained stimulation with PTH(1-34).  
1) A leak of Ca
2+
 from intracellular stores might reduces the effect of IP3 on [Ca
2+
]c 
(Huang et al., 1998; Tovey et al., 2003; Tovey et al., 2013).  
2) Internalization of a PTH1R-coupled-AC signalling complex (Ferrandon et al., 2009) 
might disrupt effective regulation of IP3R by cAMP.  
3) A decrease in CCh-evoked IP3 formation after sustained stimulation with PTH(1-34) 
might attenuate the direct stimulation of IP3R.  
 These alternatives  are explored in this chapter, together with an assessment of 
whether sustained responses to PTH(1-34) are mediated by the hyperactive AC-IP3R 
junctions proposed in earlier work to mediate the acute effects of PTH(1-34) (Tovey et 
al., 2008). 
 
4.2. Materials and Methods 
 
4.2.1. Materials 
The Forster Resonance Energy Transfer (FRET)-based IP3-biosensor plasmid was from 
Professor Colin Taylor (University of Cambridge, U.K). Properties of the IP3-biosensor 
have been reported previously (Tovey et al., 2013). Lipofectamine LTX reagent with 






 reagent was from Invitrogen Ltd (Renfrew, Renfrewshire, UK). Most the 
materials used in this chapter are listed in Table 3.2.  
 
4.2.2. IP3 measurements in HEK-PR1 cells 
In single HEK-PR1 cells, the cytosolic IP3 concentration was measured using a FRET-
based IP3-sensor. This IP3-biosensor is based on the IP3-binding core (IBC) of IP3R1 
(Tovey et al., 2013). The details of the plasmid preparation and the properties of the 
biosensor have been described previously (Tovey et al., 2013). The biosensor consists 
of the IBC attached via short linkers to enhanced yellow fluorescent protein (YFP) at its 
C-terminal and enhanced cyan fluorescent protein (CFP) at its N terminal. The binding 
of IP3 at IBC causes changes in CFP and YFP emission, which was collected each 
second. In results increase in CFP and YFP ratio was considered as decrease in FRET 
and hence, overall increase in IP3 concentration. HEK-PR1 cells were grown in 6-well 
plates (up to 60% confluence) on poly-L-lysine-coated round coverslips (22-mm 
diameter). Cells were grown for 48 h before transfecting with the plasmid encoding the 
IP3-sensor using Lipofectamine LTX reagent with PLUS
TM
 reagent. For each well, a 
transfection cocktail was prepared consisting of 6 µl of Lipofectamine LTX, 2.5 µl 
PLUS
TM
 reagent, 1 µg of the IP3 sensor plasmid and 200 µl of Opti-MEM reduced-
serum medium. After a 5-min incubation, the transfection cocktail (209.5 µl) was added 
to each well containing 2 ml of culture medium. Cells were further grown for 48 h at 37 
ºC in 5% CO2 before measuring the CFP/YFP FRET ratio, reflecting changes in 
intracellular IP3 concentration. These measurements were done under conditions that 
match those used to measure [Ca
2+
]c. An Olympus IX71 inverted fluorescence 
microscope equipped with a 40x objective and a 440/520 nm dual band-pass dichroic 
mirror was used to record fluorescence using widefield excitation at 440 nm and 
simultaneous collection of YFP (520-550 nm) and CFP (455-485 nm) emissions using 
an Olympus U-SIP split imaging TV port fitted with a 505-nm dichroic mirror. Split 
images were obtained at 1-s intervals using a Luca EMCCD camera (Andor 
Technology, Belfast, UK). YFP and CFP emissions were background corrected. The 
background was collected from non-transfected cells present in the field. IP3 binding 
causes an increase in CFP/YFP ratio, which was indicative of decreased FRET. The 
FRET ratios are presented as CFP emission/YFP emission. The transfection efficiency 
was ~65%, and 52 ± 2% (n = 17 coverslips) of transfected cells responded to the first 




CCh (1 mM) challenge with detectable FRET changes. Only these responsive cells 
were included in analyses of the effects of PTH(1-34). 
 The methods used to measure [Ca
2+
]c and cAMP were described in Chapter 3 
(Section 3.2). 
 




signals after sustained stimulation with PTH(1-34) 
do not involve a Ca
2+
 leak from intracellular stores  
The maximal Δ Ca
2+
]c signals evoked by CCh after sustained stimulation with PTH( -
34  were   5   smaller than those detected after acute stimulation with PTH(1-34) (Fig. 
3.4A, B, Table 3.5). This might be a consequence of Ca
2+ 
leaking from stores in the 
sustained presence of PTH(1-34). Therefore, ionomycin was used to define the amount 
of Ca
2+
 within intracellular stores  (Tovey et al., 2013) after sustained or acute 
stimulation of fluo-4-loaded HEK-PR1 cells with PTH(1-34). 
 Ionomycin, a Ca
2+ 
ionophore, is frequently used to modify intracellular Ca
2+
 
concentration and to calibrate fluorescent Ca
2+
 indicators (Liu et al., 1978). Addition of 
ionomycin, in the presence of BAPTA, after sustained (30 min) or acute (1 min) 
stimulation with PTH(1-34) shows that there was no effect of PTH(1-34) on the Ca
2+ 
signals evoked by ionomycin. The peak increase in [Ca
2+
]c evoked by ionomycin after 
acute or sustained stimulation with PTH(1-34) was 377 ± 22 nM and 399 ± 9 nM, 
respectively (Fig. 4.1A). To confirm that the ionomycin-evoked Ca
2+ 
signals do not 
saturate the Ca
2+
 indicator, at the end of the experiment the increase in fluo-4 
fluorescence evoked by the addition of extracellular CaCl2 was measured. The results 
show that fluo-4 fluorescence after addition of extracellular CaCl2 was significantly 
higher than that evoked by ionomycin in Ca
2+
-free HBS (Fig. 4.1B). These results 
confirm that the indicator was not saturated when ionomycin-evoked Ca
2+
 signals were 
measured. 
 After stimulation with PTH(1-34) and CCh, the residual Ca
2+ 
content of the stores 
was also measured using a similar protocol. These experiments were performed in 
parallel to the ionomycin experiments to allow direct comparisons. After prolonged 
incubation with PTH(1-34), the Ca
2+
 remaining in the intracellular stores was greater 






]c was 181 ± 12 nM) than for cells briefly incubated  with PTH(1-34) 
(97 ± 4 nM) (Fig. 4.1A). The results from cells stimulated with PTH(1-34) and CCh 
clearly show that the decrease in maximal [Ca
2+
]c signals after sustained stimulation 
with PTH(1-34) (Fig. 3.4, Table 3.4) is not because of enhanced Ca
2+
 leaks from the 
intracellular stores.  
 
 
Figure 4.1. Effects of sustained stimulation with PTH(1-34) on the Ca
2+
 contents of 
the intracellular stores. (A) Populations of HEK-PR1 cells were pre-treated with 
PTH(1-34) (100 nM) for 1 or 30 min before addition of CCh (20 µM) (open bars) or 
ionomycin (1 µM) (solid bars), or first CCh (20 µM) followed by ionomycin (solid 
bars) in the continuous presence of BAPTA (2.5 mM). Results show CCh- or 
ionomycin-evoked peak increases in [Ca
2+
]c after each treatment. Results are means ± 
SEM from 3 experiments. 
*
P < 0.05 relative to paired comparisons with the controls. 
Students paired t-test was used for analysis. . (B) HEK-PR1 cells were incubated with 
PTH(1-34) for 30 min before addition of BAPTA (2.5 mM), then ionomycin (1 µM) 
and lastly extracellular Ca
2+
 (10 mM) was added to check for indicator saturation. 
Results show typical traces from 5 wells in 1 experiment. Relative fluorescence units 




signals after sustained stimulation with PTH do 
not involve PTH1R internalization 
PTH binding to PTH1R stimulates PTH1R β-arrestin/dynamin-mediated internalization 
























































34) evokes persistent signalling from internalized PTH1R-coupled AC (Ferrandon et 
al., 2009) (Section 3.1.7). PTH(1-34), PTHrP(1-36), PTH(2-38) and Tyr
1
PTH(1-34) 
were used to assess whether internalization of PTH1R might contribute to the different 
effects of PTH(1-34) on CCh-evoked Ca
2+ 
signals after brief and sustained exposure to 
PTH. These analogues were selected based on their ability to promote internalization of 
PTH1R after PTH binding and/or show persistent signalling from internalized PTH1R-
coupled AC. PTH(1-34) shows both internalization and continuous signalling, PTH(2-
38) does not promote internalization, Tyr
1
PTH(1-34) acts as a weak partial agonist in 
promoting internalization, and PTHrP(1-36) is internalized, but does not persistently 
signal (Cupp et al., 2013; Ferrandon et al., 2009).  
  The results demonstrate that each of these PTH analogues showed an increased 
sensitivity to PTH and a decrease in the maximal Δ Ca
2+
]c signals evoked by CCh (20 
µM) after sustained, relative to acute, stimulation (Fig. 4.2A, C, 4.3A, C, Table 4.1). 
However, the levels of intracellular cAMP produced after acute or sustained stimulation 
with each of these analogues were not similar (Fig. 4.2B, D, 4.3B, D, Table 4.2). 
Tyr
1
PTH(1-34) and PTH(1-34) showed a significant increase in both the levels of 
cAMP produced and the sensitivity to PTH after sustained, relative to acute, stimulation 
(Fig. 4.2B, D, Table 4.2). Whereas, PTH(2-38) and PTHrP(1-36) did not show a 
significant increase in the amount of cAMP produced after prolonged stimulation. 
PTH(2-38) showed a significant increase in sensitivity to PTH after prolonged 
stimulation, whereas PTHrP did not (Fig. 4.3B, D, Table 4.2). These results, which rely 
heavily on published properties of the analogues used, suggest that internalization of 
PTH1R after sustained or acute stimulation is unlikely to be associated with the effect 
of PTH on CCh-evoked Ca
2+ 
signals.  
 Results shown in figures 4.2 and 4.3 were used to assess the relationship between 
the change in intracellular cAMP concentration and the corresponding potentiated Ca
2+
 
signals after acute or sustained stimulation with PTH analogues (Fig. 4.4). These cAMP 
and Ca
2+
 relationship graphs suggested that there is a disparity between the amount of 
cAMP produced and the corresponding increase in Ca
2+ 
signals for each PTH analogue 
(Fig. 4.4).  
 







Figure 4.2. Sustained stimulation with PTH analogues potentiates CCh-evoked 
Ca
2+
 signals. (A, C) Populations of HEK-PR1 cells were stimulated with PTH 
analogues for 1 or 30 min. The CCh (20 µM)-evoked Ca
2+
 responses were then 
assessed in the presence of BAPTA (2.5 mM). Results show concentration-dependent 
effects of PTH analogues on the peak Ca
2+ 
signals evoked by CCh. (B, D) Effects of 
PTH analogues on intracellular cAMP measured after 1 or 30 min under conditions 
identical to those used for measurements of [Ca
2+
]c. Results show 
3







H-cAMP. Results are means ± SEM from ≥ 3 
experiments. The code applies to all panels.  
 
















































































Figure 4.3. Sustained or acute stimulation with PTH analogues potentiates CCh-
evoked Ca
2+
 signals. (A, C) Populations of HEK-PR1 cells were stimulated with PTH 
analogues for 1 min or 30 min. The CCh (20 µM)-evoked Ca
2+
 responses were then 
assessed in the presence of BAPTA (2.5 mM). Results show concentration-dependent 
effects of the PTH analogues on the peak Ca
2+ 
signals evoked by CCh. (B, D) Effects of 
PTH analogues on intracellular cAMP measured after 1 min or 30 min under conditions 
identical to those used for measurements of [Ca
2+
]c. Results show 
3







H-cAMP. Results are means ± SEM from ≥ 3 






























































































PTHrP(1-36) 7 6 ±     28  ± 34 8 6 ±   2
*
  39 ± 2
*
 
PTH(2-38) 6 9 ±      2 6 ± 2  7 3 ±    
*





PTH(1-34) 6 7 ±    3 233 ±    7 4 ±    
*
  48 ± 6
*
 
PTH(1-34) 7 7 ±     2 5 ±  3 8 8 ±   2
*




Table 4.1. PTH analogues potentiate CCh-evoked Ca
2+ 
signals in HEK-PR1 cells. 
Effect of stimulation with PTH analogues for 1 or 30 min on the maximal Ca
2+
signals 
evoked by CCh (20 µM) and on the sensitivity to PTH(1-34), measured from 
populations of HEK-PR1 cells. Results are means ± SEM from 3 independent 
experiments. 
*
P < 0.05 relative to paired comparisons at 1 min using paired Student's t-



























Δc MP (%) 
PTHrP(1-36) 7.3 ± 0.1 0.2 ± 0.01 7.3 ± 0.2 0.3 ± 0.01 
PTH(2-38) 6.5 ± .04 0.7 ± 0.1 7.2 ± 0.1
*
 1.2 ± 0.1 
Tyr
1
PTH(1-34) 6.1 ± 0.2 1.3 ± 0.2 6.7 ± 0.2
*
 2.6 ± 0.1
*
 
PTH(1-34) 7.0 ± 0.1 1.1 ± 0.1 7.5 ± 0.2
*




Table 4.2. PTH analogues evoke cAMP formation in HEK-PR1 cells. 
Effects of stimulation with PTH analogues for 1 or 30 min on the maximal intracellular 
cAMP accumulation and sensitivity to PTH. Results are means ± SEM from 3 
independent experiments. 
*
P < 0.05 relative to paired comparisons at 1 min using 
paired Student's t-test. Results are means ± SEM from 3 independent experiments.  
 
 
Figure 4.4. Relationship between Ca
2+ 
and cAMP for HEK-PR1 cells stimulated 
with analogues of PTH.  Results from figures 4.2 and 4.3 were used to establish the a 
non linear regression relationship between cAMP and the potentiated CCh-evoked 
increase in [Ca
2+
]c for cells stimulated with the indicated PTH analogues for 1 min (A) 
or 30 min (B), therefore each line corresponds the same. 
 









































4.3.3. Sustained stimulation with PTH(1-34) decreases CCh-evoked IP3 
formation 
The 5   decrease in maximal Δ Ca
2+
]c signals seen after sustained stimulation with 
PTH(1-34) compared to acute stimulation (Fig. 3.4A, B, Table 3.4) could be a 
consequence of a decrease in IP3 formation. Hence, I measured CCh-evoked IP3 
formation after acute and sustained stimulation with PTH(1-34). A dual-simulation 
protocol was established for these experiments. HEK-PR1 cells were stimulated twice 
with CCh separated by an interval of 30 min. The results show that the first stimulation 
with a maximal CCh concentration (1 mM) increased ΔFRET ratio by 10 ± 1%. After 3 
washes with HBS and 30-min recovery interval, the second stimulation with 
submaximal (30 µM) CCh showed a 4 ± 0.1  increase in ΔFRET ratio (Fig. 4.5). The 
increase in FRET ratio evoked by a maximal CCh concentration is significantly 
different from that evoked by a submaximal CCh concentration. Furthermore, the 
FRET changes evoked by 30 µM CCh were unaffected by previous exposure to 1 mM 
CCh (Fig. 4.5B). These results demonstrate that my protocol allows change in cytosolic 
IP3 to be measured, and that 30 µM CCh does not saturate the signals (Fig. 4.5B). This 
paired analysis method reduced the variability arising from the limited dynamic range 
of the sensor.  
 The dual simulation protocol was used to determine the effects of PTH(1-34). 
The first stimulation with a maximal CCh concentration was used to identify responsive 
cells, prior to a second stimulation with a submaximal concentration of CCh after 
treatment with PTH(1-34) for 1 min (Fig. 4.6A) or 30 min (Fig. 4.6B). The results show 
that pretreatment with PTH(1-34) for 30 min significantly reduced the responses to 
CCh relative to 1 min stimulation (Fig. 4.6A, B). The ΔFRET ratio was 0.7 ± 1 % after 
a 30-min stimulation with PTH(1-34) (Fig. 4.6D, E), whereas it was 4 ± 1% after a 1-
min pretreatment with PTH(1-34) (Fig. 4.6C, E). However, in both experiments the first 
stimulation with CCh (1 mM) showed similar responses 9 ± 1% (Fig. 4.6D) and 8 ± 1% 
(Fig. 4.6C, E). It is unlikely that the increase in cAMP evoked by PTH directly reduced 
the sensitivity of the sensor because earlier analyses have shown that cAMP does not 
affect IP3 binding to IP3R (from which the sensor was derived) (Tovey et al., 2008). 
Nevertheless, it would be useful to confirm that the behaviour of the sensor is not itself 
affected by any consequences of stimulating PTH1R. These results demonstrate that 




sustained stimulation with PTH(1-34) reduced the ability of CCh to evoke an increase 





Figure 4.5. Stimulation with CCh evoked changes in cytosolic IP3 concentration. 
(A) Typical trace from a single HEK-PR1 cell showing CFP and YFP emission and the 
resultant changes in the FRET ratio (CFP/YFP) of an IP3 biosensor reflecting changes 
in intracellular IP3 concentration. Cells were stimulated twice, first with CCh (1 mM, 3 
min) (1
st
 stimulus) and then with CCh (30 µM, 3 min) (2
nd
 stimulus) after a 30 min 
interval. The typical trace is representative of 3 coverslips. The excitation and emission 
wavelengths used are shown alongside the graph. Inset illustrates the wavelengths used 
to collect each image. (B) Summary results show ΔFRET ratio (  observed / basal 
signal) for   28 control cells  Results (B  are means ± SEM from ≥ 3 coverslips  
*
P < 
0.05 relative to paired comparisons between C and 1
st
 bar or C and 2
nd
 bar as 




























































Figure 4.6. Sustained stimulation with PTH(1-34) inhibits the CCh-evoked increase 
in cytosolic IP3 concentration. (A, B) Typical traces showing the increase in FRET 
ratio after stimulation with CCh (1 mM) (1
st
), and CCh (30 µM) (2
nd
) after a 
intervening pre-treatment with PTH(1-34) (100 nM) for 1 min (A) or 30 min (B). The 
traces in are representative of 5 (A) and 7 (B) coverslips. (C, D) Summary results show 
ΔFRET ratio (  observed / basal signal  for cells pretreated with PTH(1-34) for 1 min (  
36 cells) (C  or 3  min (  34 cells  (D   Results (C, D  are means ± SEM from ≥ 3 
coverslips. (E  For each cell, ΔFRET measurements for the first (1
st
, 1 mM CCh) and 
second stimulus (2
nd





responses for the indicated treatments.
 *
P < 0.05 relative to paired comparisons with the 


















































































































4.3.4. Super-saturating cAMP junctions mediate sustained potentiation 
of CCh-evoked Ca
2+ 
signals by PTH(1-34) 
Previously, it was shown that global inhibition of cAMP formation by inhibiting AC 
with SQ/DDA, and of cAMP degradation by inhibiting PDE by IBMX (Morgan et al., 
1993) did not affect the potentiation of CCh-evoked Ca
2+
 signals evoked by acute 
stimulation with PTH(1-34). Hence, these signals were proposed to be mediated by 
AC-IP3R signalling junctions, within which super-saturating concentrations of cAMP 
reach IP3R (Tovey et al., 2008) (Section 3.1.8). Furthermore, from a comparison of the 
responses of intact cells to PTH and 8-Br-cAMP and of permeabilized cells to cAMP, 
the calculated global intracellular cAMP was estimated to ~1000-fold too low to affect 
IP3R. These results further supported the suggestion that cAMP was locally delivered to 
IP3Rs. It is not yet clear whether similar local delivery of cAMP contributes to the 
sustained responses to PTH. 
 Subsequent, experiments assess whether the sustained effects of PTH(1-34) on                                                                                                                                                     
CCh-evoked Ca
2+
 signals are mediated by cAMP junctions. The results indicate that 
acute or sustained stimulation with PTH(1-34) potentiates the increase in [Ca
2+
]c. These 
responses were not affected by inhibition of cAMP formation via AC with SQ/DDA 
(Seifert et al., 2012)  The maximal Δ Ca
2+
]c responses after acute stimulation with 
PTH(1-34) in the presence of SQ/DD  were significantly higher, and the sensitivity to 
PTH( -34  was significantly lower (    -fold) in comparison to sustained stimulation 
with PTH(1-34) (Fig. 4.7A, B, Table4.4). However, intracellular cAMP formation was 
significantly reduced by the SQ/DDA treatment. For both acute and sustained 
stimulation with PTH(1-34), SQ/DDA reduced the amount of cAMP produced by 
~70% relative to the matched controls (Fig. 4.7C, D, Table 4.5). The lack of effect of 
SQ/DDA on Ca
2+ 
signals could be a limitation of the method used to measure the Ca
2+ 
responses. However, an analysis that assumed that uniformly distributed cAMP 
regulates IP3R shows that 70% inhibition of AC by SQ/DDA should allow readily 
detectable inhibition of the effects of PTH(1-34) on CCh-evoked Ca
2+
 responses (Fig. 
4.8). These results are in line with a previous study, where it was shown that global 
inhibition of cAMP formation by inhibition of AC did not affect the potentiation of 
CCh-evoked Ca
2+
 signals by acute stimulation with PTH(1-34) (Tovey et al., 2008). 




 My results suggest that the effect of sustained stimulation with PTH(1-34) on 
Ca
2+ 
signals are also insensitive to substantial inhibition of AC. This is consistent with 
the sustained responses to PTH(1-34) also being mediated by hyperactive AC-IP3R 
signalling junctions, wherein cAMP is locally delivered at super-saturating 
















Figure 4.7. Effects of inhibition of AC on the cAMP produced and potentiation of 
CCh-evoked Ca
2+
 signals by PTH(1-34) (A, B) Populations of HEK-PR1 cells were 
incubated with SQ 22536 (1 mM) and DDA (200 µM) (SQ/DDA, 20 min) before 
stimulation with PTH(1-34) for 1 or 60 min. The effects of CCh (20µM) on Ca
2+ 
signals in the presence of BAPTA (2.5 mM) were then assessed. Results show the 
concentration-dependent effects of PTH(1-34) after stimulation with it for 1 min (A) or 
60 min (B) and the effects of SQ/DDA treatment. The peak increase in [Ca
2+
]c evoked 
by CCh are shown. (C, D) Concentration-dependent effects of a 1-min (C) or 60-min 
(D) stimulation with PTH(1-34) with or without SQ/DDA on intracellular cAMP 











H-cAMP. Results are means 
± SEM from 3 independent experiments. The codes in panel A applies to all panels. (E) 
Potentiation of PTH(1-34) on the Ca
2+ 
signals evoked by CCh are not affected by 






































































































Control 7.4 ± 0.2 364 ± 29 8.5 ± 0.20
*
 153 ± 14
*
 
SQ/DDA 7.5 ± 0.1 341 ± 43 8.9 ± 0.10
*




Table 4.3. Inhibition of AC does not affect the potentiation of CCh-evoked Ca
2+ 
signals by PTH(1-34). Effects of stimulation with PTH(1-34) for 1 or 60 min with 
SQ22536 (1 mM) and DDA (200 µM) (SQ/DDA, 20 min) pretreatment on the maximal 
Ca
2+
 signals evoked by CCh (20 µM) and on sensitivity to PTH(1-34). Results are 
means ± SEM from 3 independent experiments. 
*
P < 0.05 relative to paired 
comparisons at 1 min. Students paired t-test was used for analysis.   
 









Δc MP (%) 
Control 7.1 ± 0.1 0.4 ± 0.01 7.5 ± 0.01 0.6 ± 0.01 
SQ/DDA 7.2 ± 0.5 0.16 ± 0.01
*




Table 4.4. Inhibition of AC reduces PTH(1-34)-evoked cAMP formation. Effects of 
stimulation with PTH(1-34) for 1 or 60 min with SQ22536 (1 mM) and DDA (200 µM) 
(SQ/DDA, 20 min) pretreatment on the maximal amount of intracellular cAMP 
accumulation, and the sensitivity to PTH(1-34). Results are means ± SEM from 3 
independent experiments. 
*
P < 0.05 relative to paired comparisons with the controls. 
Students paired t-test was used for analysis.  
 






Figure 4.8. Effect of inhibiting AC on Ca
2+
 signals modulated by globally delivered 
cAMP should be readily detectable Results in figure 4.9E show the relationship 
between Δc MP and the potentiation of CCh-evoked Ca
2+
 signals for each 
concentration of PTH(1-34). Assuming (for Ca
2+
 signals regulated by globally 
distributed cAMP) that this relationship between cAMP and [Ca
2+
]c is unaffected by 
inhibition of AC, allows the effects of SQ/DDA on potentiation of CCh-evoked Ca
2+ 
signals by PTH(1-34) to be predicted. From figure 4.7C, I can compute the effects of 
SQ/DDA on the cAMP produced in response to each concentration of PTH(1-34); and 
from figure 4.7A I can compute the effect of each increase in cAMP on the potentiated 
Ca
2+
 signal. The results demonstrate that if the effects of PTH(1-34) were mediated by 





Inhibition of PDE with IBMX significantly increased the levels of cAMP detected after 
acute or sustained stimulation with PTH(1-34), whereas the potentiation of CCh-evoked 
Ca
2+
 responses by PTH(1-34) was unchanged. The results show that during acute or 
sustained stimulation with PTH(1-34), IBMX increased the levels of cAMP by   2-fold 
and ~15-fold respectively, relative to matched controls (Fig. 4.9C. D, Table 4.7). The 
peak increase in [Ca
2+
]c signals evoked by CCh after acute or sustained stimulation with 
PTH(1-34) and IBMX were similar to the matched controls (Fig. 4.9A, B). The 
maximal Δ Ca
2+
]c was significantly higher after acute compared to sustained 
stimulation with PTH(1-34) and IBMX (Table 4.6). However, the sensitivity to PTH( -






















compared to the matched controls without IBMX, and   2 -fold higher relative to acute 
stimulation (Table 4.6). There was no such effect of IBMX on the sensitivity of the 
acute response to PTH(1-34) (Fig. 4.9A).  
 For each stimulation condition, the amount of cAMP produced can be related to 
the associated potentiation of the CCh-evoked Ca
2+ 
signal. The results (Fig. 4.9E, F) 
show that there is huge disparity between the amount of cAMP and the corresponding 
Ca
2+
 signals for responses evoked by PTH(1-34) with and without IBMX. These results 
demonstrate that there is no consistent relationship between global levels of 













Figure 4.9. Effects of inhibition of PDEs on the potentiation of CCh-evoked Ca
2+
 
signals by acute and sustained stimulation with PTH(1-34). The figure legend is on 


















































































































Figure 4.9 Legend, (A, B) Populations of HEK-PR1 cells were incubated with IBMX (1 





-free HBS were then assessed. Results show the 
concentration-dependent effects of PTH(1-34) after incubation for 1 min (A) or 60 min 
(B) with and without IBMX (1 mM, 5 min) on the peak increase in [Ca
2+
]c evoked by 
CCh in the presence of BAPTA (2.5 mM). (C, D) Concentration-dependent effect of 1-
min (C) or 60-min (D) stimulation with PTH(1-34) and IBMX on intracellular cAMP 
measured under identical condition to those used to measure [Ca
2+
]c. Results show 
3
H-






H-cAMP. Results (A-D) are means ± 
SEM from 3 independent experiments. The codes in panel A apply to panels B-D. (E, 
F) Comparison of the CCh-evoked increases in [Ca
2+
]c and intracellular cAMP during 1 
min (data from Fig. 4.7A,C, Fig. 4.9A,C) (E) or 60 min (data from Fig. 4.7B, D, Fig. 
4.9B, D) (F) stimulation with PTH(1-34) allowed to establish the a non linear 
regression  relationship between the two to be defined for the different stimulation 
conditions (from Fig. 4.7), thus each line corresponds the same. 
 














Control 7.4 ± 0.2 364 ± 29 8.5 ± 0.2
*
 153 ± 14
*
 
IBMX 7.7 ± 0.1 300 ± 26 9.6 ± 0.1
*




Table 4.5. Inhibition of PDEs does not affect PTH(1-34)-potentiated Ca
2+
 signals. 
Effect of stimulation with PTH(1-34) for 1 or 60 min, with IBMX (1 mM, 5 min) 
pretreatment, on the maximal Ca
2+
 signals evoked by CCh (20 µM) and on the 
sensitivity to PTH(1-34). Results are means ± SEM from 3 independent experiments. 
*


















Δc MP (%) 
Control 7.1 ± 0.1 0.4 ± 0.01 7.5 ± .01
*
 0.6 ± 0.01
*
 




Table 4.6. Inhibition of PDEs increases the accumulation of cAMP evoked by 
PTH(1-34). Effect of stimulation with PTH(1-34) for 1 or 60 min with IBMX (1 mM, 5 
min) pretreatment, on the accumulation of intracellular cAMP, and the sensitivity to 
PTH. Results are means ± SEM from 3 independent experiments. 
*
P < 0.05 relative to 
paired comparisons at 1 min. Students paired t-test was used for the analysis.  
 
 Acute potentiation of CCh-evoked Ca
2+
 signals by PTH(1-34) was unaffected by 
simultaneous inhibition of both AC (with SQ/DDA) and PDE (with IBMX) (Fig. 
4.10A). However, during sustained stimulation the increase in the sensitivity to PTH(1-
34) evoked by IBMX (Fig. 4.9B) was partially reversed by inhibition of AC (Fig. 
4.10B). cAMP levels were also measured under similar conditions. Sustained 
stimulation with PTH(1-34) in the presence of SQ/DDA and IBMX showed only an   3-
fold increase in the level of cAMP compared to the level observed after stimulation 
with PTH(1-34) alone. Stimulation with PTH(1-34) and IBMX showed an   10-fold 
increase in the level of intracellular cAMP (Fig. 4.10C, Table 4.9).  Significant 
decreases in cAMP accumulation after inhibition of AC and PDEs in combination 
probably underlie the decrease in the sensitivity to PTH(1-34) (4.10B). However, these 
results suggested that the most likely potentiation of CCh-evoked Ca
2+ 
signals by 
sustained stimulation with PTH(1-34) and IBMX is mediated by cAMP junctions. This 













Figure 4.10. Effect of inhibiting AC and PDE in combination on PTH(1-34)- 
potentiation of Ca
2+ 
signals and cAMP formation. (A, B) Populations of HEK-
PR1cells were incubated with SQ 22536 (1 mM) and DDA (200 µM) (SQ/DDA, 20 
min) and IBMX (1 mM, 5 min) before stimulation with PTH(1-34) for 1 or 60 min. The 
effects of CCh on Ca
2+ 
signal were measured in the presence of BAPTA (2.5 mM). 
Results (A) and (B) show the concentration-dependent effects of stimulation with 
PTH(1-34) for 1-min  or 60-min respectively in the presence of IBMX and SQ/DDA 
(C) Concentration-dependent effects of 60-min stimulation with PTH(1-34) in the 
presence of IBMX and SQ/DDA, on intracellular cAMP measured under identical 
conditions to those used to measure [Ca
2+
]c. Results show 
3






H-cAMP. The codes in panel A apply to all panels. Results are 










































































The ability of IBMX to increase the sensitivity to PTH(1-34) during sustained 
stimulation with PTH(1-34) was unaffected by H89 (Fig. 4.11, Table 4.8). These results 
further suggest that PKA activity is probably not involved in the Ca
2+ 
responses evoked 




Figure 4.11. Effect of inhibiting PKA and PDE in combination on PTH(1-34) 
potentiation of Ca
2+
 signals and cAMP production. (A, B) Populations of HEK-
PR1cells were incubated with H89 (10 µM, 20 min) and IBMX (1 mM, 5 min) before 





-free conditions were then assessed. Results show the concentration-dependent 
effects of 1-min (A) or 60-min (B) stimulation with PTH(1-34) alone or with IBMX 
and H89 on the peak [Ca
2+
]c evoked by CCh (20 µM) in the presence of BAPTA (2.5 
mM). Codes in panel A apply to panel B. Results are means ± SEM from 3 independent 
experiments.  
 



















































































Control 7.9 ± 0.05 259 ± 28 8.8 ± 0.03 146 ± 20 
IBMX 7.7 ± 0.10 300 ± 26 9.6 ± 0.10
*
 177 ± 18 
IBMX +SQ/DDA 7.8 ± 0.10 259 ± 08 9.2 ± 0.05
*
 178 ± 14 
IBMX + H89 7.9 ± 0.2 246 ± 37 9.6 ± 0.10
*
 112 ± 03 
 
Table 4.7. Inhibition of PDE, AC and PKA in combination does not affect PTH(1-
34) potentiation of Ca
2+ 
signals. Effects of stimulation with PTH(1-34) for 1 or 60 min 
with IBMX (1 mM, 5 min), H89 (10 µM, 20 min) or SQ22536 (1 mM) and DDA (200 
µM) (SQ/DDA, 20 min) pretreatment, alone or in combination, on the maximal Ca
2+
 
signals evoked by CCh (20µM) and the sensitivity to PTH(1-34). Results are means ± 
SEM from 3 independent experiments. 
*
P < 0.05 relative to paired comparisons with 


























Δc MP (%) 
Control 
7.1 ± 0.1 0.4 ± 0.01 7.5 ± 0.01 0.6 ± 0.01 
IBMX 
7.4 ± 0.3 0.8 ± 0.1 7.7 ± 0.1 9 ± 0.02
 *
 
IBMX + SQ/DDA 
ND ND 8.1 ± 0.05
*




Table 4.8. Inhibition of PDE and AC in combination affects PTH(1-34)-evoked 
cAMP accumulation. Effects of stimulation with PTH(1-34) for 1 or 60 min with 
IBMX (1 mM, 5 min) or SQ22536 (1 mM) and DDA (200 µM) (SQ/DDA, 20 min) 
pretreatment, alone or in combination, on the maximal cAMP accumulation and 
sensitivity to PTH(1-34). Results are means ± SEM from 3 independent experiments. 
*
P < 0.05 relative to paired comparisons to matched controls. Students paired t-test was 
used for the analysis. ND, not determined. 
 
4.3.5. Potentiation of CCh-evoked Ca
2+
 signals by NKH477 is mediated 
by cAMP junctions  
Acute or sustained stimulation with NKH477 potentiated Ca
2+
 responses evoked by 
CCh in a similar fashion to the acute or sustained stimulation with PTH(1-34) (Fig. 3.9, 
Table 3.7). Inhibition of AC reduced the cAMP accumulation detected after acute or 
sustained stimulation with NKH477 (Fig. 4.12C, D). But the peak increase in [Ca
2+
]c 
evoked by CCh after acute or sustained stimulation with NKH477 was unaffected by 
AC inhibition using SQ/DDA relative to matched controls (Fig. 4.12A, B). 
Furthermore, the maximal Δ Ca
2+
]c signals recorded after acute stimulation with 
NKH477 and SQ/DDA (Fig. 4.12A, Table 4.10) were significantly higher than those 
recorded after sustained stimulation (Fig. 4.12B, Table 4.10).  
 Inhibition of PDE with IBMX before acute or sustained stimulation with NKH477 
significantly increased the levels of cAMP accumulation compared to matched controls 





signals remained similar after acute or sustained stimulation with 
NKH477 and IBMX relative to matched controls (Fig. 4.13A, B). IBMX caused the 
sensitivity to NKH477 to increase  3-fold during sustained stimulation (Fig. 4.13B, 




Table 4.9). These results, in addition to the results in figures 4.12 and 4.13 and Table 
4.9, suggest that NKH477 potentiated Ca
2+ 
responses are also most likely mediated by 



















Figure 4.12. Effects of inhibition of AC on the responses to NKH477.  (A, B) 
Populations of HEK-PR1 cells were incubated with SQ 22536 (1 mM) and DDA (200 
µM) (SQ/DDA, 20 min) before stimulation with NKH477 for 5 or 15 min. The effects 
of CCh on the Ca
2+
 signals were assessed in the presence of BAPTA (2.5 mM). Results 
show the concentration-dependent effects of 5-min (A) or 15-min (B) stimulation with 
NKH477 on the peak [Ca
2+
]c evoked by CCh (20 µM). (C, D) The concentration-
dependent effects of a 5-min (C) or 15-min (D) stimulation with NKH477 and 
SQ/DDA on the intracellular cAMP measured under identical conditions to those used 
to measure [Ca
2+
]c. Results show 
3






H-cAMP. The codes in panel A apply to all the panels. Results are means ± SEM from 















































































Figure 4.13. Effects of inhibition of PDEs on potentiation of CCh-evoked Ca
2+ 
signals by NKH477. (A, B) Populations of HEK-PR1 cells were incubated with IBMX 
(1 mM, 5 min) before stimulation with NKH477 for 5 or 15 min. The effects of CCh on 
the Ca
2+ 
signals evoked in Ca
2+
-free HBS were then assessed. Results show the 
concentration-dependent effects of a 5-min (A) or 15-min (B) stimulation with 
NKH477 on the peak [Ca
2+
]c evoked by CCh in the presence of BAPTA (2.5 mM). (C, 
D) Concentration-dependent effects of a 5-min (C) or 15-min (D) stimulation with 
NKH477 and IBMX on the intracellular cAMP measured under identical conditions to 
those used to measure [Ca
2+
]c. Results show 
3







H-cAMP. Codes in panel A apply to all panels. Results are means ± SEM 


























































































Control 5   ±      225 ±  9 5   ±       55 ±     
SQ/DDA 5   ±   2  234 ±  2 5   ±       72 ±  6 
IBMX 5 5 ±    2  92 ± 3   6   ±     *  56 ±    
 
Table 4.9. Effect of inhibiting PDE and AC on the potentiation of CCh-evoked 
Ca
2+ 
signals by NKH477. Effect of stimulation with NKH477, for 5 or 15 min, with 
IBMX (1 mM, 5 min) or SQ22536 (1 mM) and DDA (200 µM) (SQ/DDA, 20 min) 
pretreatment on the maximal Ca
2+
 signals evoked by CCh (20 µM) and on the 
sensitivity to NKH477. Results are means ± SEM from 3 independent experiments. 
*
P 
< 0.05 relative to paired comparisons to time matched control. Students paired t-test 




Previous work demonstrated that acute stimulation of PTH1R by PTH(1-34) stimulates 
AC and that the cAMP formed then potentiates the Ca
2+
 signals evoked by CCh (Tovey 
et al., 2008). My results are consistent with this scheme (Fig. 3.4). Several lines of 
evidence suggest that the response to PTH(1-34) is entirely mediated by cAMP, but that 
it is unlikely to be due to cAMP uniformly distributed in the cytosol. The most 
important evidence can be summarised as follows: 
1. For different stimuli that cause activation of AC, there was no consistent 
relationship between the increase in cAMP accumulation and the potentiation of 
CCh-evoked Ca
2+ 
signals (Meena et al., 2015; Tovey et al., 2008). 
2. Manipulations of cAMP accumulation by inhibition of PDE, AC or expression 
of AC subtypes, did not consistently affect the response to CCh (Meena et al., 
2015; Tovey et al., 2008). The most important evidence came from SQ/DDA, 
which caused substantial (>70%) inhibition of PTH(1-34)-evoked accumulation 




of cAMP without affecting the ability of any PTH(1-34) concentration to 
potentiate responses to CCh (Fig. 4.7, Table 4.3, 4.4).  
3. AC6 and IP3R2 were shown to be specifically associated in HEK cells and 
siRNA-mediated knockdown of either had some selective effect on the ability of 
PTH(1-34) to potentiate CCh-evoked Ca
2+
 signals (Tovey et al., 2008). 
These results, many of which have been confirmed by my experiments (Fig. 3.4, 3.6, 
4.7, Table 3.4, 3.5,4.3, 4.4), provide evidence that the cAMP that regulates IP3Rs is not 
uniformly distributed in the cytosol. Similarly spatially organised cAMP signals have 
been reported in many other systems (Rich et al., 2001). The SQ/DDA results, suggest 
an additional layer of complexity because these inhibit AC (by ~70%) and yet they 
have no effect on the ability of even a submaximal concentrations of PTH(1-34) to 
potentiate CCh-evoked Ca
2+
 signals. This observation lead to the proposal that cAMP 
might be delivered to IP3R in signalling junctions, within which, cAMP locally 
saturates associated IP3R. The concentration dependent effects of PTH(1-34) would 
then come from graded recruitment of these junctions (Fig.4.7, 4.8, 4.9). It is possible 
that a minor subtype of AC that is unaffected by SQ/DDA contributes 
disproportionately to the regulation of IP3R while not significantly contributing to the 
overall level of cAMP (Seifert et al., 2012). The 70% inhibition of AC by SQ/DDA 
might then report the behaviour of irrelevant subtypes of AC. A similar problem might 
arise if SQ/DDA does not again access to the AC that regulates IP3Rs.  
 However, previously when the expression of Gαs was decreased using siRN , 
the CCh-evoked Ca
2+
 responses were typical in HEK-PR1 cells, FK potentiated them 
and also the response to FK was not affected by inhibition of AC, while the sensitivity 
to PTH was decreased by inhibition of AC using SQ/DDA in similar cells. These 
results demonstrate that when the safety margin for signalling between IP3R and 
PTH1R was entirely eroded by reducing expression of Gαs, the requirement for  C 
activity was revealed. This further validates that cAMP mediates the effects of PTH on 
IP3R (Tovey et al., 2008). Despite all these results, if the existence of hyperactive 
junctions is not persuasive, the existence of some preferred pool of cAMP that regulates 
IP3R cannot be avoided. Further, this evidence shows that potentiation of CCh-evoked 
Ca
2+
 signals by PTH(1-34) requires local communication between AC and IP3R 
motivated my analysis of sustained responses to PTH(1-34) during which functional 
PTH1R-AC-complex are supposed to be internalized. The proposed or hypothesised  
primary site for the formation of AC-IP3R junctions was near PM (Tovey et al., 2008) 




and it was interesting to find what exactly happens when the primary site for cAMP 
synthesis (which is supposed to be near the PM) would change with the internalisation 
of PTH1R-AC complex during sustained PTH(1-34) stimulation.     
 Sustained stimulation with PTH(1-34) potentiates Ca
2+ 
signals evoked by CCh 
almost 50% less, than acute stimulation (Fig. 3.4, Table. 3.5). I anticipated three 
potential mechanisms which may contribute to the decrease in maximal Ca
2+ 
release 
after sustained stimulations with PTH(1-34). 
1. At higher concentrations (>300 nM) PTH(1-34) stimulates PLC (Table. 3.1). This 
leads to IP3 formation which could cause a leak of Ca
2+
 from intracellular stores via 
IP3R, during sustained stimulation with PTH(1-34) (Fig. 4.1A, Table. 4.1) (Bisello et 
al., 2002; Castro et al., 2002; Cupp et al., 2013; van der Lee et al., 2013). However, 
the PTH analogues which do not stimulate the PLC pathway, like PTH(2-38) and 
Tyr
1
PTH(1-34) ( Fig. 3.6, Table 3.11) (Cupp et al., 2013), also showed lesser Ca
2+
 
release after sustained stimulation. In addition I also checked store content using 
ionomycin and this remained unaltered (Huang et al., 1998; Tovey et al., 2003; 
Tovey et al., 2013). 
2. Binding of PTH(1-34) to PTH1R could cause internalization of the PTH1R (Section. 
3.1.6). Different PTH analogues: PTH(1-34), PTH(2-38), PTHrP(1-36), Tyr
1
PTH(1-
34) (Table 3.1) were used to confirm this probability. The results in figure 4.2A, C, 
figure 4.3A, C, and Table. 4.2 suggest that internalization of PTH1R is not associated 
with the decrease in maximal Ca
2+ 
response after sustained stimulation with PTH(1-
34). However, this experiment needs to be confirmed probably by over expressing 
GFP-tagged-PTH1R in HEK-wt cells and subsequently tracking PTH1R before and 
after PTH treatment under the confocal microscope. Besides, the association of 
PTH1R internalization with the increased levels of cAMP produced cannot be 
averted (Fig. 4.2B, D, 4.3B, D, Table. 4.3). Probably the increase in cAMP levels is 
due to a) continuous activation of AC, and/or b) a decrease in cAMP degradation via 
PDEs. Perhaps internalized PTH1R-coupled-AC complex (Ferrandon et al., 2009) 
changes the location of cAMP formation, which is not accessible to PDEs. However, 
PKA has been reported to stimulate PDEs and thereby regulate intracellular cAMP 
concentrations (Brown et al., 2012), but seems like not much effective in this 
setting. 
3. Higher levels of cAMP accumulation during sustained stimulation with PTH(1-     
34) (Fig. 4.2B, 4.7D, 4.9D Tables. 4.3, 4.5, 4.7) could also affect CCh-evoked IP3 




formation or increase degradation of IP3 and thereby decrease maximal Ca
2+
 release. 
From results in figure 4.6 it is suggested that the decrease in CCh-evoked IP3 
formation after sustained stimulation with PTH(1-34) is the potential cause for 
decrease maximal [Ca
2+
]c, rather than leak of Ca
2+
 from intracellular stores or 
internalization of PTH1R.    
Sustained stimulation with PTH(1-34) potentiated CCh-evoked Ca
2+
 signals and the 
sensitivity to PTH( -34  was increased by     fold in comparison to acute stimulation 
(Fig. 3.4, Table. 3.5). Possibly it could be due to an increase in the sensitivity of cAMP 
accumulation to PTH(1-34) (Fig. 4.2, Table. 4.3). As the sensitivity to PTH(1-34) 
further increases when the cAMP levels were assessed after inhibition of PDEs and 
significantly reversed back when PDEs and ACs were inhibited together (Fig. 4.9, 4.10, 
Table 4.5, 4.6, 4.7), these results further confirm that higher cAMP levels are 
responsible for the increase in sensitivity to PTH(1-34). Also, PKA cannot be 
associated with it as sustained stimulation with PTH(1-34) potentiated CCh-evoked 
Ca
2+ 
signals were normal after inhibition of PDEs and PKA together, the sensitivity to 
PTH remain unchanged (Fig. 4.11, Table 4.7 ). 
 Acute and sustained Ca
2+
 responses to PTH analogues (Table 3.1) were similar to 
those evoked by PTH(1-34) (Fig. 4.4, 4.3, Table. 4.2). Furthermore, acute and sustained 
responses to 8-Br-cAMP or direct activation of AC mimicked the responses evoked by 
PTH(1-34), and the maximal effects of sustained exposure to each stimulus were non-
additive (Fig. 3.9, 3.10, Table. 3.7, 3.8). Therefore, I conclude that attenuated 
potentiation of CCh-evoked Ca
2+
 signals during sustained exposure to PTH(1-34) is 
mediated by a sustained increase in cytosolic cAMP that perhaps does not require PKA 
or internalization of PTH1R signalling complexes. Previously, it was  reported that 
PKA can inhibit the activation of PLC-β2 via Gβγ subunits by phosphorylating PLC 
(Liu et al., 1996) and hence can affect the intracellular IP3 concentrations. However, 
this possibility seems unlikely because the inhibition of PKA did not affect sustained 
stimulation with PTH(1-34) potentiated CCh-evoked Ca
2+ 
signals.  
 The insensitivity of sustained responses to PTH(1-34) (Fig. 4.7, Table. 4.4) and 
NKH477 (Fig. 4.12, Table. 4.10) to substantial inhibition of AC suggests that similar to  
 acute stimulation with PTH(1-34) potentiated CCh-evoked Ca
2+
 signals, most likely 
these responses are also mediated by cAMP junctions, wherein globally distributed 
cAMP is not involved in the sustained stimulation with PTH(1-34) potentiated  Ca
2+ 
signals, rather these signals are also regulated by local supersaturating cAMP 




concentrations. However, these results would be more informative in proving AC 
involvement  if a HEK-PR  cell line with reduced expression of Gαs by means of 
siRNA could be used (Tovey et al., 2008). I conclude, and despite evidence that 
sustained stimulation with PTH(1-34) evokes internalization of functional AC 
signalling complexes (Ferrandon et al., 2009), that PTH1R retains its ability to signal 
via hyperactive AC-IP3R signalling junctions during sustained stimulation. Sustained 
stimulation with PTH(1-34) in the presence of IBMX caused the global concentration 
of intracellular cAMP to increase to levels sufficient to sensitize IP3R without the usual 
need for junctional delivery of cAMP. This was evident from the increased sensitivity 
to PTH(1-34) (Fig. 4.9, Table. 4.6) and NKH477 (Fig. 4.13, Table. 4.10) after sustained 
stimulation in the presence of IBMX, and its partial reversal by inhibition of AC with 
SQ/DDA (Fig. 4.10, Table. 4.8). These results demonstrate that SQ/DDA can, under 
these experimental conditions, attenuate the effects of PTH(1-34) on CCh-evoked Ca
2+
 
signals and reinforces my conclusion that hyperactive cAMP signalling junctions 
normally mediate the effects of PTH(1-34) (Fig. 3.4). On the other hand, the increase in 
sensitivity in the presence of IBMX for sustained durations could be because under 
these conditions, cAMP may be sensitising both junctional and extra junctional IP3Rs, 
and perhaps the recruitment of the extra junctional IP3R will be the first to be affected 
by inhibition of ACs, whereas junctional signalling remains functional (Fig. 4.14). As 
results in Figure 4.10 and Table 4.7 show; inhibition of PDEs and ACs together 
reversed the increased sensitivity to PTH(1-34) shown in the presence of IBMX. 
However sensitivity was still higher in comparison to its controls (Fig. 4.10, Table 4.7).  
  






Figure. 4.14. (A) Communication between IP3R and PTH1R-AC complex is anticipated 
to be mediated by local delivery of supramaximal cAMP concentration from AC to 
IP3Rs within junctional complexes. The implication is that the concentration-dependent 
effects of PTH are then mediated by recruitment of these all-or-nothing junctions, 
rather than from graded activity within each (Meena et al., 2015; Tovey et al., 2008). 
(B) Usually cAMP is delivered to IP3R within signalling junctions (left panel), but the 
substantial accumulation of cAMP during sustained stimulation with PTH and IBMX 
(right panel) attains global intracellular cAMP concentrations enough to sensitize IP3Rs 
beyond active junctions (Meena et al., 2015).   
 
 Although the global increase in cAMP increased the sensitivity to PTH(1-34) 
(Fig. 4.9) and NKH477 (Fig. 4.12), it had no effect on the maximal response, which 
remained smaller than that evoked by acute stimulation. This occurred despite there 
being no loss of Ca
2+ 
from intracellular stores during sustained activation of AC. This 
observation demonstrates that ineffective delivery of cAMP to IP3R during sustained 
stimulation does not the cause the diminished potentiation of CCh-evoked Ca
2+
 signals. 
Instead, sustained increases in intracellular cAMP reduce the amounts of IP3 produced 
after CCh stimulation. So far it is not addressed whether this results from decreased 














during sustained stimulation with PTH(1-34) are mediated by cAMP, probably 
independently of PKA and dependent on delivery of cAMP within hyperactive 
signalling junctions.  
 




Chapter. 5. Conclusions 
Ca
2+ 
and cAMP are ubiquitous intracellular messengers that regulate nearly all aspects 
of cellular activity (Bruce et al., 2003; Siso-Nadal et al., 2009; Willoughby et al., 
2007). The versatility of cAMP and Ca
2+
 is achieved by the complex spatial and 
temporal organization of their concentration changes within cells. This intricacy allows 
signals delivered to different parts of a cell to trigger various responses (Dyachok et al., 
2006; Gorbunova et al., 2002; Mongillo et al., 2006; Zaccolo et al., 2006). In addition, 
cross-talk between cAMP and Ca
2+ 
adds further versatility, and allows cells to process 
information arriving from various receptors (Bruce et al., 2003; Gerbino et al., 2005; 
Lefkimmiatis et al., 2009; Tovey et al., 2008). These properties: cross-talk between 
second messengers and spatiotemporal complexity, allow cells to respond appropriately 
and specifically to different environmental signals using a limited range of intracellular 
signals. 
 Hitherto, the effects of cAMP were suggested to be mediated by three families of 
proteins: Epacs, PKA and CNGC. Each of  these cAMP targets has a conserved cAMP-
binding domain, where cAMP binds and activates the protein (Rehmann et al., 2007). 
However, the work reported in chapters 3 and 4 is associated with understanding a new 
mode of cAMP signalling, which involves a local and direct interaction between the 
cAMP produced by a specific AC and IP3R (Meena et al., 2015). This regulation of 
IP3R by cAMP occurs in the absence of an obvious cAMP-binding motif within the 
primary sequences of IP3Rs. The latter is not unexpected because regulation of IP3Rs 
requires unusually high concentrations of cAMP (Tovey et al., 2008; Tovey et al., 
2013). The conclusions from Chapter 3 and 4 can be summarised as follows: 
1. Both acute and sustained stimulation with PTH(1-34) potentiate CCh-evoked 
Ca
2+ 
signals. However, in comparison to acute stimulation, the maximal Ca
2+ 
release was about 50% lower and the sensitivity to PTH(1-34) was about 10-
fold greater after sustained stimulation with PTH(1-34) (Meena et al., 2015). 
2. Both acute and sustained stimulation with PTH(1-34) are entirely mediated by 
cAMP, and probably independent of PKA and Epacs (Meena et al., 2015). The 
independence of PKA is most convincing for the acute responses to PTH(1-34). 
3. Sustained stimulation with PTH(1-34) has no effect on the basal leak of Ca2+ 
from intracellular stores, nor does internalisation of PTH1R contribute to the 
diminished response. The most likely reason for the diminished potentiation of 






 release after sustained stimulation with PTH(1-34) is that 
after this treatment CCh causes a reduced accumulation of IP3. The mechanism 
for this diminished intracellular accumulation of IP3 is unresolved, but it is 
likely to be caused by cAMP (Meena et al., 2015).      
4. The increase in sensitivity to PTH(1-34) after sustained stimulation was solely 
due to the more substantial formation of cAMP after sustained stimulation 
(Meena et al., 2015).    
5. My results are consistent with a model in which PTH(1-34) via PTH1R 
stimulates AC and locally delivers cAMP at supersaturating concentrations to 
associated IP3Rs, thereby increasing their sensitivity to IP3 and so potentiating 
the Ca
2+
 signals evoked by CCh (Tovey et al., 2008). This junctional delivery of 
cAMP is maintained during sustained stimulation with PTH(1-34), but 
prolonged activity of the junction leads to an inhibition of IP3 production. These 
cAMP junctions allow fast and robust signalling from AC to its targets, and 
without the need for PKA. I suggest that cAMP junctions deliver cAMP directly 
to both IP3R and to a target (possibly PLC or an enzyme that degrades IP3) 
responsible for diminished IP3 accumulation (Meena et al., 2015).  
  
 An important question is where does cAMP bind to regulate IP3R? It may bind 
either directly to IP3R or to a protein tightly associated with IP3R for example NHERF 
1 or 2, both of which are expressed in HEK-PR1 cells (Wang et al., 2010) and favour 
coupling via Gq or Gi/o to PLCβ (Wang et al., 2007). However, there are problems 
involved with identifying the cAMP-binding site: 
 a) It has low affinity for cAMP, which limits possibilities to use native proteins 
 for P
32
-cAMP binding, pull-down with immobilised cAMP, or photo-affinity 
 labelling.  
 b) The lack of sequence similarity between IP3R and consensus cAMP-binding 
 sites, and no apparent relationship with low-affinity cAMP-binding sites for 
 example PDEs. The best way to address this issue may be by performing 
 structure-activity relationship studies with cAMP analogues on IP3-evoked Ca
2+ 
 
release in permeabilized cells. These experiments would help to define 
 recognition properties of the cAMP-binding site. In addition they may also help 
 in ruling out a role for PKA and Epacs.   




 In a parallel study of human aortic smooth muscle cells, the IP3-mediated Ca
2+
 
signals evoked by activation of H1 histamine receptors were attenuated by 
prostaglandin E2 (PGE2). PGE2 stimulated cAMP formation and thereby inhibition of 
Ca
2+
 signals (Pantazaka et al., 2013). This PGE2-mediated inhibition of IP3-evoked 
Ca
2+
 release was partially reversed by inhibition of PKA, although the data are not yet 
compelling (unpublished work from Pantazaka et al). It is noteworthy, that these effects 
of PGE2 appear also to require delivery of cAMP within junctions analogous to those 
proposed to mediate sensitization of IP3Rs. These results suggest that local delivery of 
cAMP can lead to diminished accumulation of IP3 in other cells too. The role of PKA in 
this effect remains somewhat ambiguous, as it does to some extent in the experiments 
with PTH(1-34). The issue needs to be re-examined with better tools than H89. These 
might include KT5720 and myristoylated PKI (Davies et al., 2000) or by using 
transfected PKI or the mutant regulator PKA subunit RevAB, which does not bind to 
cAMP (Morgan et al., 2014). Future studies need therefore to determine 
unambiguously whether PKA contributes to the inhibition of IP3 accumulation evoked 
by the sustained stimulation with PTH(1-34) and to resolve the target (formation of IP3 
or its metabolism).  
 It is possible that mechanisms additional to the reduced accumulation of IP3 may 
also contribute to the smaller CCh-evoked Ca
2+
 signals after sustained stimulation with 
PTH(1-34). PKA can increase removal of Ca
2+ 
from cytosol by activating Ca
2+ 
pumps 




 exchanger (Karashima et al., 2007). These 
possibilities need also to be addressed. 
 Previously using immunoprecipitation assay and siRNA techniques it has been 
proved that specifically AC6 and IP3R2 are involved in forming junctions (Tovey et al., 
2008). In addition to this, the existence of junctional communication among various 
intracellular molecules has also been observed in other cell types like a) excitation-
contraction coupling in striated muscle, where voltage-sensing dihydropyridine 
receptors in the PM modulate the opening of RyR in the ER across a narrow junctional 
complex. Coupling of these proteins is developed from chemical coupling mediated by 
Ca
2+
 (cardiac muscles) to conformational coupling between two side by side protein 
(skeletal muscles) (Di Biase et al., 2005), b) Neuromuscular junctions of focally 
inverted skeletal muscles, where release of acetylcholine from presynaptic terminals 
saturates postsynaptic receptors and leads to all-or-nothing contraction of the myofibril 
(Fig.  5.1). Graded contraction of the muscle then results from graded recruitment of 




these all-or -nothing fibrillar responses. Similar to these junctions, AC-IP3R junctions 





Figure 5.1. AC-IP3R junctions may be similar to neuromuscular junctions in 
delivering supersaturating concentrations of stimulus to a target. Direct delivery of 
cAMP to IP3R within ‘signalling junctions’ (red box  increases the sensitivity of IP3Rs 
to IP3. This potentiates the Ca
2+
 release evoked by IP3 formed in response to the 
activation of M3R. The all-or-nothing mode of activation of these AC-IP3R signalling 
junctions is analogous to the behaviour of focally innervated skeletal muscle (lower 
panel), where release of acetylcholine at the neuromuscular junction (bottom) evokes 
all-or-nothing contraction of individual myofibrils. Graded contraction of the muscle 
fibre results from recruitment of contracting myofibrils (right panels at bottom). Image 
redrawn from Meena et al., 2015. 
 
 Even though the proposed AC-IP3R junctions show similarities with 
neuromuscular junctions, their existence and/or assembly after sustained stimulation 
with PTH(1-34) needs to be confirmed at the molecular level. The key questions to be 
addressed are a) How exactly communication is taking place between these junctions, 























intracellular organelles are actually taking part in the formation of AC-IP3R junctions? 
c) Are these junctions ACs and IP3Rs subtype specific? d) Whether these junctions are 
intracellular physical entities or do they assemble on demand for certain time 
durations? Only after resolving all these puzzles can the existence of AC-IP3R junctions 
be fully elucidated. Nevertheless, experimental results from Chapter 3 and 4 fully 
supports the hypothesis that  ''sustained stimulations with PTH(1-34) potentiated CCh-
evoked Ca
2+  
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